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Variation is common in human birth defects and this variability is 
influenced by genes and the environment. How genes and the environment 
interact in causing birth defect variability is a fundamental question in biology. I 
sought to investigate these interactions using a zebrafish model of fetal alcohol 
spectrum disorder. Fetal alcohol spectrum disorder (FASD) is an umbrella term 
that describes all ethanol-induced fetal defects. It is highly variable and also 
highly prevalent, with an estimated 1% of the population being affected. FASD 
can cause variable defects, including those affecting the craniofacial skeleton, a 
neural crest- and mesoderm-derived structure.  Although both timing and dosage 
can influence FASD variability, genetics is an underlying factor. Little is known of 
the genes that cause susceptibility to FASD, and so I sought to uncover these 
genes and the mechanism of their interaction with ethanol.  
Using a novel zebrafish genetic screen to uncover gene-ethanol 
interactions, we found a synergistic interaction between platelet-derived growth 
factor receptor alpha (pdgfra) and ethanol. Pdgfra is a receptor tyrosine kinase 
involved in cell migration, proliferation, and survival. Untreated pdgfra mutants 
display cleft palate. In a percentage of ethanol in which wildtype zebrafish are 
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unaffected, pdgfra mutants display exacerbated loss of the entire palatal 
skeleton. Furthermore, pdgfra heterozygotes display variable craniofacial 
defects, uncovering latent haploinsufficiency. Genetic analysis of a group of 
children with and without FASD suggests that this interaction is highly conserved. 
In zebrafish, further analysis of the mechanism of this pdgfra-ethanol interaction 
revealed a protective role of pdgfra to ethanol-induced neural crest cell death. 
Analysis of the Pdgfra downstream pathway PI3K/AKT/mTOR revealed an 
inhibitory effect of ethanol at the level of mTOR. Together, these data suggest 
that genes functioning in growth factor signaling could predispose to ethanol-
induced defects.  
Analysis of another growth factor signaling gene, fgf8a, supported this 
hypothesis. Ethanol interacts with fgf8a to cause posterior mesoderm-derived 
craniofacial defects. This phenotype can be recapitulated by blocking both fgf8a 
and fgf3, suggesting ethanol broadly attenuates growth factor signaling. Analysis 
of the fgf8a;fgf3 phenotype suggests that Fgf signaling is required for proper 
specification, via hyaluronan synthetase 2, of the mesoderm-derived posterior 
craniofacial skeleton. To test whether ethanol may also broadly attenuate Pdgf 
signaling, we analyzed pdgfra;pdgfrb mutant phenotypes and saw a 
recapitulation of the pdgfra-ethanol interaction. The synergistic pdgfra;pdgfrb 
phenotype may be due to a similar increase in neural crest cell death observed in 
the pdgfra-ethanol interaction. Together, these data reveal genes involved in 
growth factor signaling may act to protect against ethanol-induced craniofacial 
defects. 
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Chapter 1: General Introduction and Significance 
 
How genetics and the environment influence morphological variation is a 
fundamental biological question. The primary bulk of this variation is generated 
during development, where gene-environment interactions can sculpt the 
multicellular organism. In instances of impaired genetics and suboptimal 
environments, synergistic effects can result in a wide variety of birth defects. 
Nowhere is this clearer than in examples of teratogenesis.   
Teratogens are any environmental agent that can cause birth defects. One 
of the most well known teratogens is ethanol and fetal exposure to ethanol can 
cause fetal alcohol spectrum disorders (FASD, described in detail below). FASD 
is highly variable, with craniofacial tissues often damaged. While the timing and 
volume of ethanol exposure influence FASD variability, there is clear genetic 
susceptibility to FASD. What these predisposing FASD loci are is still an open 
question.  
To address this question, we utilized a zebrafish model of FASD, focusing 
on the craniofacial skeleton, to uncover and characterize gene-ethanol 
interactions. The broader significance of this research was to understand how 
genes and environment cause phenotypic variation in general, to broaden FASD 
diagnosis, and to provide mechanistic understanding of these gene-ethanol 
interactions that may help in future treatments of this incredibly prevalent birth 





1.I. Fetal Alcohol Spectrum Disorder  
Ethanol was first described as a human teratogen in 1968 (Lemoine et al., 1968), 
and diagnosed as Fetal Alcohol Syndrome in 1973 (Jones et al., 1973; Jones 
and Smith, 1973). Since then, a yet broader representation of the effects of 
ethanol on the developing fetus have been categorized and termed fetal alcohol 
spectrum disorders (FASD). FASD is reported to occur as frequently as 1:100 
(Sampson et al., 1997) live births in the US, with some world communities 
showing a prevalence of 20% (May et al., 2013), making alcohol consumption 
one of the most common causes of human birth defects.  
Alcohol’s teratogenic endpoints are very diverse. The most severe end of 
the spectrum of FASD show pre- and post-natal growth retardation, intellectual 
disability coupled with abnormal morphogenesis of the brain, and craniofacial 
defects, diagnosed as FAS (Calhou and Warren, 2007; Hoyme et al., 2005; 
Jones, 2011). The most mild end of the FASD spectrum involves neurological 
cognitive disorders that are sometimes manifest as late as adolescence (Calhoun 
and Warren, 2007). Other FASD defects include heart, ear, ocular, and limb-
associated malformations (Jones, 2011). The variability seen within FASD can be 
attributed to a number of factors, including the amount and timing of alcohol 
ingested by the mother during pregnancy, malnutrition, epigenetic changes, and 
underlying genetic susceptibility (Perkins et al., 2013). Recent research is 
beginning to shed new light on the latter. 
 
1.II. Gene-ethanol interactions (from McCarthy and Eberhart, 2014) 
Since as early as the 1970s, when the criteria for FAS diagnosis were 
established, underlying genetic factors have been considered to be important. 
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The most convincing evidence in humans for genetic susceptibility to FAS lies in 
the results of twin studies (Chasnoff, 1985). Monozygotic twins have been shown 
to be 100% concordant for FAS, while dizygotic twins, also sharing a common 
uterine environment, only displayed 63% concordance (Streissguth and 
Dehaene, 1993). The precise genetic players underlying susceptibility to FASD 
have remained elusive. Human FASD studies have primarily focused on 
candidate genes, including allelic variants of the alcohol dehydrogenase gene 
ADH1 (Etheredge et al., 2005; Mitchell et al., 2001; Romitti et al., 1999).  Other 
genes that may predispose to human FASD remain elusive. Thus, research has 
come to rely on animal models to direct our understanding of genetics underlying 
FASD. Pathways uncovered in animal models that are especially sensitive to 
ethanol teratogenesis are reviewed below.  
 
1.II.a. Metabolic Pathways 
Alcohol is metabolized first into acetaldehyde via alcohol dehydrogenase (ADH), 
catalase, and cyp2E1 (Deehan et al., 2013; Figure 1.1). Acetaldehyde is further 
catabolized into acetate, an important biosynthetic molecule, via acetaldehyde 
dehydrogenase. This pathway produces harmful byproducts, including 
acetaldehyde itself and reactive oxygen species. Because of this, how well a 
mother and the fetus can catabolize ethanol and its constituent metabolites may 
be an important factor in FASD.  
The first gene ever implicated in FASD was ADH.  In humans, different 
alleles of ADH1 encode for enzymes that catabolize ethanol at different rates. A 
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number of studies have linked these allele-specific ADH genes to FASD 
prevalence. In humans, it has been shown that the ADH1B2 and ADH1B3 alleles 
encode for enzymes with faster catabolism (Das et al., 2004; Green and Stoler, 
2007; Jacobson et al., 2006; May et al., 2007; McCarver et al., 1997; Viljoen et 
al., 2001). These alleles are underrepresented in FASD children and their 
mothers, suggesting that genes regulating ethanol catabolism may regulate 
FASD susceptibility. 
Animal studies provide clear evidence that this catabolic pathway is 
important in ethanol teratogenesis. Superoxide dismutase is an essential enzyme 
for clearing reactive oxygen species. In mice, maternal transgenic 
overexpression of Superoxide dismutase protects litters from ethanol-induced 
decreases in fetal body weight and viability (Wentzel and Eriksson, 2006). 
Furthermore, dams harboring a targeted mutation in Superoxide dismutase were 
found to have increased risk of fetal resorptions and decreased body weight of 
embryos exposed to ethanol. However, zygotic Superoxide dismutase genotype 
had no apparent effect on resorption rates or viability, suggesting that the 
mother’s ability to clear alcohol metabolites is important in susceptibility to 
ethanol-induced defects. Indeed, earlier mouse studies linked ethanol-
metabolizing activity and maternal genotype to increased incidences of ethanol-
induced fetal malformations and death (Chernoff, 1980; Gilliam and Irtenkauf, 
1990). However, these studies did acknowledge that maternal genotype was not 
the only influencing factor in susceptibility to ethanol teratogenesis. 
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Zygotic genotype can also generate susceptibility to ethanol teratogenesis 
alone or in combination with the maternal genotype. Acetaldehyde accumulation 
has been linked to DNA damage and increased oxidative stress, hallmarks of 
ethanol teratogenesis (Dong et al., 2009; Ramachandran et al., 2001; 
Ramachandran et al., 2003). To counteract these damaging byproducts, cells 
further catabolize acetaldehyde via Aldh and mobilize DNA repair enzymes such 
as Fanconi anaemia genes (Fancd) (Mirchandani and D’Andrea, 2006). 
Recently, the function of both Aldh2 and Fancd2 has been shown to be essential 
for protection against ethanol teratogenesis (Langevin et al., 2011; see Fig. 1.1). 
In this study, mouse pups exposed prenatally to alcohol have no increase in 
mortality if they are born to wild-type mothers, regardless of zygotic genotype. 
Similarly, female mice heterozygous for Aldh2 were able to have viable Aldh2-/-
;Fancd2-/- pups. However, in the presence of ethanol these pups had a decrease 
in viability and an increase in the prevalence of exencephaly and eye 
abnormalities. Furthermore, a small percentage of ethanol-treated Aldh2+/-
;Fancd2-/- pups also showed an increase in eye abnormalities and exencephaly. 
Collectively, these studies strongly suggest that in mammalian systems, 
teratogenesis caused by deficits in the ethanol catabolic pathway is the result of 
a complex interaction of maternal and zygotic genotypes. 
Together, these studies strongly suggest that proper alcohol catabolizing 
activity during pregnancy, in both the mother and the fetus, is an important factor 
in FASD susceptibility. Increased alcohol intake leads to an increase in 
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acetaldehyde and reactive oxygen species formation, which together, can lead to 
deleterious effects including DNA damage and cell death. Concurrent with a lack 
of proper catabolizing activity, susceptibility increases in mice lacking proper 
DNA-damage repair enzymes, such as Fancd2. In effect, these types of deficits 
most likely lead to cell death, however, it is unclear if this would be a tissue-
specific effect or not. Lastly, these studies promote the idea that FASD variability 
is most likely manifest as complex genetic interactions within the mother and/or 
the fetus.  
 
1.II.b. Sonic Hedgehog (Shh) pathway 
One of the most well-studied developmental signaling molecules is Sonic 
Hedgehog (Shh). Shh is a secreted glycoprotein first synthesized as a 45kDA 
precursor protein, which undergoes autocatalytic cleavage to produce a carboxy 
terminal fragment (Shh-C) and a 19kDa active fragment (Shh-N) (Stone et al., 
1996; see Figure 1.2). Shh-N is then further modified via addition of cholesterol 
and palmitate to form the functionally active Shh ligand (Mann and Beachy, 2000; 
Porter et al., 1996). Upon sterol modification, Shh is transported to the cell 
membrane via lipid rafts and released from the secreting cell (Mao et al., 2009). 
Shh signaling occurs when the ligand attaches to patched, releasing inhibition of 
smoothened, leading to activation of Gli transcription factors to regulate gene 
expression (Ruiz I Altaba et al., 2002).  
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Mutation of Shh pathway genes causes developmental deficits in 
numerous tissues. These defects include neural crest-specific cell death, 
misspecification of the dorsal-ventral axis of the neural tube and loss of midline 
craniofacial structures as occurs in the holoprosencephaly (HPE) spectrum 
(Chiang et al., 1996; Cordero et al., 2004; Eberhart et al., 2006; Jeong et al., 
2004; Pan et al., 2013; Roessler and Muenke, 2010; Wada et al., 2005). These 
same phenotypes can be present in children with FAS (Johnson and 
Rasmussen, 2010; Jones, 2011), suggesting that ethanol disrupts Shh signaling.  
There is an abundance of molecular evidence that ethanol alters the Shh 
pathway in both cell culture and animal models (see Fig. 1.2). Ethanol has been 
found to decrease the expression of Shh in chicken (Ahlgren et al., 2002; 
Brennan and Giles, 2013), mouse (Aoto et al. 2008), and zebrafish (Li et al., 
2007). Furthermore, co-application of exogenous Shh with ethanol has been 
shown to alleviate ethanol-induced defects (Ahlgren et al., 2002; Aoto et al., 
2008; Li et al., 2007; Loucks and Ahlgren, 2009; Zhang et al., 2011; Zhang et al., 
2012). In addition to altering levels of transcription, ethanol has also been shown 
to disrupt proper membrane fluidity and composition (Polley and Vemparala, 
2012), which might account for some of ethanol’s effects on the Shh pathway. In 
vitro studies have found that ethanol perturbs proper association of active Shh 
ligand with lipid rafts destined to the membrane (Mao et al., 2009). Ethanol 
exposure leads to a decrease in the amount of membrane-associated cholesterol 
(Li et al., 2007), which is vital for proper Shh signaling. Similar to the effects of 
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exogenous Shh ligand, supplemental cholesterol reduces the teratogenicity of 
ethanol (Li et al., 2007; Ehrlich et al., 2012). Additionally, microarray data 
suggests that differences in expression of polysaccharide genes, also important 
in membrane-based cell communication and function, partly contributes to strain 
sensitivity to ethanol-induced defects in mice (Downing et al., 2012). These data 
support the hypothesis that ethanol directly affects Shh-mediated and 
membrane-based signaling.  
While Shh has long been implicated in ethanol teratogenesis, only recently 
has a genetic interaction between ethanol and the Shh pathway been discovered 
(see Fig. 1.2). Ethanol interacts with the gene encoding the Shh co-receptor 
Cdon to cause HPE (Hong and Krauss, 2012). Cdon mutant mice have a low 
penetrance of minor holoprosencephaly phenotypes, and the strain background 
used in this study has been shown to be resistant to ethanol teratogenesis. 
However, ethanol-exposed Cdon mutant mouse embryos have defects in early 
midline patterning, Shh signaling, and increased susceptibility to HPE and 
craniofacial defects. For example, ethanol increased lobar HPE by 50% in 
treated Cdon mutants. Increased prevalence of cranial defects including those 
affecting the palate and premaxillary bones occurred as well. While ethanol 
exacerbated the phenotypes present in Cdon mutants, no defects in ethanol-
treated heterozygotes were reported, suggesting a weak interaction.  
Ethanol may interact more strongly with other members of the Shh 
signaling pathway. Ethanol exposure reveals haploinsufficiency in mice carrying 
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mutant alleles of Shh or Gli2 (Keitzman et al., unpublished). These ethanol-
treated heterozygous mice have variable craniofacial and HPE-like defects. 
Additional evidence in zebrafish supports Shh’s role in predisposing to ethanol 
teratogenesis. Ethanol acts synergistically with suboptimal morpholino 
knockdown of agrin, an extracellular membrane protein required for Shh-
mediated signaling, or of shh which results in variable eye defects, including 
reduced size, in zebrafish (Zhang et al., 2011; Zhang et al., 2012). Collectively, 
both in vitro and in vivo data suggest that ethanol may broadly perturb Shh 
signaling at multiple levels, and that genetic predisposition may exacerbate these 
molecular disruptions. 
 
1.II.c. Growth Factors 
Growth factor signaling pathways are major mediators of tissue growth, 
proliferation, and survival; all of which are processes disrupted by ethanol. 
Growth factor signaling involves ligand activation, receptor dimerization, and 
activation. Receptor activation signals through cytoplasmic effectors that function 
in activating downstream intracellular pathways important for numerous cellular 
roles (de la Monte and Wands, 2010; Hsuan and Tan, 1997; Tallquist and 
Kauzlauskas, 2004). One of the most well studied effectors with relevance for 
ethanol teratogenesis is Phosphoinositide-3 kinase (PI3K).  
PI3K functions partly through the AKT and mTOR pathways (McGough et 
al., 2009; Siegenthaler and Miller, 2005). PI3K phosphorylates inositol 
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phospholipids to generate second messenger phosphoatidylinositol-3,4,5- 
triphosphates (PIP3). PIP3 levels are regulated via phosphatase and tensin 
homolog (PTEN), which converts PIP3 back into inactive PIP2. When PTEN is 
inactive, PIP3 activates AKT, which causes a cascade effect on a number of 
downstream constituents involved in cellular growth and survival including 
forkhead transcription factors, BCL-2, MDM2, and mTORC1 (Downward, 2004; 
Manning and Cantley, 2007). mTORC1 functions in cellular growth and survival 
via activation of elongation factors (EIF) and p70 S6 Kinase (Dobashi et al., 
2011). Disruption of this pathway at the level of PI3K, AKT, or mTOR leads to 
decreased cellular survival, proliferation, and growth (Cai et al., 2013; Kim et al. 
2013). 
Numerous in vitro studies show that ethanol exposure leads to decreased 
signaling through the PI3K/AKT/mTOR pathway. Microarray data showed a 
disparity in activation of genes in the PI3K pathway, including Akt and Pten, in 
mouse strains with differing sensitivity to ethanol-induced defects (Green et al., 
2007). PI3K activation is reduced in human neuronal cells exposed to ethanol (de 
la Monte et al., 2000), while in rat neuronal cell cultures ethanol causes a 
reduction in activated AKT (de la Monte and Wands, 2002). Ethanol decreases 
mTOR and S6 kinase phosphorylation in mouse myocytes (Hong-Brown et al., 
2006), similarly, in vivo studies in rat hearts show decreased mTOR 
phosphorylation in the presence of ethanol (Vary et al., 2008). It has also been 
shown that the activity of PTEN, which inhibits PI3K signaling, increases in cell 
 11 
cultures exposed to ethanol (Xu et al., 2003). Furthermore, increasing growth 
factor signaling or PI3K activity has been shown to alleviate some ethanol-
induced defects (McGough et al., 2009; Siegenthaler and Miller, 2005; de la 
Monte et al., 2000; Jegou et al., 2013). Together, these data suggest that ethanol 
perturbs proper growth factor mediated PI3K/AKT/mTOR signaling, suggesting 
that variants in the PI3K pathway could underlie FASD.  
Many growth factor pathways use PI3K/mTOR signaling, so it might be 
predicted that gene-ethanol interactions will exist for these growth factors. In 
support of this model, transgenic expression of insulin-receptor, which signals via 
PI3K, protects against ethanol-induced motor deficits in Drosophila (McClure et 
al., 2011). It is possible that ethanol perturbs growth factor signaling at many 
levels. Ethanol has been shown to inhibit phosphorylation of Insulin-receptor in 
cell cultures (de la Monte et al., 1999) and rat liver (Sasaki et al., 1994). 
Numerous studies have shown that ethanol perturbs proper expression of a 
number of growth factors and their receptors. These include insulin-receptor, 
brain-derived growth factor, TGFB, and VEGF (de la Monte et al., 2000; Jegou et 
al., 2013; Feng et al., 2005). Collectively, these results show that growth factor 
signaling may be a major target of ethanol, underlying FASD susceptibility.  
 
1.II.d. Zebrafish as a FASD model system  
While these examples of gene-ethanol interactions strongly support a genetic 
susceptibility to FASD, they are likely just scratching the surface of gene-ethanol 
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interactions that exist. Furthermore, few of the above mentioned studies 
characterized the gene-ethanol interactions mechanistically, prompting further 
analysis and detail. To uncover other gene-ethanol interactions and to be able to 
describe the mechanism of these interactions, it prompts the use of the highly 
versatile model system Danio rerio, also known as the zebrafish.   
Zebrafish have been used to study the effects of ethanol since as early as 
1910 (Stockard, 1910). These early studies described relatively high ethanol 
concentrations causing cyclopia, a defect observed only in very severe cases of 
FAS (Cohen and Sulik, 1992; Johnston and Bronsky, 1995). Since then, 
zebrafish research has added to these initial findings showing similarities in more 
subtle FAS and FASD characteristics including neuronal (Blader and Strahle, 
1998; Joya et al., 2014), ocular (Dlugos and Rabin, 2007), heart (Dlugos and 
Rabin, 2010), and craniofacial (Ali et al., 2011) deficits.  While one study showed 
strain-specific defects to ethanol (Dlugos and Rabin, 2003), none of these 
studies sought to identify specific gene–ethanol interactions.  
Zebrafish is highly amenable to uncovering gene-ethanol interactions due 
to the ease of both forward and reverse genetics. Zebrafish allow for fast 
screening of genes for phenotypic traits because of their high fecundity and rapid 
maturation. Furthermore, because they fertilize their eggs externally, zebrafish 
allow for control over both the timing and dosage of ethanol (Fig. 1.3). 
Transgenics also allow for precise cell-tracking and tissue labeling to be 
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employed in investigating the mechanisms by which ethanol and genes interact 
to affect normal craniofacial development.  
1.III. Craniofacial Development 
The craniofacial skeleton is a vertebrate novelty. The evolutionary premise of the 
craniofacial skeleton is thought to be two-fold: 1) to house and protect the brain 
and head sensory organs; and, 2) to allow for a predatory lifestyle (Northcutt and 
Gans, 1983). The development of this structure is incredibly conserved across 
vertebrate species (Knight and Schilling, 2006), and, as such, analysis of 
craniofacial development in zebrafish informs our understanding of human 
development (Knight and Schilling, 2006).  
 
1.III.a. Evolution of Vertebrates 
 Vertebrates are a subphyla of chordata. The chordates all share distinct 
attributes that separate them from other phyla: 1) the appearance of the 
mesoderm-derived notochord, which is a structurally important organ that 
provides rigidity; 2) a dorsal neural tube, which will contribute to the expansion of 
the neural network including the brain; 3) somites, a mesoderm-derived tissue 
that forms along the anterior-posterior axis that functions to form muscles for 
movement; 4) a postanal tail; and, 5) pharyngeal slits (Satoh et al., 2012). 
Several characteristics separate vertebrates from invertebrate chordates 
including the generation of a vertebral column, and the formation of a craniofacial 




1.III.b. Development of the vertebrate craniofacial skeleton 
Although vertebrates include an incredible array of different organisms from fish, 
amphibians, birds and mammals, the development of the craniofacial skeleton is 
incredibly conserved across these species (Knight and Schilling, 2006). 
Craniofacial form strictly adheres to fundamental similarities among species due 
to a shared phylotypic stage (Schmidt and Starck. 2010; Galis and Metz, 2001). 
In vertebrates this stage is called the pharyngeal stage and it occurs following 
gastrulation, the time at which all three germ layers become specified (Wolpert, 
1992). It is characterized by the formation of the head, including the appearance 
of pharyngeal arches, eyes, and a swelling of the brain (Graham and Richardson, 
2012; Graham, 2001; Frisdal and Trainor, 2014). One of the most significant 
similarities between vertebrates at this stage is the appearance of the neural 
crest.  
 
1.III.c. The neural crest 
The neural crest is a multipotent tissue that is novel to vertebrates and is often 
dubbed the “fourth germ-layer” (Baker and Bronner-Fraser, 1997b; Hall, 2000; 
Green et al., 2015; Knight and Schilling, 2006; Sauka-Spengler et al., 2008; Yu, 
2010). As a multipotent cell type, the neural crest generates the peripheral 
nervous system, cardiomyocytes, melanocytes, and most of the craniofacial 
skeleton, among other tissues (Kunisada et al., 2014; Mayor and Theveneau, 
2013; Sauka-Spengler and Bronner-Fraser, 2010). Neural crest cells are 
specified at the boundary between the neural and non-neural ectoderm (Baker 
and Bronner-Fraser, 1997a; Basch et al., 2006). They then undergo an epithelial-
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to-mesenchymal transition, migrate, and collect into regions where they will 
terminally differentiate (Baker and Bronner-Fraser, 1997b; Hall, 2000; Knight and 
Schilling, 2006; Sauka-Spengler et al., 2008). In the anterior, cranial neural crest 
cells migrate in distinct streams to populate the reiterated pharyngeal arches. 
Within the pharyngeal arches neural crest cells are bounded by endodermal and 
ectodermal epithelia and surround a mesoderm core (Knight and Schilling, 2006).  
 Within the pharyngeal arch the neural crest rely on surrounding tissues, 
including all three germ layers, for proper patterning and morphogenesis (Couly 
et al., 2002; David et al., 2002; Kimmel et al., 2001; Knight and Schilling, 2006; 
Noden, 1983; Schilling et al., 2001; Seufert and Hall, 1990; Trainor and Krumlauf, 
2000). Patterning of the neural crest along the anterior-posterior and dorsal-
ventral axes is critical for craniofacial development and is regulated by numerous 
genes including Hox (Rijili et al., 1993; Trainor, 2003) and Dlx (Depew et al., 
2002; Takechi et al., 2012; Talbot et al., 2010) genes, respectively. Similarly, 
numerous signaling molecules including BMP (Alexander et al., 2011), Shh 
(Eberhart et al., 2006; Wada et al., 2005), and Wnt (Alexander et al., 2014; Le 
Pabic et al., 2014) shape individual skeletal elements. Occurring simultaneously 
during morphogenesis is the terminal differentiation of these neural crest cells 
into cartilage or bone (Kobayashi and Kronenberg, 2014). The embryological 
craniofacial structures that will eventually form are called the viscerocranium and 
the neurocranium.  
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The general organization of the embryonic craniofacial skeleton includes 
the viscerocranium, which gives rise to all of the jaw, pharyngeal, and inner ear 
skeleton, and the neurocranium, which will give rise to the palate, skull base, and 
skull vault. The palate and skull base are connected and demarcated into pre- 
and postchordal structures, respectively. The postchordal neurocranium forms 
along the notochord, and the prechordal forms anterior of the notochord. In 
mouse, chick, xenopus, and axolotl, the neural crest will contribute to all of the 
viscerocranial elements as well as the prechordal neurocranium (Chai et al., 
2000; Couly et al., 1993; Gross et al., 2008; Koentges and Lumsden, 1996; 
McBratney-Owen et al., 2008; Sefton et al., 2015). In chick and mouse, some 
regions of the postchordal neurocranium are also neural crest derived, forming 
connective sites with more anterior neural crest-derived structures (Koentges and 
Lumsden, 1996; McBratney-Owen et al., 2008). Studies in zebrafish confirm 
these findings (Crump et al., 2004; Eberhart et al., 2006; Wada et al., 2011), and 
a more in-depth analysis of the neural crest contributions to the zebrafish 
craniofacial skeleton will be reviewed later in more detail in this, and following, 
chapters. Regions of the craniofacial skeleton that are not generated by neural 
crest are mesoderm derived.  
1.III.d. The cephalic mesoderm 
While the neural crest give rise to most of the craniofacial skeleton, there is also 
contribution by the cephalic mesoderm (Couly et al., 1993; McBratney-Owen et 
al., 2008). In mouse and chick, the cephalic mesoderm forms most of the 
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postchordal neurocranium around the tip of the notochord, as well as the 
posterior skull vault, forming sutures with the neural crest-derived anterior skull 
vault (Couly et al., 1993; McBratney-Owen et al., 2008). These processes occur 
after much of the organogenesis of the brain and other tissues have ceased 
(Balczerski et al., 2012). Although we know what craniofacial structures the 
cephalic mesoderm gives rise to, we know little of the morphogenetic pathways 
that direct this formation.  
 All mesoderm derives from a population of endomesoderm at the 
beginning of gastrulation (Cooke, 1989). The prechondrogenic cephalic 
mesoderm is among this group of cells and all mesoderm undergoes cellular 
movements as gastrulation proceeds (David, 2015; Denoyelle et al., 2001; 
Dumortier and Rohde and Heisenberg, 2007). At the end of gastrulation, the 
prechondrogenic cephalic mesoderm forms abutting the notochord, where they 
begin chondrogenic differentiation via interactions with surrounding tissues, and 
in mouse, this occurs in a posterior to anterior fashion (McBratney-Owen et al., 
2008). Like the neural crest, the cephalic mesoderm undergoes terminal 
chondrogenic differentiation. One of the few signaling pathways we know 
regulate the proper chondrogenic differentiation of the cephalic mesoderm is Shh 
(Balczerski et al., 2012). Early in development, Shh is initially expressed by the 
notochord, which later activates Shh in the ventral neural tube (Dessaud et al., 
2008). Balczerski and colleagues showed that Shh from the notochord was the 
signaling source required for the activation of the prechondrogenic and 
chondrogenic genes sox9a and col2a1a in the cephalic mesoderm, respectively. 
In chapter 3, I will revisit the development of postchordal neurocranial, adding the 
Fgf signaling pathway as an important contributor to this process.  
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1.III.e. Zebrafish craniofacial development and anatomy 
Zebrafish undergo similar events shared by all vertebrates that culminate into the 
formation of the head. In zebrafish, gastrulation begins at 6 hours post 
fertilization (hpf) and ends at 10 hpf. At this time point, precursors of the cephalic 
mesoderm have migrated to the notochord (Hammerschmidt et al., 2004), and 
the neural crest is being specified at the dorsal neural tube (Baker and Bronner-
Fraser, 1997a; Knight and Schilling, 2006). At 12 hpf, the cranial neural crest 
begin migrating and will populate the pharyngeal arches beginning at 
approximately 24 hpf (Eberhart et al., 2008). Here, they will undergo numerous 
genetic and morphogenetic programs to give rise to the embryonic structures of 
the craniofacial skeleton.  
In zebrafish, the craniofacial skeleton is readily observed as early as 4 
days post fertilization (Fig. 1.4; Schilling and Kimmel, 1997). The neurocranium 
can be split into prechordal and postchordal structures (Fig. 1.4). The prechordal 
structures include the ethmoid plate and the trabeculae, collectively called the 
palate (Fig. 1.4; Schilling and Kimmel, 1997; Swartz et al., 2011). The 
postchordal neurocranium is composed of the parachordals, the anterior 
basicapsular commissures, the posterior basicapsular commissures, the lateral 
commissures, the auditory capsule, and the occipital arches (Fig. 1.4; Schilling 
and Kimmel, 1997; van de beer, 1934). 
The viscerocranium is composed of numerous cartilage elements 
including Meckel’s cartilage, palatoquadrate, hyosymplectic, interhyal, 
ceratohyal, and ceratobranchial (Schilling and Kimmel, 1997). The first 
pharyngeal arch will give rise to the Meckels cartilage and the palatoquadrate, as 
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well as the ethmoid plate and trabeculae (Fig. 1.4; Crump et al., 2004), while the 
second arch will give rise to the hyosymplectic, interhyal and ceratohyal (Fig. 
1.4), and the more posterior arches (3-7) giving rise to the ceratobranchial 
cartilages (not shown). The postchordal neurocranium is primarily derived from 
cephalic mesoderm in all species examined, with data in zebrafish shown in 
chapter 3.   
 
1.IV. Growth factor signaling in craniofacial development 
Numerous genetic pathways regulate proper craniofacial development including 
both the Platelet-derived growth factor (Pdgf) and Fibroblast growth factor (Fgf) 
signaling families. Growth factor signaling pathways share common attributes 
including receptor activation and signal transduction (Fambrough et al., 1999; 
Pawson and Scott, 1997). The general makeup of a growth factor signaling 
pathway involves receptors and their ligands. The receptors are transmembrane, 
hosting an extracellular domain required for ligand binding, and an intracellular 
cytoplasmic domain that functions in signal transduction (Pawson and Scott, 
1997). Most growth factor receptors dimerize to function, which is activated by 
dimerization of ligands. After ligand binding, receptors auto-phosphorylate each 
other on their intracellular tyrosine kinase domains. This promotes the activation 
of multiple downstream pathways involved in a diversity of cellular functions 
including cellular migration, proliferation, morphogenesis, patterning, and survival 
(Lemmon and Schlessinger ,2010; Pawson and Scott, 1997; Tallquist and 
Kazlauskas, 2004). While numerous growth factor signaling pathways are 
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involved in proper craniofacial development, here, I will focus specifically on the 
Pdgf and Fgf signaling pathways.  
1.IV.a. Platelet-derived growth factor signaling 
The platelet-derived growth factor signaling family is composed of two receptors, 
alpha and beta, with four ligands in mouse and humans and six in zebrafish 
(Eberhart et al., 2008; Hoch and Soriano, 2003; Tallquist and Kazlauskas, 2004). 
The receptors can both homo- and heterodimerize and have ligand-preference 
for activation (Tallquist and Kazlauskas, 2004). Pdgfr’s contain two intracellular 
tyrosine kinase domains that can activate numerous intracellular pathways, 
namely PI3K, PLCg, Ras, and Src (Klinghoffer et al., 2002; Tallquist and 
Kazlauskas, 2004). Although both Pdgfra and Pdgfrb have similar intracellular 
activation domains, they function differently in development.  
Numerous genetic mutants have been generated to uncover the varying 
functions of the Pdgf receptors. Null mutants of both Pdgfra and Pdgfrb are 
embryonic lethal (Soriano, 1994; Soriano, 1997) and display differing 
phenotypes. Pdgfra knockout mice have severe developmental deficits, including 
those affecting heart, vertebrae, and craniofacial tissues (Soriano, 1997). Loss of 
the PI3K-activating tyrosine site of Pdgfra leads to phenotypes most similar to the 
null (Klinghoffer et al., 2002), suggesting that PI3K is the effector most vital for 
Pdgfra function in development. Pdgfrb knockout mice have defects in 
vasculogenesis, as well as defects in kidney and heart formation (Soriano, 1994). 
Of the two Pdgf receptors, Pdgfrb seems dispensible for proper craniofacial 
development. However, Pdgfra;Pdgfrb PI3K double mutants have defects closely 
mirroring the Pdgfra null knockout (Klinghoffer et al., 2002). The mechanism of 
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this interaction is still unclear and is the focus of chapter 4. How Pdgfra functions 
in the cranial neural crest, however, has been much more extensively studied.  
  In both mouse and zebrafish, Pdgfra is expressed in the migrating cranial 
neural crest (Eberhart et al., 2008; Liu et al., 2002; Schatteman et al., 1992), and 
reduced Pdgfra function results in cleft palate (Eberhart et al., 2008; Klinghoffer 
et al., 2002; Tallquist and Soriano, 2003). Furthermore, in humans, PDGFRA has 
been linked to congenital cleft palate (Rattanasopha et al., 2012). These data 
suggest a strong conservation of gene function across species. Mechanistically, 
palatal clefting is due to a neural crest migration defect in both mice and 
zebrafish (Eberhart et al. 2008, Vesudevan and Soriano, 2014), where the most 
anterior neural crest cells fail to properly populate the first pharyngeal arch 
(Eberhart et al., 2008). Pdgf ligands act as chemoattractants to the pdgfra-
expressing neural crest, and this allows for proper neural crest migration 
(Eberhart et al., 2008). In these genetic analyses, the functions of Pdgfra are 
observed when the environmental conditions are optimal. When placed in 
stressed conditions, such as ethanol, Pdgfra plays a second role in the neural 
crest beside migration, namely survival. This is the focus of chapter 2.   
 
1.IV.b. Fibroblast growth factor signaling 
Fibroblast growth factors (Fgf’s) are part of a large family of intercellular signaling 
molecules that consists of 4 receptors in all vertebrates with 22 ligands in mouse 
and human and 27 ligands in zebrafish (Itoh, 2007). They are crucial throughout 
development (Carter et al., 2014; Ornitz and Itoh, 2001; Thisse and Thisse, 
2005), including neural and mesoderm induction and specification (Sivak et al., 
2005), cartilage homeostasis (Ellman et al., 2013), as well as numerous aspects 
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of craniofacial development. For example, Fgf3 and Fgf8 are required for proper 
migration, survival, and patterning of the neural crest (Creuzet et al., 2004; 
Crump et al., 2004). Multiple Fgf receptors are implicated in cranial suture 
formation (Nie et al., 2006; Rice et al., 2000) and, furthermore, Fgfs are 
implicated in a number of congenital craniofacial disorders with reported skull 
base defects including Aperts, Crouzon, and DiGeorge Syndromes (Tokumaru et 
al., 1996; Aggarwal et al., 2006). While Fgfs function in early mesoderm 
induction, specification, and migration (Ornitz and Itoh, 2001; Sivak et al., 2005; 
Thisse and Thisse, 2005), no known role has been determined in the later-
forming cephalic mesoderm. This is the focus of chapter 3.   
 
1.V. Outline of dissertation 
The main goal of my dissertation research was to identify and characterize gene-
ethanol interactions. In short, I found that genes involved in growth factor 
signaling are especially vulnerable to ethanol teratogenesis. I focused on 
elucidating the ethanol interaction with platelet-derived growth factor receptor 
alpha (pdgfra), and, through this work, uncovered a second ethanol-interacting 
gene fibroblast growth factor 8a (fgf8a). Due to the nature of the fgf8a-ethanol 
interaction, I then focused my efforts in elucidating the function of Fgfs in 
craniofacial development.  
In an initial ethanol-sensitivity screen using known craniofacial mutants, 
we found a synergistic interaction between ethanol and pdgfra. Using a number 
of different assays, I found an increase in cranial neural crest cell death in 
ethanol-treated pdgfra mutants, and that pdgfra protects against this cell death 
via activation of the PI3K/AKT/mTOR pathway. I developed a two-hit model of 
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ethanol teratogenesis, where subteratogenic levels of ethanol and suboptimal 
levels of growth factor signaling synergize to cause FASD.  
Building on the hypothesis that reduced growth factor signaling 
predisposes to ethanol-induced defects, we tested a different growth factor 
signaling gene, fgf8a. It interacted with ethanol to cause a completely different 
craniofacial defect than that observed with pdgfra and ethanol. It caused the 
postchordal neurocranium to be lost. Due to the nature of this phenotype, I was 
interested in understanding the function of Fgfs in postchordal neurocranial 
development. Using a number of genetic, cell tracking, and in situ hybridization 
assays, I uncovered a hierarchy of genetic signaling pathways regulating the 
formation of the postchordal neurocranium. This involved Fgfs functioning in 
specification of the mesoderm precursors of this structure, and Shh functioning in 
later differentiation. 
Lastly, I wanted to revisit the function of Pdgf signaling in craniofacial 
development. There are two Pdgf receptors, alpha and beta, and it was unclear 
whether ethanol interacted with pdgfra alone to cause the exacerbated 
craniofacial defects, or whether ethanol broadly attenuated all Pdgf signaling, 
including pdgfrb. Using double pdgfra;pdgfrb mutants, we tested whether dual 
loss of pdgfra and pdgfrb could phenocopy the ethanol-treated pdgfra mutant 
phenotype. Indeed, we found that pdgfra and pdgfrb synergistically function in 
craniofacial development. I am currently determining the mechanism of this 









Figure 1.1: Ethanol metabolism leads to cell-damaging reactive oxygen species 
(ROS), increased DNA damage, and cell death; a problem exacerbated by 
Fancd2 deficiency. (Top panel) In wildtype animals, alcohol is catabolized to 
acetaldehyde, a potentially harmful degradation product. Its accumulation is 
prevented by further enzymatic degradation to acetate (represented by the solid 
line), via alcohol dehydrogenase 2 (Aldh2). The proper function of Aldh2 also 
prevents accumulation of reactive oxygen species (ROS), cell death, and DNA 
damage (represented by the dashed line).  Furthermore, Fancd2 functions in 
repairing DNA damage that may accrue during alcohol exposure. (Bottom panel) 
In Aldh2;Fancd2 double mutant fetuses carried by double heterozygous dams, 
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acetaldehyde is not degraded (represented by the dashed line), yielding an 
increase in ROS, cell death and DNA damage (represented by the solid line). 
Loss of Fancd2 may increase risk of DNA damage, and, with the effects of 
acetaldehyde accumulation, lead to FASD-like defects. Double-cross denotes 


















Figure 1.2: Ethanol has been shown to interact with several members of the Shh 
signaling pathway (denoted in red). In the producing cell, Shh mRNA is first 
translated into a precursor protein, which is then modified via glycosylation (Shh-
N). Shh-N is then packaged into lipid raft domains, in which Agrin also gets 
packaged, and is then shipped extracellularly to the receiving cell. Shh-N binds to 
Patched, which releases Smoothened to activate Gli transcription factors. Cdon 
is a co-receptor of Patched. Ethanol causes holoprosencephaly and craniofacial 
defects in Cdon mutant mouse embryos and heterozygous Gli2 and Shh mice 
(Keitzman et al., unpublished, red arrow). Injection of shh or agrin morpholinos 
results in ocular defects in zebrafish. Asterisks denote members of the pathway 









Figure 1.3: Zebrafish screen to uncover gene-ethanol interactions. To test for 
ethanol sensitive genes, zebrafish with known mutations (marked by asterisk) 
were interbred to give rise to clutches that will be composed of wildtype, 
heterozygous, and mutant offspring. These were split into two groups, one 
treated with 1% ethanol at various times, and tested for ethanol sensitivity of 
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Figure 1.4: The zebrafish cranial neural crest and craniofacial skeleton. The 
panel on the far left shows a 24 hour post fertilization embryo labeling neural 
crest cells in white. These neural crest cells are formed into pharyngeal arches 
labeled 1-7. At 5 days post fertilization, zebrafish neural crest cells will give rise 
to corresponding neurocrania (middle panel) and viscerocrania (right panel) 
marked by coloration (red=first arch, yellow=second arch). The neurocranium is 
separated into prechordal (pre.) and postchordal (post.) regions, respectively. 
The prechordal neurocranium is called the palate. abc= anterior basicapsilur 
commissure, ch=ceratohyal, hs=hyosymplectic, ep=ethmoid plate, 
hs=hyosymplectic, ih=interhyal, lc=lateral commissure, Mc=Meckels cartilage, 
n=notochord, oa= occipital arch, pbc= posterior basicapsilur commissure, 










Chapter 2: Pdgfra protects against ethanol-induced craniofacial 
defects in a zebrafish model of FASD. (McCarthy et al., 2013) 
2.I. Abstract 
Human birth defects are highly variable and phenotypic variability can be 
influenced by both the environment and genetics. However, the synergistic 
interactions between these two variables are not well-understood. Fetal Alcohol 
Spectrum Disorders (FASD) is the umbrella term used to encompass  the wide 
range of outcomes following prenatal alcohol exposure. While FASD are caused 
by prenatal ethanol exposure, FASD are thought to be genetically modulated, 
although the genes regulating sensitivity to ethanol teratogenesis are largely 
unknown. In a small shelf screen for ethanol susceptibility loci, we found that 
platelet-derived growth factor receptor alpha (pdgfra) interacted synergistically 
with ethanol during zebrafish craniofacial development. Analysis of the PDGF 
family in a human FASD genome-wide dataset links PDGFRA to craniofacial 
phenotypes in FASD, prompting a mechanistic understanding of this interaction. 
In zebrafish, untreated pdgfra mutants have cleft palate due to defective neural 
crest cell migration, while pdgfra heterozygotes develop normally. Ethanol-
exposed pdgfra mutants have profound craniofacial defects that include the loss 
of the palatal skeleton and hypoplasia of the pharyngeal skeleton. Furthermore, 
ethanol treatment revealed latent haploinsufficiency, causing palatal defects in 
approximately 62% of pdgfra heterozygotes. Neural crest apoptosis partially 
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underlies these ethanol-induced defects in pdgfra mutants, demonstrating a 
protective role for Pdgfra. The PI3K/mTOR pathway mediates the protective 
functions of Pdgfra. Collectively, our results suggest a model where combined 
























Phenotypic variability is typical in human disorders. This variability can be caused 
by a combination of genetic and environmental factors. While we have gained 
insight into these separate genetic and environmental influences, the synergistic 
interactions between the two are largely unknown. We sought to understand 
these interactions by examining the effects of embryonic alcohol exposure on 
craniofacial development using a zebrafish model.  
 Fetal alcohol spectrum disorders (FASD) encompass the range of defects 
associated with prenatal exposure to ethanol. By some estimates, FASD affect 
somewhere from 1% of the North American population (Sampson et al., 1997) to 
2-5% of the United States and Western Europe (May et al., 2005; May et al., 
2007). Defects and deficits associated with FASD are variable and lie along a 
continuum with the most severe form represented by Fetal Alcohol Syndrome 
(FAS), which is clinically diagnosed by growth retardation, deficiencies in brain 
growth (reduced head circumference and/or structural brain anomaly), and 
distinct facial features (microcephaly, short palpebral fissures, thin upper lip, 
and/or smooth philtrum) (Jones and Smith, 1973). Other craniofacial defects can 
arise in FAS, including cleft palate (Swayze et al., 1997). The variability of the 
defects found in FAS and FASD are partly attributed to the timing and dosage of 
fetal exposure to ethanol (Ali et al., 2011; Sulik, 2005; Sulik et al., 1986). 
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However, genetic factors are also likely to influence FASD, yet these influences 
are poorly understood.  
Several lines of evidence suggest a genetic component to FASD (Warren 
and Li, 2005). Different strains of mice, rats, chickens and zebrafish show 
differing sensitivity to ethanol exposure (Boehm et al., 1997; Debelak and Smith, 
2000; Dlugos and Rabin, 2003; Thomas et al., 1998). Recently, work in mouse 
has shown that the Hh pathway gene, Cdon, interacts with ethanol (Hong and 
Krauss, 2012). The Hh pathway has also recently been shown to interact with 
ethanol during zebrafish neural development (Zhang et al., 2013). In humans, the 
most compelling evidence for a genetic component to FASD is twin studies 
showing greater concordance for FAS between monozygotic than for dizygotic 
twins (Streissguth and Dehaene, 1993). In a small South African cohort, 
resistance to FAS associates with carrying the alcohol dehydrogenase (ADH) 
B*2 allele, which catabolizes alcohol at a faster rate than other ADH isozymes 
(Viljoen et al., 2001). Together, these studies provide evidence for gene-
environment interactions being involved in susceptibility to FASD.  
 The zebrafish provides an excellent model system in which to study gene-
ethanol interactions. Zebrafish eggs are fertilized externally, simplifying the 
analysis of zygotic genes that interact with ethanol. Furthermore, this external 
development allows for the precise timing and dosage of ethanol exposure. 
Zebrafish embryos display FASD defects when exposed to ethanol and the 
effects of ethanol timing and dosage have been well studied in zebrafish as far 
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back as 1910 (Ali et al., 2011; Arenzana et al., 2006; Dlugos and Rabin, 2003; 
Lockwood et al., 2004; Loucks and Carvan, 2004; Stockard, 1910).  Yet we know 
very little about how genetic factors influence ethanol-induced phenotypes, such 
as perturbations of proper craniofacial development.  
In all vertebrate species, the majority of the craniofacial skeleton derives 
from the cranial neural crest (Couly et al., 1993; Evans and Noden, 2006; Gross 
and Hanken, 2008; Knight and Schilling, 2006; LeLievre, 1978; Noden, 1978; 
Yoshida et al., 2008). Neural crest cells are generated between neural and non-
neural ectoderm. Neural crest cells undergo an epithelial-to-mesenchymal 
transition, which allows them to migrate into the periphery to form a wide variety 
of cell types (Theveneau and Mayor, 2012). In cranial regions these cells will 
migrate into serially reiterated structures called pharyngeal arches (Grevellec and 
Tucker, 2010). In the zebrafish, this occurs beginning at 10 hours post 
fertilization (hpf), and ends around 30 hpf (Eberhart et al., 2008). Morphogenetic 
processes within the pharyngeal arches will eventually shape the craniofacial 
skeleton by 5 days post fertilization (dpf). In the zebrafish, the first pharyngeal 
arch contributes to jaw structures including Meckel’s cartilage and the 
palatoquadrate, as well as palatal elements, including the ethmoid plate and 
trabeculae (Cubbage and Mabee, 1996; Kesteven, 1922; Shah et al., 1990; 
Swartz et al., 2011). The second arch contributes to the jaw support skeleton 
including the hyosymplectic, ceratohyal and interhyal. 
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From genetic screens and cell lineage analyses, a great deal has been 
learned concerning the genetic pathways controlling the development of these 
craniofacial elements. Numerous signaling pathways regulate craniofacial 
development, including the Platelet-derived growth factor (Pdgf) signaling 
pathway. Pdgfra is a receptor tyrosine kinase, known to regulate a number of 
processes including cellular migration, proliferation, and survival (Tallquist and 
Kazlauskas, 2004; Wu et al., 2008). A key effector of Pdgfra signaling is PI3K, 
which can regulate numerous cell behaviors, including migration via activation of 
small GTPases and survival and growth via activation of mTOR (Downward, 
2004; Klinghoffer et al., 2002; Zhou and Huang, 2010). In both mouse and 
zebrafish, most, if not all, cranial neural-crest cells express Pdgfra and Pdgfra 
function is required in the neural crest (Eberhart et al., 2008; Soriano, 1997; 
Tallquist and Soriano, 2003). While the precise function of Pdgfra is not known in 
mouse, in zebrafish Pdgfra is necessary for proper neural crest cell migration 
(Eberhart et al., 2008). 
The work described here uncovers a second role for pdgfra in the neural 
crest: protection against ethanol-induced teratogenesis. Testing five craniofacial 
mutants, cyp26b1, gata3, pdgfra , smad5, and smoothened, for dominant 
enhancement of ethanol teratogenesis we found that only pdgfra heterozygotes 
and mutants showed enhanced craniofacial defects after ethanol exposure. In a 
small human dataset with variable prenatal alcohol exposure, we find support for 
a gene-ethanol interaction with single nucleotide polymorphisms (SNPs) in PDGF 
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family members associating with different craniofacial phenotypes. In zebrafish, 
the susceptibility to craniofacial defects is at least partly due to neural crest cell 
apoptosis following ethanol exposure. The pdgfra-ethanol interaction is due to 
the combined genetic and environmental attenuation at or downstream of the 
mechanistic target of rapamycin (mTOR), part of the Phosphoinositide 3 kinase 
(PI3K) pathway. Collectively, our data show that genetic screens using zebrafish 
will have important implications in FASD research, both in uncovering genetic 




2.III.a. pdgfra and ethanol synergistically interact 
We sought to identify gene-ethanol interactions that might underlie the 
craniofacial variability observed in FASD. We reasoned that some genetic loci 
that influence ethanol teratogenicity would cause craniofacial phenotypes when 
mutated. We initially screened five craniofacial mutants for ethanol sensitivity: 
smob577, cyp26b1b1024, gata3b1075, smad5b1100 and pdgfrab1059. For this initial 
screen, embryos were placed in media containing 1% ethanol from 6 hours post 
fertilization (hpf) until 5 dpf, when craniofacial phenotypes were examined. At this 
concentration, the tissue levels of ethanol are approximately 41 mM (188.6 
mg/dL or 0.18 BAC), as determined by headspace gas chromatography, and 
wild-type embryos are largely unaffected. This is a concentration of ethanol 
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achieved in binge drinkers (Lange and Voas, 2000). We found no clear 
differences in phenotypes between ethanol-treated and untreated smo, cyp26b1, 
gata3 or smad5 mutants nor any indication that ethanol caused 
haploinsufficiency in heterozygotes. In contrast, ethanol appeared to interact 
synergistically with the hypomorphic pdgfrab1059 allele, dramatically exacerbating 
mutant phenotypes and uncovering latent haploinsufficiency (Figs., 2.1 and 2.2, 
discussed in greater detail below). We partially rescued these ethanol-induced 
defects by elevating Pdgfra levels via pdgfra mRNA injection or morpholino 
knockdown of miR140, which negatively regulates pdgfra, (Fig. 2.3, Fig. 2.4, 
Eberhart et al., 2008), demonstrating specificity of the interaction. The variability 
that we observed in these rescues was consistent with the variation that we 
previously observed in rescuing untreated pdgfra mutants and our finding that the 
craniofacial skeleton is highly sensitive to the overall levels of Pdgfra (Eberhart et 
al., 2008). There are also likely to be between embryo differences in signal 
strength downstream of the receptor, such as altered Pten function, which would 
impact negative feedback into the signaling pathway (Carracedo and Pandolfi, 
2008) to add to the inherent variability in these rescue experiments. Collectively, 
these results show that ethanol interacts with a subset of gene products involved 
in craniofacial development. 
Untreated pdgfra mutants have a loss of the ethmoid plate which leads to 
a significant reduction in the length of the palate (Fig. 2.1C, asterisk, Fig. 2.5) 
and have slightly smaller pharyngeal skeletal elements (Fig. 2.2C,G-I, Table 2.1). 
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Untreated heterozygous siblings develop normally (Fig. 2.1B, Fig. 2.2B,G-I, Fig. 
2.5, Table 2.1). Treatment with 1% ethanol from 10 hpf to 5 dpf had a minor 
effect on the neurocranium of wild-type embryos, with 11% of treated wild types 
having a reduced ethmoid-plate (Fig. 2.1D,G) and the overall length of the palate 
was not significantly reduced (Fig. 2.5). Treated wild-type embryos displayed a 
slightly smaller hyosymplectic (Fig. 2.2I, Table 2.1) cartilage, however, Meckel’s 
cartilage and the palatoquadrate appeared unaffected (Fig. 2.2G,H and Table 
2.1). Statistical analyses of the size of these elements showed that, indeed, only 
the hyosymplectic was reduced by ethanol. 
Ethanol-treatment caused craniofacial defects in 62% of pdgfra 
heterozygotes (Fig 2.1E,G), a dramatic increase compared to 11% of wild-type 
embryos with an identical treatment. Because heterozygous embryos rarely have 
craniofacial defects, this substantial increase in the number of embryos with 
craniofacial defects is specific to the pdgfra/ethanol interaction. The defects 
observed included gaps in the ethmoid-plate (asterisk and arrow in Fig. 2.1E) 
and breaks in the trabeculae (arrowheads in Fig. 2.1E). Ethanol-treated 
heterozygotes also displayed significantly shorter palates when compared to 
untreated heterozygotes and ethanol-treated wildtypes (Fig. 2.5A). 
Heterozygosity for pdgfra alone had no effect on the size of the palatal skeleton 
and ethanol caused a slight, nonsignificant, reduction to the palate in wild-type 
siblings (Fig. 2.5A).  The palatal skeleton was significantly reduced in ethanol-
treated pdgfra heterozygotes, compared to these two comparison groups. 
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Therefore, ethanol has a specific synergistic effect on palatal development in 
pdgfra heterozygotes. Furthermore, ethanol caused a statistically significant 
reduction in the size of the hyosymplectic cartilage in heterozygotes compared to 
ethanol-treated wildtypes and untreated heterozygotes (Fig. 2.2E,I and Table 
2.1). Because the hyosymplectic is reduced in ethanol treated wild-type embryos 
and untreated heterozygotes, this effect appears additive. These results show 
that the pdgfra and ethanol interact synergistically in palatal development and 
that the hyosymplectic is further reduced in ethanol-treated pdgfra heterozygotes 
as compared to treated wild-type embryos. 
In 100% of treated pdgfra mutants, as compared to approximately 10% of 
untreated mutants, the anterior neurocranium was completely lost (Fig. 2.1F). 
Not surprisingly, this loss led to a statistically significant decrease in the length of 
the palate, relative to treated wild-type embryos and untreated mutants (Fig. 2.5). 
The ethanol-treated mutant embryos also had a statistically significant reduction 
of the palatoquadrate, Meckel’s cartilage, and the hyosymplectic compared to 
untreated mutant and ethanol-treated wild-type and heterozygotes (Fig. 2.2F,G-I, 
and Table 2.1). All of the reductions observed in the ethanol-treated mutants are 
far beyond that predicted by an additive effect of ethanol-treatment in wild-types 
and loss of pdgfra without ethanol. Ectodermal and cardiac edema was also 
present in 100% of treated pdgfra mutants (not shown). Collectively, these 
results provide strong support that pdgfra and ethanol synergistically interact 
during craniofacial development.  
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The severity and variability of ethanol-induced defects is partly dependent 
on concentration and developmental timing (Ali et al., 2011; Sulik, 2005). 
Therefore, we tested these variables across ethanol-treated pdgfra genotypes. 
We initially tested 24-hour time windows for sensitivity and then narrowed down 
the sensitive window. While treatments initiating after 24 hpf had no effect, we 
found that a 1% ethanol treatment from 10-24 hpf is the shortest time window 
sufficient to fully recapitulate the mutant phenotypes obtained by treatment from 
10 hpf to 5 dpf (Fig. 2.1G, Fig. 2.2G-I, Fig. 2.5, Table 2.1). In heterozgyotes this 
shorter exposure still lead to significant differences in the neurocranium, in fact 
the difference in length between the treated wild-type and heterozygous embryos 
was even more marked (Fig. 2.1G, Fig. 2.5). No significant alterations to the 
hyosymplectic were observed (Fig. 2.2G-I, Table 2.1). These results suggest that 
the palatal skeleton is most sensitive to brief ethanol exposure. 
We tested lower ethanol concentrations to determine how sensitive pdgfra 
mutants and heterozygotes were to ethanol teratogenesis. Treatment with 0.5% 
ethanol, a tissue concentration of 19 mM (88 mg/dL), from 10 hpf to 5 dpf caused 
neurocranial defects in 3% and 13% of wild-type and heterozygotes, respectively 
(Fig. 2.1G). Under these conditions, 38% of pdgfra mutants completely lacked 
the palatal skeleton (Fig. 2.1G). This clear increase in the percentage of 
heterozygous and mutant embryos with palatal defects, is associated with 
reductions in the size of the crest-derived cartilages (Fig. 2.2G-I, Table 2.1), 
although these differences did not reach a level of significance. Shorter 
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treatments with 0.5% ethanol had no apparent effect (data not shown). Thus, 
attenuation of Pdgf signaling sensitizes embryos to ethanol-induced craniofacial 
defects, and this sensitivity occurs roughly when neural crest cells are migrating 
to and populating the pharyngeal arches, although migration does continue after 
24 hpf in zebrafish palatal development (Dougherty et al., 2013).  
We analyzed non-crest-derived cartilages to determine if ethanol had a 
general effect on cartilage development. First, we examined the posterior 
neurocranium because it is of presumed mesoderm origin. Surprisingly, we 
discovered a previously undescribed function of Pdgfra in posterior neurocranial 
development, with the size of the posterior neurocranium significantly reduced in 
untreated mutants, relative to wild-type embryos (Fig. 2.5). This requirement may 
relate to the requirement for Pdgfra function for migration and survival of early 
mesoderm precursors (Van Stry et al., 2005; Van Stry et al., 2004). As then 
would be expected, ethanol did interact with pdgfra in the development of these 
cartilages (Fig. 2.5) to generate an overall effect of microcephaly. Second, we 
analyzed cartilage of the pectoral fin and found no difference between ethanol-
treated mutants, ethanol-treated wild-type embryos and untreated mutants (Fig. 
2.6). This result suggests that there is no generalized chondrogenic defect in the 
ethanol-treated pdgfra mutants. Consistent with this, we found that colIIa was 
expressed appropriately in the posterior neurocranium of ethanol-treated 
mutants, although, as expected from the phenotype, no ethmoid plate or 
trabeculae condensations were present (Fig. 2.7). Collectively, these findings 
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show that proper development of the entire neurocranium requires Pdgfra 
function and that ethanol interacts synergistically with pdgfra having the most 
profound effects on the neural crest-derived skeleton, which we focus on here. 
The regulation and function of Pdgf signaling is highly conserved across 
vertebrate species, prompting us to seek evidence from a published human 
sample (Jones et al., 2006) for interactions between PDGF family members and 
prenatal ethanol exposure. We asked whether there was evidence for ethanol 
usage/SNP interaction on human craniofacial features. We tested members of 
the human PDGF family, including PDGFB, PDGFC, PDGFD, PDGFRA and 
PDGFRB, using a well-characterized sample from the US (See Table 2.2 for a 
complete list of the SNPs analyzed) (Mattson et al., 2010; Moore et al., 2007). 
Due to the small size of PDGFA (12,700 bp), no SNPs were genotyped or 
analyzed in this gene. The best evidence for gene-ethanol interactions in humans 
was found in the two PDGF Receptor genes. The most significant evidence for a 
gene-ethanol interaction was observed with 2 SNPs in PDGFRB, when analyzing 
midfacial depth (rs2304061; p=3.7x10-6 and rs1075846; p<3.5 x10-5). These 
SNPs are in modest linkage disequilibrium (r2=0.57). These SNPs were also 
moderately associated with lower facial depth (both p<9.9x10-4).  In addition, a 
single SNP in PDGFRA was associated with the measures of outer canthal width 
and midfacial depth (p=1.3 x10-4 and p=1.7 x10-4).  Together, these results 
provide evidence that zebrafish gene-ethanol interactions may be conserved in 
humans.   
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2.III.b. Neural crest cell apoptosis increases in ethanol-exposed pdgfra 
mutants. 
High doses of ethanol can cause neural crest cell apoptosis (Cartwright and 
Smith, 1995; Sulik, 2005), and Pdgf signaling has been implicated in mesoderm-
cell survival (Van Stry et al., 2005). We postulated that the craniofacial defects in 
ethanol-treated mutants and heterozygotes could be due, at least in part, to an 
increase in cranial neural crest cell death. In support of this model, treating 
pdgfra mutants with ethanol and caspase-inhibitor III partially rescued the 
ethanol-induced craniofacial defects (Fig. 2.8G, compare to Fig. 2.1C,F). We do 
not expect a full rescue with this treatment, because clefting of the ethmoid plate 
is due to a migratory defect (Eberhart et al., 2008). Thus, this partial rescue 
supports the model in which elevated apoptosis underlies some of the effect of 
ethanol on pdgfra mutants. 
We directly determined the levels of apoptosis using anti-active caspase 
immunohistochemistry in the neural crest cell labeling fli1:EGFP transgenic line. 
We quantified neural crest cell death in the first and second arch at 20 and 24 
hpf, encompassing the developmental time window in which pdgfra mutants are 
most sensitive to ethanol (Fig. 2.8A-D and A’-D’). We did not observe any 
increase in cell death in ethanol-treated groups at 20 hpf compared to untreated 
controls (not shown). At 24 hpf, there were low levels of neural crest cell death in 
all untreated genotypes, ranging from 1-2 cells/side of the embryo (Fig. 2.8E). 
The frequency of cell death was slightly increased in ethanol-treated wild-type 
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embryos (3.4 cells/side) and further increased in ethanol-treated heterozygotes 
(4.79 cells/side, Fig. 2.8E), although this effect was not clearly synergistic. In 
ethanol-treated pdgfra mutants, we found a statistically significant and non-
additive increase in apoptosis compared to all other groups (Fig. 2.8E, 10.3 
cells/side, tukey test *p-value=<0.01). In all ethanol-treated genotypes, there 
were frequently non-fli1:GFP-positive cells undergoing apoptosis just dorsal to 
the first arch, in the relative position of the trigeminal ganglion. There were, 
however, no global elevations in apoptosis at 24 hpf between ethanol-treated 
mutants and sibling counterparts compared to their untreated mutants and 
siblings (Fig. 2.9), suggesting that the pdgfra-ethanol interaction leads to an 
increase in neural-crest specific cell death. Quantification of the ratio of cell death 
compared to total cells showed a linear increase in all ethanol-treated groups at 
24 hpf (Fig. 2.8F). Ethanol-treatment did not reduce cell proliferation at 24 hpf in 
pdgfra mutants relative to untreated controls, however, we did observe a rise in 
cell proliferation in wild-type embryos (Fig. 2.10). This rise in proliferation may 
compensate for the slight increase of cell death at this time.  
While pdgfra mutants are most sensitive to ethanol from 10-24 hpf, the 
effects of ethanol could potentially continue after the treatment. Therefore, we 
analyzed cell death after a 6-hour recovery period from ethanol. Strikingly, we 
observed a significant and synergistic increase in cell death at 30 hpf, after 
ethanol was removed at 24 hpf in pdgfra mutants (14.2 cells/side, tukey test *p-
value=<0.01, Fig 2.8E). The trend for elevated cell death in pdgfra 
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heterozygotes, seen at 24 hpf, was abolished with just 6 hours recovery (Fig. 
2.8E,F). This timing of 24-30 hpf correlates with when Pdgfra ligands begin to be 
expressed in the epithelia adjacent to the neural crest (Eberhart et al., 2008). 
These data suggest that pdgfra protects against ethanol-induced neural crest cell 
death during neural crest condensation in the arches, and may be a 
compensatory mechanism against ethanol-induced cell death following ethanol 
exposure.  
Detailed fate maps of the pharyngeal arches in the zebrafish at 24 hpf 
allow us to directly compare the location of cell death to the skeletal structures 
disrupted across ethanol-treated pdgfra genotypes. At 24 hpf, neural-crest cells 
condensing on the roof of the oral ectoderm contribute to most of the anterior 
neurocranium (Crump et al., 2006; Eberhart et al., 2006). Also, cells located 
dorsally in the 1st and 2nd pharyngeal arches contribute to the palatoquadrate and 
hyosymplectic (Crump et al., 2004; Crump et al., 2006; Eberhart et al., 2006). 
These are the skeletal elements that were reduced to the greatest extent in 
ethanol-treated pdgfra mutants, and increased cell death in ethanol-treated 
mutants and heterozygotes occurred in these precursor regions (Fig. 2.11). The 
regions of enhanced cell death are also adjacent to the oral ectoderm and 
pharyngeal pouches, sources of ligands for Pdgfra (Eberhart et al., 2008). 
Collectively, these data show that the pdgfra-ethanol interaction causes an 
increase in neural crest cell death starting at 24 hpf, which contributes to the 
ethanol-induced craniofacial defects at 5 dpf. 
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2.III.c. Combined loss of Pdgf signaling and ethanol exposure impinges on 
mTOR signaling. 
In combination with our previous analyses (Eberhart et al., 2008), our results 
show that Pdgf signaling functions in both neural crest migration and protection 
from ethanol-induced apoptosis. A main pdgfra effector regulating cell survival 
and migration in vitro and in Xenopus mesoderm cells is Phosphoinositide 3 
kinase (PI3K) (Downward, 2004; Van Stry et al., 2005; Xiong et al., 2010). 
Additionally, PI3K is the major effector of Pdgfra regulating craniofacial 
development in mouse (Klinghoffer et al., 2002). In different in vitro analyses, 
ethanol has been suggested to downregulate several components of the PI3K 
pathway, including PI3K itself, AKT and mTOR, both downstream of PI3K (Guo 
et al., 2009; Hong-Brown et al., 2010; Vary et al., 2008; Xu et al., 2003). We 
hypothesized that PI3K signaling mediates Pdgfra protection from ethanol-
induced apoptosis. We increased PI3K signaling by injecting untreated and 
ethanol-treated hypomorphic pdgfra mutants with morpholinos against the 
negative regulator of PI3K, pten (Croushore et al., 2005). These injections left 
wild-type and heterozygous embryos largely unaffected as compared to controls 
(Figs. 2.12 and 2.13). Upregulating the PI3K pathway in either untreated or 
ethanol-treated mutants nearly fully rescued the palate defects when compared 
to untreated and ethanol-treated mutant controls (Fig. 2.14A-D). Injection of pten 
morpholinos also rescued the pharyngeal skeletal elements of ethanol-treated 
mutants to a nearly wild-type appearance (Fig. 2.14A’ compare D’).  
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We wanted to test whether activation of this pathway at the level of mTOR 
could also rescue the ethanol-induced mutant phenotypes. L-Leucine has been 
shown to increase mTOR activity, leading to a rise in cell growth and survival 
(Hong-Brown et al., 2012; Kimball and Jefferson, 2006). Supplementing ethanol 
with 50mM L-Leucine partially rescued the ethanol-treated phenotype (Fig. 
2.14E-F,E’-F’), and had no apparent affect on either untreated heterozygote or 
wildtype silbings (Fig. 2.15).  However, following a 10-24 hpf ethanol treatment 
with L-Leucine treatment alone from 24 to 48 hpf did not rescue ethanol-induced 
defects in mutants (Fig. 2.16, compare to Fig. 2.1). These data show that 
elevating either PI3K or mTOR signaling is sufficient to protect against ethanol-
induced craniofacial defects in a Pdgfra attenuated embryo.  
If the pdgfra/ethanol interaction is due to inhibition of the PI3K pathway 
downstream of Pdgfra, then pharmacological blockade of the PI3K pathway 
should recapitulate the ethanol defects in pdgfra mutants. Consistent with this 
model, treating pdgfra mutants with inhibitors of either PI3K (wortmannin) or 
mTOR (rapamycin) from 10 hpf to 24 hpf phenocopied the ethanol-induced 
defects of the palatal skeleton (Figs 2.17F,I,L and M, Fig. 2.18) and caused 
reductions in the pharyngeal skeleton compared to mutant controls and wild type- 
and heterozygous-treated counterparts (Fig. 2.19F,I,L-O). Furthermore, these 
treatments also uncovered latent haploinsufficiency, causing variable defects 
including those affecting the ethmoid plate and trabeculae (Fig. 2.17H,K,M). 
While there are subtle differences between the treatments that could be due to 
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dosage or mechanism of action, the overall pattern of pharyngeal reduction is 
highly similar across treatments (Fig. 2.19). These data suggest that attenuation 
of the PI3K-mTOR pathway may underlie the pdgfra/ethanol interaction.  
To directly test the effects of ethanol on the PI3K pathway in pdgfra 
mutants, we detected phosphorylated forms of the PI3K target, AKT, and the 
mTOR target, eIF4B (Fig. 2.20). Heads from untreated and ethanol-treated 
pdgfra mutants and siblings were collected at 24 hpf. Downstream of mTOR, 
ethanol-treated mutants showed a decrease in levels of phospho-eIF4B 
compared to untreated embryos and ethanol-treated controls (Fig. 2.20C,D). 
Upstream of mTOR, we observed an increase in levels of phospho-AKT in both 
ethanol-treated mutants and controls compared to their untreated counterparts 
(Fig. 2.20A,B). These data are consistent with a growing body of evidence, 
primarily in vitro and in cancer models, that shows that inhibiting mTOR leads to 
an increase in AKT phosphorylation (Carracedo and Pandolfi, 2008; Hsu et al., 
2011; Soares et al., 2013). To validate this feedback in the developing zebrafish, 
we assayed phospho-AKT levels in rapamycin-treated embryos. Indeed blocking 
mTOR led to an increase in levels of phosphorylated AKT in both mutants and 
wildtypes compared to DMSO-treated controls (Fig. 2.21), similar to the effects of 
ethanol. These data support a model in which ethanol, in combination with loss of 
Pdgf signaling, attenuates the activity of mTOR, leading to hypophosphorylation 




Collectively, our results provide insight into the genetic susceptibility to ethanol-
induced defects. Using zebrafish, we show that attenuated Pdgf signaling and 
ethanol exposure synergistically interact to cause variable craniofacial defects. 
This interaction may be conserved in humans, through our analysis of the human 
datatset herein, although further analysis in humans is necessary to confirm this 
finding. We suggest a model in which attenuated growth factor signaling interacts 
with ethanol to reduce the activity of PI3K/mTOR signaling, at or downstream of 
mTOR thus causing developmental perturbations. At low levels of attenuation, 
whether from slight reduction in growth factor signaling or low doses of ethanol, 
the system can compensate. However, those embryos with reduced growth 
factor signaling, even reductions that would not cause defects alone, that receive 
a “second hit” via ethanol, can develop craniofacial defects.  
 
2.IV.a. Pdgfra regulates both neural-crest cell migration and protection 
from ethanol-induced apoptosis. 
Pdgf signaling is essential for midfacial development across vertebrate species 
(Eberhart et al., 2008; Soriano, 1997; Tallquist and Soriano, 2003). At least in 
zebrafish, Pdgfra regulates the appropriate migration of neural-crest cells that will 
generate the midfacial skeleton (Eberhart et al., 2008). It is only in the presence 
of ethanol that we reveal the requirement of Pdgfra signaling in neural-crest cell 
survival. The increased apoptosis in ethanol-treated pdgfra mutants could be 
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attributed to the fact that the pdgrab1059/b1059 mutant allele is a hypomorph 
(Eberhart et al., 2008). In this model, the amount of Pdgfra signaling left in the 
hypomorph is sufficient for cellular survival. However, in the presence of ethanol, 
these signals no longer promote survival. This model is consistent with the 
finding that there is elevated cell death in Pdgfra null mice (Soriano, 1997). 
However, in a neural crest conditional Pdgfra mutant, apoptosis did not appear 
elevated (Tallquist and Soriano, 2003), which may suggest an alternate model. 
The pdgfra-ethanol interaction could be due to broad inhibition of mTOR 
signaling, across growth factor pathways. The zebrafish mutation project 
(http://www.sanger.ac.uk/Projects/D_rerio/zmp/) has identified a putative null 
pdgfra allele. Analysis of this mutant allele will aid in distinguishing between 
these two possibilities.  
 Proper Pdgfra signaling relies heavily on PI3K activation. In mouse, 
knockout of the PI3K-domain of Pdgfra leads to craniofacial defects, which mimic 
the full knockout phenotype (Klinghoffer et al., 2002). In frog, the PI3K domain of 
Pdgfra is necessary and sufficient for proper mesoderm migration and survival 
(Nagel et al., 2004; Van Stry et al., 2005). In our studies, increasing PI3K-
mediated signaling through pten morpholino knockdown leads to a near wild-type 
phenotype in both untreated and ethanol-treated pdgfra mutants. This finding 
suggests that increasing PI3K function in ethanol-treated pdgfra mutant embryos 
rescues both survival and migration, since the midline defects are due to a 
migratory defect.  
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While elevating PI3K signaling does rescue the defects in pdgfra mutants, 
understanding the precise mechanism will require additional studies. GTPases, 
which promote migration, and AKT, which supports survival and migration, rely 
on the PIP3 substrate of PI3K (Zhou and Huang, 2010). Thus, it is possible that 
the migratory and survival functions of Pdgfra are controlled by different signaling 
components immediately downstream of PI3K.  
mTOR most likely regulates cell survival and growth in ethanol-treated 
embryos. L-leucine supplementation does not rescue the midline defects in our 
pdgfra mutants, which are caused by a migratory defect. In ethanol-treated 
mutants, we observe a decrease in the levels of activated eIF4B and an increase 
in levels of activated AKT, suggesting that ethanol impairs growth signaling at the 
level of mTOR or below. Further evidence that ethanol may be impairing mTOR 
activity specifically is the finding that phosphorylated levels of AKT are increased 
in ethanol treatment. A similar increase in activated AKT is observed in our 
model via rapamycin treatment of pdgfra mutants. Blocking mTOR function may 
release inhibitory feedback loops; for example, pancreatic cancer cells treated 
with rapamycin show elevated levels of phosphorylated AKT compared to 
untreated controls (Soares et al., 2013). It is interesting to speculate that the 
upregulation of AKT in ethanol-treated siblings may buffer against deleterious 
phenotypes by elevating cell proliferation. However, a more extensive analysis of 
the PI3K and mTOR pathways will be necessary to fully understand how Pdgfra-
mediated migration and protection are controlled intracellularly. 
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2.IV.b. Ethanol may broadly disrupt growth-factor signaling pathways 
The interaction observed between ethanol and pdgfra supports a model in which 
PI3K-dependent growth-factor genes interact with ethanol. Notable among these 
genes is insulin receptor (Insr).  Insr functions in proper brain development. 
Reducing the expression of insr in newly born rat pups causes defects similar to 
those found in rat models of FASD (de la Monte et al., 2011). Increasing insulin 
receptor expression in a drosophila model of FASD rescues neurobehavioral 
defects caused by ethanol-exposure (McClure et al., 2011). These data, along 
with our observations of pdgfra, strongly suggest that growth factor genes play a 
significant role in the susceptibility to ethanol teratogenesis. Because growth 
factor signaling is used throughout development, attenuated growth factor 
signaling, along with ethanol exposure, could explain a large portion of the 
variability found in FASD. This model is consistent with the human dataset in 
which the phenotypes associated with gene/ethanol interactions are different 
between PDGFRA and PDGFRB. As the human dataset grows, it will be of great 
interest to further examine the extent of interactions between ethanol and PI3K-
dependent growth factors. 
 
2.IV.c. Zebrafish as a model of gene-environment interactions 
The zebrafish provides a powerful tool in uncovering both the genetics and the 
mechanisms involved in FASD susceptibility. Due to the vast array of genetic 
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resources available and the ease of administering ethanol to the externally 
fertilized embryos, it is feasible to screen hundreds of genes in a relatively short 
period of time. As we have done here, findings in zebrafish can be used to direct 
analyses in human datasets that may not yet be large enough for genome-wide 
power. We have found evidence for pdgfra-ethanol interactions in both zebrafish 
and human. Although the human dataset we analyzed is small, by focusing on a 
small number of genes the likelihood of detecting false associations was greatly 
decreased. After correcting for the testing of SNPs across five genes, and 
therefore five essentially independent tests, the associations we found in the 
genes encoding for the human PDGF receptors were significant, with all p-values 
< 0.01.  This significant association even withstands a more strict correction of 
treating all 118 SNPs as independent tests (0.05/118=4.2x10-4). Thus the 
zebrafish model has guided focused studies in a human dataset with variable 
alcohol exposure and allowed us to detect a gene-ethanol interaction that 
contributes to the observed variation in craniofacial measures. Importantly, due 
to the conservation of gene function across vertebrate species, we can then 
understand the mechanism of these interactions using the zebrafish model 
system. Collectively, our findings provide a predictive mechanistic model for at 
least some gene-ethanol interactions that underlie the craniofacial defects in 
FASD.  
Although we have focused on the craniofacial aspect of FASD, the 
zebrafish also provides an excellent model in which to study the neural aspects 
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of this disorder. The brain is the most commonly affected organ in FASD, with 
defects to the cerebellum and oligodendrocytes being common (Hoyme et al., 
2005; Swayze et al., 1997). Further analysis of our pdgfra-ethanol interaction 
could reveal more subtle neural-specific defects.  Pdgfra is important for 
oligodendrocyte maturation and migration in mouse (McKinnon et al., 2005), 
although the function of pdgfra in zebrafish oligodendrocyte development has not 
been tested. It would be of interest to determine if oligodendrocytes are disrupted 
in ethanol-treated pdgfra mutants.  
Due to its genetic tractability the zebrafish has long been a valuable model 
system for understanding developmental processes. We currently understand an 
enormous amount regarding the genetics regulating development from work in 
numerous model systems. Due to the level of this understanding, we are now 
well poised to gain substantial knowledge about how the environment impinges 
on the genetic networks underlying development (so called Eco-Devo). Our work 
here and recent work examining gene-environment interactions underlying 
ototoxicity (Coffin et al., 2010) demonstrate that the same characteristics (e.g. 
genetic amenability, ease of imaging and external fertilization) that make 






2.V. Materials and Methods 
2.V.a. Danio rerio (zebrafish) care and use 
All embryos were raised and cared for using established protocols  (Westerfield, 
1993) with IACUC approval from the University of Texas at 
Austin. Tg(fli1:EGFP)y1 transgenic embryos express GFP in neural crest cells 
shortly after the onset of migration, and in the vasculature (Lawson and 
Weinstein, 2002). Here they are called fli1:EGFP throughout the text. Embryos 
were treated in EM with 1.0% and 0.5% ethanol, 1.5uM wortmannin (W1628, 
Sigma) ; 3uM rapamycin (S1120, Selleck); and 25uM caspase inhibitor 3 
(Cat#264155, Calbiochem). L-leucine has been used at 100mM in zebrafish 
(Payne et al., 2012), we found that a 50mM solution was sufficient to provide 
rescue in our experiments. The pdgfrab1059, (Eberhart et al., 2008), smad5b1100 
(Sheehan-Rooney et al., 2013) and smob577 (Varga et al., 2001) alleles have 
been described. The gata3b1075 and cyp26b1b1024 alleles were recovered from a 
forward genetic screen at the University of Oregon and will be described in detail 
elsewhere. 
2.V.b. Morpholino and RNA injection 
Gene Tools (Philomath, OR, USA, http://www.gene-tools.com) supplied 
morpholino oligonucleotides ptena and ptenb (Croushore et al., 2005) as well as 
mir140 MO (Eberhart et al., 2008). We injected one or two-cell stage zebrafish 
embryos with approximately 3 nl of morpholinos with working concentrations of: 
3.5 mg/ml ptena/ptenb, and 1.2 mM mir140. pdgfra mRNA was made using the 
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mMessenger mMachine and Poly A cloning kits (Ambion, Austin, TX). Stock 
solutions (concentration approximately 300 ug/ml) were either injected 
(approximately 3 nl) directly or diluted at ratios of 1:10 and 1:20 into 1-cell stage 
embryos.  
2.V.c. Immunohistochemistry 
Embryos were fixed and prepared for immunohistochemistry following the 
procedure outlined in (Maves et al., 2002). Primary antibody solution (anti-active 
caspase III, G748A, Promega; phospho-Histone H3, 012M4830, Sigma) was 
added at a 1:300 dilution in blocking solution, and embryos were incubated 
overnight at 4C on a shaker. Embryos were then washed 3X 20 minutes in 
PBDTx at room temperature. Embryos were incubated with secondary antibody 
(Alexa Fluor 568 anti-rabbit IgG, A10042, Invitrogen) at a dilution of 1:300 in 
blocking solution for 5 hours, covered, at room temperature. Embryos were 
washed 1-2X in PBS, and neural-crest cell death was viewed and quantified 
using a Zeiss LSM 710 confocal. For quantification of the ratio of cell death, 
embryos were counter stained with ToPro (Invitrogen) and all nuclei within a 
single representative z plane were counted. The z plane was aligned through the 
lateral 1st and 2nd arches such that the oral ectoderm and 1st pouch, but not the 
mesodermal cores, were visible. 
2.V.d. Immunoblotting  
Tissue samples were harvested from the pdgfrab1059;fli:EGFP line. Mutants were 
visually sorted from wild-type/heterozygotes by their neural crest cell migration 
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defect (Eberhart et al., 2008). Embryos were euthanized, dechorionated and then 
deyolked using a fire-pulled glass pipette. Heads were separated from the tail at 
the posterior end of the otic vesicle. Heads were collected in a 1.5 ml 
microcentrifuge tube. Samples were placed in HKET buffer (25 mM HEPES HCl 
7.4; 150 mM KCl; 1 mM EDTA; 1% Triton-X) with a protease inhibitor cocktail mix 
(complete Mini, 04 693 124 001, Roche), homogenized, centrifuged at 15,000 
rpm for 15 min at 4C, and the resulting lysate removed and quantified using the 
Pierce BCA protei assay kit (#23227, Thermo Scientific). Lysates were analyzed 
by electrophoresis using the NUPAGE SDS-PAGE gel system (Invitrogen). After 
electrophoresis, proteins were transferred to a nitrocellulose membrane and 
blocked by immersion in PBST (phosphate-buffered saline containing 0.1% 
Tween-20 and 5% BSA) overnight at 4C. The membranes were then incubated 
overnight in 4C with the following antibodies: AKT (#4691, Cell Signaling), pAKT 
(#4060, Cell Signaling), eIF4B (#3592, Cell Signaling), peIF4B (#3591, Cell 
Signaling), and b-actin (#4967, Cell Signaling). After 3 successive 10 min PBST 
washes, membranes were incubated at room temperature for 1 hour in 
secondary antibody (anti-rabbit for all antibodies; #7074, Cell Signaling). 
Membranes were washed 3X 10 min in PBST, and treated for 5 minutes in 
SuperSignal West Pico Chemiluminescent Substrate (#34077, Thermo Scientific) 
and exposed on UV film. Membranes were reprobed using stripping buffer 
containing 0.2 M Glycine, 0.05% Tween-20, pH 2.5 for 30 min. at 70C. 
Membranes were washed 2X with TBST, reblocked for 1 hour at room 
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temperature, and placed in primary antibody. ImageJ was used to quantify blots 
(Schneider et al., 2012).   
2.V.e. Cartilage and Bone staining and area measurements 
Five day postfertilization (dpf) zebrafish embryos were stained with Alcian Blue 
and Alizarin Red (Walker and Kimmel, 2007), then flat mounted (Kimmel et al., 
1998). Images were taken with a Zeiss Axio Imager-AI microscope, and palate 
and neurocranial lengths and widths and jaw and jaw-support elements were 
measured using AxiovisionLE software (AxioVs40 V4.7.1.0). All graphs were 
made in Microsoft Excel 2011.  
2.V.f. Confocal microscopy and figure processing 
Confocal z-stacks were collected on a Zeiss LSM 710 using Zen software. 
Images were processed in Adobe Photoshop CS.  
2.V.g. Statistical Analysis 
Origin 7.0 was used for oneway ANOVA and Tukey’s range test for the cell 
death, cell death ratio, palate and neurocranial and pharyngeal arch 
measurement analysis, statistical significance was set at 0.05. Graphpad Prism 
5.02 was used for the gas chromatography data.  
2.V.h. Measurement of ethanol concentration using headspace gas 
chromatography 
To determine ethanol tissue concentration relative to media exposure, 
headspace gas chromatography (GC) was utilized. Embryos were exposed to 
ethanol in media at 1% or .5%. Samples were taken at 1 hour and 14 hours post 
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ethanol exposure coordinating with 11 hours and 24 hpf, respectively. Additional 
embryos were removed from ethanol at 14 hours post ethanol exposure, washed 
three times with fresh media and allowed to equilibrate in fresh media for one 
hour where samples were again taken. Samples consisted of 10-pooled embryos 
that were quickly rinsed in fresh media and treated with 50 µL of Pronase (2 mg / 
mL) for 10 minutes to aid in the removal of the chorion. 450 µL of 5 M NaCl was 
then added to each sample and the samples were vortexed for 10 minutes to 
homogenate the embryos. For each sample, an aliquot of 10 µL was transferred 
to a 2 mL GC vial and sealed with a PTFE silicon septum and plastic cap. For 
each time point, a media reference sample was also collected, diluted 10 fold in 5 
M NaCl and a 10 µL aliquot was transferred to a 2 mL GC vial and sealed. A 
Varian CP 3800 gas chromatograph with flame ionization detection and a Varian 
CP 8400 headspace autosampler, heated to 58°C, was used to analyze the 
concentrations of ethanol in the samples. The stationary phase was an HP 
Innowax capillary column (30 m × 0.53 mm × 1.0 µm film thickness) and helium 
was the mobile phase. Resulting ethanol peaks were recorded using Varian Star 
Chromatography Workstation software, and calibration was achieved using 
external standards from .3125 to 40 mM ethanol in 5 M NaCl. Ethanol 
concentration in the embryos samples were compared to media controls by a 




2.V.i. Human sample 
The published data were collected as part of an ongoing international 
consortium, the Collaborative Initiative on Fetal Alcohol Spectrum Disorders 
(CIFASD). Participants were recruited from three sites (San Diego and Los 
Angeles, California and Atlanta, Georgia). This study was approved by the 
Institutional Review Board at each site. All participants and/or their 
parent(s)/legal guardian(s) provided written informed consent. 
As part of the study visit, each participant was examined by a trained 
dysmorphologist who completed a standardized, uniform assessment (Jones et 
al., 2006). Patients with a recognizable craniofacial syndrome other than FAS 
were excluded. An objective classification system, based solely on structural 
features (palpebral fissure, philtrum, and vermillion border) and growth deficiency 
(head size and height and/or weight) consistent with the revised Institute of 
Medicine criteria (Hoyme et al., 2005), was used to classify subjects. Under this 
scheme, a participant could receive a preliminary diagnosis of FAS, no FAS, or 
deferred (Jones et al., 2006). Alcohol exposure data were collected at the 
interview, or from a review of available study data. The extent of reported 
prenatal alcohol exposure information was then classified into one of three 
categories: none, minimal (> 1 drink/week average and never more than two 
drinks on any one occasion during pregnancy), and greater than minimal (>4 
drinks/occasion at least once/week or >3 drinks/week).  Alcohol exposure was 
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confirmed via review of records or maternal report, if available (Mattson et al., 
2010).  
As part of the study visit, a three-dimensional facial image was collected 
using the 3dMD system (3dMD, Atlanta, Georgia).  Landmarks were identified on 
the 3D model and used to obtain linear measurements. Replication of landmark 
placement was required, with less than 2 mm difference per linear measurement.  
If the tolerance criterion was not met, a third measurement was taken and the 
average of the two closest measurements was chosen for analysis. For bilateral 
measurements, only the left side was used in analyses.  Although a set of sixteen 
standard anthropometric measurements (Moore et al., 2007) were obtained, for 
this study we only utilized a subset: inner canthal width, outer canthal width, 
lower facial height, lower facial depth and midfacial depth – which best modeled 
the craniofacial defects seen in the zebrafish model. 
Genomewide single nucleotide polymorphism (SNP) genotyping was 
completed at the Johns Hopkins GRCF SNP Center using OmniExpress genome 
array, which includes over 700,000 SNPs. Standard review of both sample and 
SNP was performed (see supplemental text). Race and ethnicity were reported 
by the participant or the parent/guardian as part of the study visit and were then 
confirmed based on the SNP genotypes using a principal component analysis 
(see Supplemental Text for more details). To reduce phenotypic heterogeneity 
due to race, we limited the analyses to those subjects who based on their SNP 
genotypes were of European American descent (n=102). 
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The regulation and function of Pdgf signaling is highly conserved across 
vertebrate species; therefore, we identified the SNPs within each of the 5 genes 
in the PDGF pathway. Due to the small size of PDGFA (12,700 bp), no SNPs 
were genotyped or analyzed in this gene, therefore, we could only test the role of 
5 of the 6 genes in the PDFG pathway. Univariate analysis was performed for 
each SNP using linear regression framework to test whether the SNP genotype x 
alcohol exposure interaction accounted for a significant proportion of the variation 
in the 5 key anthropometric measures. Within the model we also included the 
main effects of SNP genotype and alcohol exposure. All measures were 
corrected for age and gender.  We utilized a Bonferroni correction for the number 
of genes (5 genes) being tested, which resulted in a significance threshold of 
0.01 (0.05/5). 
2.V.j. Ethics Statement 
Data were collected as part of an ongoing international consortium, the 
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). 
Participants were recruited from three sites (San Diego and Los Angeles, 
California and Atlanta, Georgia). This study was approved by the Institutional 
Review Board at each site. All participants and/or their parent(s)/legal 
guardian(s) provided written informed consent. All embryos were raised and 




2V.k. Human GWAS 
Genotyping was performed at the Center for Inherited Disease Research (CIDR).  
All DNA sources consisted of saliva samples.  A total of 731,442 SNPs were 
genotyped on the OmniExpress array, of which 728,140 SNPs passed CIDR 
genotyping control and were released for analysis.  Out of the 240 samples 
submitted for genotyping, three samples were dropped by CIDR due to poor 
quality genotyping.  Two additional samples were dropped due to chromosomal 
abnormalities.  All remaining individuals were genotyped on at least 98% of the 
SNPs.  All samples were examined for cryptic relatedness and population 
stratification.   There were 16 half-sibling pairs and 37 full sibling pairs in the 
sample.   A principal component-based analysis was performed in eigenstrat 
(Price et al., 2006) on both the sample data and HapMap reference samples to 
assign subjects to racial groups.  The final European American sample consisted 
of 102 individuals, of which 102 had both a 3D image and alcohol exposure 
information. 
SNPs were included for analysis if the call rate was greater than 98% in 
the entire sample, and SNPs were removed if the minor allele frequency was less 
than 0.01 or if there was significant deviation from Hardy Weinberg equilibrium 
(p<10-6).  The final dataset consisted of 688,359, of which 118 were analyzed in 
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2.VII. Figures  
 
Figure 2.1: Ethanol exacerbates pdgfra mutant neurocranial defects and reveals 
haploinsufficiency. (A-F) show flat-mounted dorsal views of 5 dpf zebrafish 
neurocrania, stained for cartilage and bone using Alcian Blue and Alizarin Red, 
respectively. Anterior is to the left. (A) Control wild-type neurocranium. (B) 
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Control pdgfra heterozygotes develop normally. (C) Untreated pdgfra mutants 
have clefting of the ethmoid plate (asterisk), although the trabeculae are still 
present. (D-E) Neurocrania of embryos treated with 1.0% ethanol from 10 hours 
post fertilization (hpf) to 5 days post fertilization (dpf). (D) Wild-type embryos are 
predominantly normal following ethanol treatment. (E) Ethanol-treated pdgfra 
heterozygotes display variable palatal defects, including partial clefting of the 
ethmoid plate (asterisk), holes in the ethmoid plate (arrow) and breaks in the 
trabeculae (arrowhead). (F) Ethanol-exposed mutants have an invariant and 
complete loss of the palatal skeleton. (G) Quantification of palatal defects across 
genotypes and treatments: control (no ethanol), 0.5% ethanol from 10 hpf to 5 
dpf, 1.0% ethanol from 10 hpf to 5 dpf, and 1.0% ethanol from 10-24 hpf. The 












Figure 2.2: Ethanol induces pharyngeal hypoplasia in pdgfra mutants. (A-F) show 
flat mounted jaw and jaw support elements, anterior to the left, stained for 
cartilage and bone with Alcian Blue and Alizarin Red, respectively. Untreated 
control (A) wild-type, (B) pdgfra heterozygous and (C) pdgfra mutant embryos all 
have normally shaped cartilages. (D & E) Treatment with 1.0% ethanol from 10 
hpf to 5 dpf does not effect the overall shape of cartilages in (D) wild-type or (E) 
pdgfra heterozygous embryos. (F) Ethanol treatment greatly disrupts the shape 
of the palatoquadrate and hyosymplectic cartilages in pdgfra mutants. (G-I) 
Graphs show the quantification of the average area of the (G) Meckel’s (mc), (H) 
palatoquadrate (pq) and (I) hyosymplectic (hs) cartilages (standard error bars are 
depicted at 1.5 SEM, see Supplemental Table 1 for full ANOVA statistical 
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analysis). wild-type,light bar; pdgfra heterozygote, gray bar; pdgfra mutants, dark 
bar. Jaw cartilages are Meckel’s cartilage (mc) and the palatoquadrate (pq). Jaw 





















Figure 2.3: pdgfra mRNA partially rescues the ethanol-induced defects. (A-C) 
show pdgfra mutant (-/-) 5 dpf neurocrania, and (A’-C’) are the corresponding jaw 
and jaw support elements collectively stained for cartilage and bone using Alcian 
Blue and Alizarin Red, respectively. Anterior is to the left. (A,A’) Untreated control 
pdgfra mutant; (B, B’) 1.0% ethanol-treated pdgfra mutant from 10-24 hpf, (C, C’) 
pdgfra mRNA injection partially rescues the trabeculae (D, arrowhead), jaw and 
jaw support defects in 1.0% ethanol-treated pdgfra mutants (note particularly the 






Figure 2.4: mirn140 morpholino protects pdgfra mutants against ethanol-induced 
defects. (A-I) show dorsal views of 5 dpf zebrafish neurocrania stained for 
cartilage and bone using Alcian Blue and Alizarin Red, respectively. Anterior is to 
the left. (A-C) Untreated control embryos of each genotype. (D-F) Embryos from 
each genotype treated with 1.0% ethanol from 10-24 hpf. (G-I) Embryos injected 
with mirn140 morpholino (MO) and treated with 1.0% ethanol from 10-24 hpf. 
Arrowhead points to the distal tip of the trabeculae in the mutants in each 
treatment. Figure provided by Mary E. Swartz.  
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Figure 2.5: Ethanol-treatment causes a decrease in overall neurocranial length 
and width in pdgfra mutants.  Graphs depict the average (A) palate length, (B) 
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posterior neurocranial length, and (C) neurocranial width in micrometers. X-axis 
on all graphs denote either untreated, 0.5% ethanol from 10 hpf-5dpf, 1% ethanol 
from 10 hpf to 5 dpf, or 1% ethanol from 10 hpf to 24 hpf (standard error bars are 
depicted at 1.5 SEM, non-overlapping bars indicate significant differences; 
Moses, 1987). Wild-type, light bar; pdgfra heterozygote, gray bar; mutant, dark 
bar. (D) Depicts alcian and alizarin stained 5 dpf untreated wildtype 
neurocranium. Palate length was measured from the most anterior part of the 
ethmoid plate (ep) to the ends of the trabeculae (tr). The posterior neurocranium 
was measured from the most posterior part of the occipital arches (oc) to the 
ends of the trabeculae (tr). Neurocranial width was measured between the most 
lateral edges of the lateral commissures (lc). (E) Statistical analyses comparing 
the genotype/ethanol interactions to individual genotype and treatment controls. 
“Y” denotes a significant difference. Wildtype (+/+) comparisons denote if there is 












Figure 2.6: Ethanol treatment does not disrupt the pectoral fin in pdgfra mutants. 
Panels A-D depict fin cartilage elements, proximal to the left, stained for cartilage 
and bone using Alcian Blue and Alizarin Red, respectively. Untreated (A) 
wildtype and ethanol-treated (B) wildtype. Untreated (C) pdgfra mutant and 







Figure 2.7: colIIa expression is unaffected in cartilage elements not lost in 
ethanol-treated pdgfra mutants. (A-H) show ventral views of 48 hpf colIIa in situ 
hybridization images with anterior to the left. (A, C, E, G) show the oral ectoderm 
(outline in white dots) showing ventral cartilage structures. (B, D, F, H) show the 
neurocranium. White arrows point the complete neurocranium in untreated and 
ethanol-treated wildtype siblings. Dark arrows label the most anterior region of 
the neurocranium in untreated and ethanol-treated mutants. Figure provided by 





Figure 2.8: Ethanol-treated pdgfra mutants exhibit an increase in neural crest cell 
death. (A-D) are confocal images of 24 hpf anti-active caspase 3-stained 
fli1;EGFP embryos . (A’-D’) show the active-caspase 3 staining only. Anterior is 
to the left. (A-A’) Untreated pdgfra mutants have low levels of neural crest 
apoptosis. (B-B’) Low levels of neural crest apoptosis are also present in ethanol-
treated wild-type embryos treated with 1.0% ethanol from 10-24 hpdf. (C-C’) 
Ethanol treatment causes a slight increase in neural crest cell death in 
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heterozygotes. (D-D’) pdgfra mutants have greatly elevated levels of neural crest 
apoptosis. (E) Graph depicts quantification of cell death across genotypes at 24 
hpf and 30 hpf after ethanol was removed at 24 hpf (Untreated control=dark bars, 
ethanol=light bars). Ethanol-treated pdgfra mutants show significant cell death 
compared to all other genotypes (One-way ANOVA, *p=<.05). (F) Graph depicts 
quantification of the ratio of cell death compared to total cell numbers across 
genotypes (Untreated control=dark bars, ethanol=light bars). (G) 5 dpf pdgfra 
mutant treated with 1.0% ethanol and 25 µM caspase inhibitor from 10-24 hpf 
and stained for cartilage and bone using Alcian Blue and Alizarin Red, 
respectively. Anterior is to the left. Arrowheads denote partial rescue of the 





Figure 2.9: Ethanol treatment does not cause developmental delay or global 
increases in cell death in pdgfra mutants. (A,C,E,G, A’,C’,E’,G’) show 24 hpf 
embryos, anterior to the left, stained for active caspase 3. There is no 
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widespread elevation of apoptosis in the head or trunk of ethanol treated pdgfra 
mutants as compared to other groups. The trunk and yolk are outlined by white 
dots in A”,B”,C” and D”. (B,D,F,H) DIC images of ethanol treated and untreated 
pdgfra mutants and siblings show that ethanol treated pdgfra mutants are not 
developmentally delayed and have no gross morphological defects at 24 hpf. 
With the exception of the ethmoid plate and the trabeculae, all precartilage 


















Figure 2.10: Neural crest-specific proliferation is not reduced in ethanol-treated 
pdgfra mutants. Graph depicts average number of pHH3-positive neural crest 
cells in untreated (white bar) versus ethanol-treated (gray bar) wild-type (+/+) and 











Figure 2.11: At 24 hpf ethanol-induced cell death occurs in pharyngeal arch 
areas destined to contribute to the jaw and jaw support elements. (A-D) depict 24 
hpf embryos, anterior to the left. Each dot marks the relative position of an 
apoptotic neural crest cell. (A) Untreated controls, yellow marks the first 
pharyngeal arch, grey marks the second pharyngeal arch.  (B-D) 1.0% ethanol-
treatment from 10-24 hpf in (B) wild-types, (C) pdgfra heterozygotes, and (D) 
pdgfra mutants. Cell death is enriched in areas fated to become the palatal 
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skeleton and dorsal pharyngeal arch skeletal elements. Wild-type, blue dots; 






















Figure 2.12: pten morpholino injection does not alter neurocranial development in 
untreated and ethanol-treated wild-type and pdgfra heterozygotes. (A-H) show 
dorsal views of 5 dpf zebrafish neurocrania, stained for cartilage and bone using 
Alcian Blue and Alizarin Red, respectively. Anterior is to the left. (A-B) Untreated 
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controls. (C-D) 1.0% ethanol treatment from 10-24 hpf. (E-F) pten morpholino 
injections. (G-H) pten morpholino injections with 1.0% ethanol treatment from 10-





















Figure 2.13: pten morpholino injections do not alter jaw and jaw support 
development in untreated and ethanol-treated wild-type and pdgfra 
heterozygotes. (A-H) Flat mount views of 5 dpf zebrafish jaw and jaw supports, 
stained for cartilage and bone using Alcian Blue and Alizarin Red, respectively. 
Anterior is to the left. (A-B) Untreated controls. (C-D) 1.0% ethanol treatment 
from 10-24 hpf. (E-F) pten morpholino injections. (G-H) pten morpholino 
injections with 1.0% ethanol treatment from 10-24 hpf. Meckel’s cartilage, mc; 




Figure 2.14: Injection of pten morpholino rescues the craniofacial defects in 
ethanol-treated pdgfra mutants. (A-D) show 5 dpf pdgfra mutant (-/-) neurocrania 
and (A’-D’) are the corresponding pharyngeal skeletal elements, stained for 
cartilage and bone using Alcian Blue and Alizarin Red, respectively. Anterior is to 
the left. (A-A’) Untreated mutants have clefting of the ethmoid plate, asterisk. (B, 
B’) Treatment with 1.0% ethanol from 10-24 hpf causes loss of the palatal 
skeleton and hypoplasia of the pharyngeal skeleton. (C-D’) Injection of pten 
morpholino (MO) rescues the craniofacial phenotypes of both (C-C’) untreated 
and (D-D’) ethanol exposed pdgfra mutants. Arrowheads mark the partially 





Figure 2.15: L-leucine does not alter the craniofacial skeleton of untreated and 
ethanol-treated wild-type and pdgfra heterozygotes. 5 dpf Alcian Blue and 
Alizarin Red stained flat mounted (A-H) neurocrania and (A’-H’) jaw and jaw 
supports. (A,A’,E,E’) Untreated controls. (B,B’,F,F’) 1.0% ethanol treatment from 
10-24 hpf. (C,C’,G,G’) 50 mM L-leucine treatment from 10-24 hpf. (D,D’,H,H’) 50 








Figure 2.16: L-leucine treatment from 24 to 48 hpf does not rescue the ethanol-
induced defects in 10-24 hpf treated mutants. Flat mounted 5 dpf Alcian Blue and 
Alizarin Red stained (A-C) neurocrania and (A’-C’) jaw and jaw supports, Ethanol 
was administered from 10-24hpf and 50mM L-leucine was added from 24-48 hpf. 







Figure 2.17: Both wortmannin and rapamycin phenocopy the effects of ethanol 
on pdgfra mutants. (A-L) show 5 dpf zebrafish neurocrania stained for cartilage 
and bone using Alcian Blue and Alizarin Red, respectively. Anterior is to the left. 
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Embryos were treated from 10-24 hpf with (A-C) DMSO, (D-F) 1.0% ethanol, (G-
I) 1.5 µM wortmannin or (J-L) 3 µM rapamycin.  Asterisks denote ethmoid-plate 
defects (ep), arrowheads denote trabeculae defects (tr). (M) Graph of percent 
defects found in all three genotypes, across treatments. Unaffected denotes a 
wild-type phenotype, ep denotes ethmoid-plate defects (e.g. arrow and asterisk 
in K), tr denotes trabeculae defects (e.g. arrowhead in H). The zebrafish palate 






Figure 2.18: Both wortmannin- and rapamycin-treated pdgfra mutants show a 
decrease in overall neurocranial length and width. Embryos were treated from 
10-24 hpf with either DMSO, 1.0% ethanol, 1.5 µM wortmannin or 3 µM 
rapamycin. Inhibition of either PI3K or mTOR phenocopies the effects of ethanol. 
Graphs depict the average (A) palate length, (B) posterior neurocranial length, 
and (C) neurocranial width in microns (standard error bars are 1.5 SEM, non-
overlapping bars indicate significance; Moses, 1987). Wild-type, light bar; pdgfra 
heterozygote, gray bar; mutant, dark bar. (D) An Alcian Blue and Alizarin Red 
stained 5 dpf untreated wildtype neurocranium. Palate length was measured from 
the most anterior part of the ethmoid plate (ep) to the ends of the trabeculae (tr). 
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The posterior neurocranium was measured from the most posterior part of the 
occipital arches (oc) to the ends of the trabeculae (tr). Neurocranial width was 
measured between the most lateral edges of the lateral commissures (lc). D, 
















Figure 2.19: Treating pdgfra mutants with wortmannin or rapamycin induces 
pharyngeal skeleton hypoplasia. (A-L) show jaw and jaw support elements, 
anterior to the left, stained for cartilage and bone using Alcian Blue and Alizarin 
Red, respectively. Embryos were treated from 10-24 hpf with either (A-C) DMSO, 
(D-F) 1.0% ethanol, (G-I) 1.5 µM wortmannin or (J-L) 3 µM rapamycin. Inhibition 
of either PI3K or mTOR phenocopies the effects of ethanol. (M-O) Graphs depict 
the average area sizes of (M) the Meckel’s, mc (N) palatoquadrate, pq and (O) 
hyosymplectic, hs cartilages. X-axis on all graphs denote  D, DMSO; E, ethanol; 
W, wortmannin, R, rapamycin (standard error bars are depicted at 1.5 SEM, see 
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Supplemental Table 1 for full ANOVA statistical analysis). Wild-type, light bar; 
pdgfra heterozygote, gray bar; mutant, dark bar. Meckel’s cartilage, mc; 





















Figure 2.20: Ethanol affects phosphorylation of AKT and pEIF4B in ethanol-
treated pdgfra mutants. Tissue samples consist of 24 hpf harvested pdgfra 
mutant (-/-) and mixed pdgfra heterozygote/wild-type (+/?) heads in either 
untreated control or 1.0% ethanol treatment from 10-24 hpf. (A) Immunoblot was 
stripped and reprobed for total AKT, phospho-AKT (pAKT), and bactin for total 
loading control. Both ethanol-treated pdgfra heterozygote/wildtype and  pdgfra 
mutants have elevated levels of phospho-AKT compared to untreated 
counterparts. (B) Immunoblot was stripped and reprobed for total eIF4B (teIF4B), 
phospho-eIF4B (peIF4B), and bactin for loading control. pdgfra mutants have 
decreased levels of phospho-eIF4B compared to untreated mutants and both 







Figure 2.21: Rapamycin-treatment leads to an increase in phosphorylated AKT in 
both pdgfra mutants and siblings as compared to DMSO-treated controls.  Tissue 
samples consist of 24 hpf harvested pdgfra mutant (-/-) and sibling (+/?) heads 
from embryos of either DMSO or 3mM rapamycin treatment from 10-24 hpf. (A) 
Immunoblot was stripped and reprobed for total AKT, phospho-AKT (pAKT), and 
b-actin as a loading control. Rapamycin treatment caused elevated levels of 
phospho-AKT compared to untreated counterparts. (B) Graph of the 










  Mc pq hs 
0.50%       
+/+ N N N 
+/- N N N 
-/- N N N 
1.00%       
+/+ N N Y 
+/- N N Y 
-/- Y Y Y 
10-24       
+/+ N N N 
+/- N N N 
-/- Y Y Y 
 
 
Table 2.1: ANOVA statistics describing significant differences of skeletal 
elements across genotype and treatments. Tables are categorized by skeletal 
elements Meckel’s (mc), palatoquadrate (pq), and hyosympletctic (hs). ”Y” 
denotes a significant difference between the genotype/ethanol interaction relative 
to the genotype and ethanol treatment alone. wt, wild type; het, heterozygous; 
mut, mutant. Treatments are: unt, untreated; 0.5%, 0.5% ethanol from 10 hpf-5 








    
Table 2.2: Human SNP-ethanol interactions produce craniofacial measurement 
changes. Significant SNP-ethanol interactions associated with changes in 
craniofacial measurements are highlighted in yellow. Chr, chromosome; SNP, 
single-nucleotide polymorphism identification number; BP, base-pair; MAF, minor 
 98 
allele frequency; ICW, inner canthal width; OCW, outer canthal width; LFH, lower 
facial height; LFD, lower facial depth; MFD, mid-facial depth (Mattson et al., 




















Chapter 3: An Fgf-Shh signaling hierarchy regulates early 
specification of the zebrafish skull.1 
3.I. Abstract 
The neurocranium generates most of the craniofacial skeleton and consists of 
prechordal and postchordal regions. Although development of the prechordal is 
well studied, little is known of the postchordal region. Here we characterize a 
signaling hierarchy necessary for postchordal neurocranial development 
involving Fibroblast growth factor (Fgf) signaling for early specification of 
mesodermally-derived progenitor cells. The expression of hyaluron synthetase 2 
(has2) in the cephalic mesoderm requires Fgf signaling and Has2 function, in 
turn, is critical for postchordal neurocranial development. While Hedgehog (Hh)-
deficient embryos also lack a postchordal neurocranium, this is due to a later 
defect in chondrocyte differentiation. Inhibitor studies demonstrate that 
postchordal neurocranial development requires early Fgf and later Hh signaling. 
Collectively, our results provide a mechanistic understanding of early postchordal 
neurocranial development and demonstrate a hierarchy of signaling between Fgf 
and Hh in the development of this structure. 
1 Authors: Neil McCarthy1, Julien Y. Bertrand3, and Johann K. Eberhart1,2. 
1Department of Molecular Biosciences; Institute of cell and molecular biology, Waggoner Center for 
Alcohol and Alcohol Addiction Research, University of Texas, Austin, Texas. 
2Department of Molecular Biosciences; Institue of Neurobiology, University of Texas, Austin, Texas.  
3Department of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland.  
 100 
3.II. Introduction  
The neurocranium is an embryonic structure that generates essential craniofacial 
structures including the skull vault, skull base, and palate. The palate and skull 
base are connected and demarcate the prechordal, or anterior, and postchordal, 
or posterior, regions of the neurocranium, respectively. Extensive fate mapping in 
tetrapod species demonstrate that the neural crest and mesoderm contribute to 
the prechordal and postchordal neurocranium, respectively (Couly et al., 1992 
and 1993; Crump et al., 2004; Eberhart et al., 2006; Gross et al., 2008; Koentges 
and Lumsden, 1996; McBratney-Owen et al., 2008; Wada et al., 2011). Despite 
our knowledge of the tissue origins of the neurocranium, mechanistic studies of 
development have overwhelmingly focused on the prechordal neurocranium, 
while the postchordal region has been left largely neglected.  
For proper formation, the neurocranium requires the orchestration of 
numerous signaling and morphogenetic events, and is dependent on interactions 
with surrounding neural as well as non-neural ectoderm, mesoderm, and 
endoderm (Alexander et al., 2011; Kimmel et al., 2001; Marcucio et al., 2011; 
Noden and Trainor, 2005; Richtsmeier and Flaherty, 2013). The complexity of 
these interactions implicates the involvement of multiple signaling molecules in 
neurocranial development. Much progress has been made in elucidating those 
factors that induce craniofacial formation and patterning. These factors include 
many signaling pathways, including Shh, Fgf, Bmp, and Wnt (Alexander et al., 
2014; Marcucio, 2005; Richtsmeier et al., 2013; Wada et al, 2005; Wilson and 
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Tucker, 2004). No one single factor can direct craniofacial formation; instead, 
they interact in spatial and temporal hierarchies that coordinate craniofacial 
growth and development.  
While we know of many of the signaling hierarchies in the neural-crest 
derived-portions of the craniofacial skeleton, little is known of the mesoderm-
derived portions. Hosokawa et al showed that development of the posterior skull 
vault, a mesoderm-derived structure, involves a signaling hierarchy between 
TGF-B and Msx2 (Hosokawa et al., 2007). In mouse, chick, and zebrafish, Shh is 
a critical midline signal necessary for chondrocyte differentiation in the 
postchordal neurocranium, as well as other regions of the skull (Balczerski et al., 
2012; Eberhart et al., 2006; Wada et al., 2005). Specification of the early cephalic 
mesoderm, however, is refractory to sonic hedgehog signaling (Balcezerski et al., 
2012), suggesting that other signals are necessary for early cephalic mesoderm 
specification. Due to their proximity to the postchordal neurocranium and their 
importance in numerous aspects of craniofacial development, the Fibroblast 
growth factor (Fgf) family is a prime candidate for this function. 
Fgfs are part of a large family of intercellular signaling molecules (Itoh, 
2007) that emanate from multiple tissue sources in the head.  They are also 
crucial in numerous aspects of craniofacial development, including the proper 
migration, survival, and patterning of the neural crest (Creuzet et al., 2004; 
Crump et al., 2006; Hu et al., 2009; Wilson and Tucker, 2004) as well as cranial 
suture formation (Nie et al., 2006; Rice et al., 2000). Furthermore, Fgfs are 
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implicated in a number of congenital craniofacial disorders with reported skull 
base defects including Aperts and Crouzon (Aggarwal et al., 2006; Tokumaru et 
al., 1996). In a screen for gene-ethanol interactions, it was found that fgf8a and 
ethanol interact to affect postchordal neurocranial structures that could be 
recapitulated with rapamycin, an inhibitor of mTOR which is a constituent of 
growth factor signaling (Fig 3.1C and 3.1D compared to 3.1B; McCarthy et al., 
2013). Ethanol seems to broadly attenuate growth factor signaling (McCarthy et 
al., 2013), suggesting that the postchordal defects in the fgf8a-ethanol interaction 
are due to attenuated Fgf signaling. However, it is unclear what role Fgfs play in 
early postchordal neurocranial development in the absence of ethanol.  
Here, we characterize a signaling hierarchy required for proper 
postchordal neurocranial development involving Fgf and Shh signaling. Loss of 
function of both fgf3 and fgf8a lead to a striking loss of the postchordal 
neurocranium that can be rescued by restoring Fgf3 and Fgf8a signaling centers 
in the brain and mesoderm. We go on to precisely describe, for the first time, the 
dual tissue origins of the zebrafish neurocranium. The zebrafish postchordal 
neurocranium has small pockets of neural crest-derived areas occurring in a 
mostly mesodermally-derived structure. In situ analysis reveals that both the 
early cephalic mesoderm marker hyaluron synthetase 2 (has2) and markers for 
chondrocytes are lost in fgf3;fgf8a knockdown embryos, and that has2 is required 
for postchordal neurocranial development in an Fgf-dependent manner. 
Examination of Hh loss-of-function embryos reveals that Hh signaling is 
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dispensable for specification of head mesoderm. These results provide evidence 




3.III.a. The postchordal neurocranium requires fgf8a and fgf3.  
The neurocranium can be split into anterior and posterior halves (dashed line in 
Fig. 3.2A). While much research has been directed at the development of the 
neural crest-derived prechordal neurocranium (Fig. 3.2A, prech.), little is known 
of the development of the postchordal neurocranium (Fig. 3.2A, postch.). The 
postchordal neurocranium includes the parachordal cartilages (pc), which abut 
the notochord (n); as well as the anterior and posterior basicapsular 
commissures (abc & pbc, respectively) which encircle the developing ear, the 
lateral commissures (lc), and the occipital arches (oc) (Fig. 3.2A; de Beer, 1937). 
Due to its development adjacent to the notochord and the hindbrain, we 
reasoned that signals from one or both of these structures could influence 
posterior neurocranial development.  
Fgf8 and Fgf3 signal cooperatively to pattern the hindbrain, making these 
two Fgfs prime candidates for our analyses. We used a combination of genetic 
and morpholino-based loss of function of these Fgf ligands, each of which 
resulted in similar results (Fig. 3.2 and 3.3). Whereas neither fgf8a nor fgf3 
single-mutants show any profound postchordal neurocranial defects (Fig. 3.2B 
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and 3.2C compared to 3.2A), the vast majority of the postchordal neurocranium 
is absent in double fgf8a;fgf3 mutants (Fig. 3.2E, arrowhead), with only the 
prechordal neurocranium and occipital arches remaining. Furthermore, even the 
loss of a single allele of fgf3 in an fgf8a mutant background gives rise to variable 
postchordal neurocranial defects, including anterior basicapsular and 
parachordal cartilage loss (Fig. 3.2D, arrowheads). These mutants also have 
severe viscerocranial defects (not shown, Crump et al., 2004). Because, at least, 
fgf8a is maternally expressed (Reifers et al., 1998), we extended our analyses 
using the well-characterized morpholinos against each of these Fgfs (Crump et 
al., 2004; Liu et al., 2003; Maves et al., 2002).  
Morpholinos targeting either fgf8a or fgf3 injected into fgf3 or fgf8a 
mutants, respectively, recapitulated postchordal neurocranial defects observed in 
the double mutants (Fig. 3.3). Embryos injected with fgf3 morpholinos display 
infrequent loss of the anterior basicapsular commissure (24%, n=6/24, Fig. 3.3), 
however the remainder of the neurocranium in these embryos is well developed. 
Embryos injected with fgf3 morpholinos also consistently display fused otoliths 
(Fig. 3.2) as well as variable viscerocranial defects, including fusions of Meckel’s 
cartilage and the palatoquadrate, and loss of the ceratobranchial cartilages (data 
not shown; Crump et al., 2004). As in our mutant analysis, we found strong 
synergy between fgf8a and fgf3 in development of the postchordal neurocranium.  
In contrast to phenotypes in single mutants, the postchordal neurocranium 
is lost in fgf3 morpholino-injected fgf8a mutants (100%, n=21/21, Fig. 3.2). The 
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ethmoid plate and trabeculae are retained, albeit reduced, in these embryos 
(n=21/21). Viscerocranial defects also occur in these embryos, including variable 
hyosymplectic loss, severe reductions and fusions of Meckel’s cartilage and the 
palatoquadrate (data not shown; Crump et al. 2004). Lastly, we could 
recapitulate the postchordal neurocranial loss in fgf8a morpholino-injected fgf3 
mutants (Fig. 3.2). Together, these data show fgf3 and fgf8a synergize during 
postchordal neurocranial development.  
Fgf signaling occurs through four receptors (Itoh et al., 2002); however, 
they are expressed in multiple tissues throughout development (Sivak et al., 
2005; Thisse and Thisse, 2005). To understand which receptor is involved in 
postchordal neurocranial development, we used the fgf8a mutant line and a 
suboptimal dose of morpholino to target each receptor individually. While fgfr1, 
fgfr2, and fgfr4 knockdowns in the fgf8a mutant background caused variable ear 
and viscerocranial defects, no postchordal neurocranial defects were found (not 
shown). However, a suboptimal dose of fgfr3 morpholino injected into fgf8a 
mutants showed variable defects to the postchordal neurocranium that mirrored 
those seen in fgf8a;fgf3 double loss-of-function embryos (Fig. 3.4). These data 
suggest that Fgfr3 is a strong candidate for Fgf-mediated postchordal 





3.III.b. The mesoderm and neural ectoderm are Fgf sources required for 
postchordal neurocranium formation.  
Fgf signaling is required throughout development, forming numerous centers of 
activity including the mesoderm and neural ectoderm early, and the endoderm 
and otic placode later (Crump et al., 2004; Sivak et al., 2005; Thisse and Thisse, 
2005). To investigate the required Fgf signaling source for postchordal formation, 
we generated genetic chimeras to re-introduce Fgf signaling from wild-type donor 
tissues in fgf3;fgf8 knockdown hosts. We tested four tissue sources: the 
mesoderm, neural ectoderm, endoderm, and otic placode (Fig. 3.5). While 
neither endoderm nor otic placode transplants restored the neurocranium 
(n=0/12 for endoderm, n=0/9 for otic placode, Fig. 3.5A-A’’, 3.5B-B’’), we 
observed a partial rescue of the postchordal neurocranium in embryos receiving 
either mesoderm or neural ectoderm transplants (n=4/7 for mesoderm, n=8/16 
for neural ectoderm, Fig. 3.5C-C’’, 3.5D-D’’, 3.5H). In these transplants most of 
the parachordal cartilage and anterior basicapsular commissure were present, 
but rescue was incomplete, suggesting that both tissues might be required. To 
test this dual requirement, double mesoderm and neural ectoderm transplants 
were performed, and indeed, complete rescue of the postchordal neurocrania on 
the transplanted side in fgf3;fgf8a loss-of-function hosts was attained (n=4/12 for 
full rescue, n=3/12 for partial rescue, Fig. 3.5E-E’’, 3.5H). Together, these data 
suggest that Fgf signaling from the mesoderm and neural ectoderm cooperate 
during formation of the postchordal neurocranium.   
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The otic placode is induced by Fgf signaling from the neural ectoderm 
(Leger and Brand, 2002; Sai and Ladher, 2015), so it is possible that we restored 
these signals by our neural ectoderm transplants. Thus, the partial rescue by 
neural ectoderm could be due to the otic placode. To directly test this possibility, 
we injected embryos with dlx3b and foxi1 morpholinos which results in the loss of 
the otic placode (Solomon et al., 2002; Solomon et al., 2003). While injection of 
both dlx3b and foxi1 caused complete loss of the otic placode at 24 hpf (Fig. 3.6), 
only the anterior basicapsular commissure was missing or reduced in these 
embryos (Fig. 3.6). These data show that while the otic placode may provide 
signals required for the anterior basicapsular commissure, defects to the otic 
placode itself do not explain the extensive loss of the postchordal neurocranium 
found in fgf3;fgf8 loss of function embryos.  
 
3.III.c. The postchordal neurocranium is primarily mesoderm-derived.  
Deeper analysis of the role of Fgf signaling in postchordal development requires 
a detailed characterization of the precursors to this structure. However, the 
origins of the postchordal neurocranium are unknown in zebrafish. To fully 
characterize any neural crest contribution to the postchordal neurocranium, we 
utilized three neural-crest labeling transgenic lines, sox10:KikGR, sox10:Kaede, 
and sox10:Cre;ubi:RSG (Balczerski et al., 2012; Dougherty et al., 2013; Kague et 
al., 2012). The sox10:KikGR and sox10:Kaede embryos were photoconverted at 
24 hpf to label all neural crest cells, while the sox10:Cre;ubi:RSG line genetically 
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labels neural crest cell descendants (Kague et al., 2012). Results in all 3 lines 
were identical, with extensive labeling in the ethmoid plate (ep) and trabeculae 
(tr) of the prechordal neurocranium (Fig. 3.7A-D, 3.7G, data not shown; Eberhart 
et al., 2006; Kague et al., 2012; Wada et al., 2005). We also observed highly 
localized labeling within postchordal structures. Labeled areas included the 
lateral auditory capsule as well as the lateral and anterior-most region of the 
anterior basicapsular commissure (Fig. 3.7A-D, 3.7G). It is of interest that this 
precise region articulates with the second arch crest-derived hyosympletic of the 
viscerocranium (Crump et al., 2004).  
The first and second arches are composed of Hox-negative and Hox-
positive neural crest cells, respectively (Crump et al., 2006). These arches 
undergo dynamic morphogenetic movements that involve numerous neural crest-
specific cellular rearrangements (Crump et al., 2004; Crump et al., 2006; 
Eberhart et al., 2006). To elucidate which pharyngeal arch contributes neural 
crest cells to the postchordal neurocranium, we performed fate mapping with 
sox10:Kaede embryos. We photoconverted either the first or second arch at 26 
hpf (Fig. 3.8; Crump et al., 2006), and found that the second arch crest 
contributed to the lateral auditory capsule (Fig. 3.8), while the first arch crest 
contributed to the lateral and anterior most region of the anterior basicapsular 
commissure (Fig. 3.8). Together, these results show that Hox-negative and Hox-
positive neural crest cells contribute to adjacent regions of the postchordal 
neurocranium. 
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In both mouse and chicken, mesoderm contributes significantly to the 
posterior neurocranium. We used the mesoderm-labeling drl:CreERT2;ubi:switch 
line to track mesoderm derivatives in zebrafish (Fig. 3.9; Mosimann et al., 2011). 
Tamoxifen was added from 6 hpf to 24 hpf to induce Cre- excision. We find a 
pattern of labeling perfectly complimentary to that generated by the neural crest 
(Fig. 3.7E–G). The parachordal cartilages, posterior basicapsular commissures, 
and occipital arches appear to be completely of mesoderm origin (Fig. 3.7E-G). 
The regions of the anterior basicapsular commissure that were not labeled by 
neural crest are also of mesoderm origin (Fig. 3.7E-G). The lateral commissure 
was the only structure where neural crest and mesoderm cells appear to mix 
(Fig. 3.7). Collectively, these data provide a high-resolution fate map of neural 
crest and mesoderm contribution to the neurocranium and suggest that, even in 
regions of dual origin, there is little mixing between these cell types. 
In order to determine what happens to this mesoderm population in Fgf 
loss-of-function embryos, a detailed fate map of these postchordal progenitor 
cells was necessary. We used Kaede photoconversion to label and track groups 
of cells from 24 hpf to 4 days post fertilization (dpf), when the postchordal 
neurocranium is well formed in zebrafish (Fig. 3.10A-D). We injected fli1:EGFP 
embryos with Kaede mRNA and labeled head mesoderm just dorsal to the 
pharyngeal arches for our analyses (Schilling and Kimmel, 1994). In the images, 
the intense EGFP fluorescence masks the much dimmer green Kaede 
fluorescence so only the red, photoconverted, Kaede is apparent. We find that at 
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24 hpf, the progenitors of the postchordal neurocranium are positioned within the 
head in relative accord to their location at 4 dpf (Fig. 3.10E and 3.10E’, see Fig. 
3.11 for individual data). Overall, no relative change in position of these labeled 
cells occurred between 24 hpf and 4 dpf. Cells labeled anterior of the otic 
capsule (o.c.) maintain this position at 4 dpf (Fig. 3.10E and 3.10E’, dark grey 
shade). Those cells labeled more medial and posterior to the otic capsule at 24 
hpf populate areas medial and posterior 4 dpf (Fig. 3.10E and 3.10E’, gray and 
light gray shades). During this same time period, neural crest cells appear to 
undergo extensive cell rearrangements in forming skeletal structures (Crump et 
al., 2006; Le Pabic et al., 2014). We find little dispersion of labeled mesoderm 
cells, suggesting a lack of similar rearrangements in the mesoderm-derived 
skeleton. Together, these data show that the progenitors of the postchordal 
neurocranium are appropriately positioned along the anterior to posterior axis at 
24 hpf.  
 
3.III.d. Proper specification of the head paraxial mesoderm requires Fgf 
signaling.  
Our fate map of the postchordal neurocranium shows that these cartilage 
precursors are in place by 24 hpf. To investigate whether these precursors are 
present in embryos lacking fgf3 and fgf8a, we analyzed the expression of the 
prechondrogenic marker sox9a and the cartilage marker col2a1a. Compared to 
un-injected and control morpholino-injected fgf8a mutants, fgf3;fgf8a double loss 
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of function embryos display a loss of col2a1a in the cephalic mesoderm (Fig. 
3.12D, compared to 3.12A-C, asterisks; Piotrowski et al. 2000). The notochord 
staining for col2a1a is retained in double loss-of-function embryos, demonstrating 
specificity of the effect (Fig. 3.12D, arrowheads denote anterior notochord). 
Furthermore, the pre-cartilage marker sox9a is also lost in these fgf3 morpholino-
injected fgf8a mutants (Fig. 3.12H, compared to 3.12E-G). Together, these data 
suggest that the head paraxial mesoderm that will generate these cartilages is 
either mislocalized or improperly specified when Fgf signaling is attenuated. 
To directly address if head paraxial mesoderm is mislocalized in Fgf loss-
of-function embryos, we tracked endomesoderm progenitor cells from the 
initiation of gastrulation (6 hpf) to the end of gastrulation (10 hpf) via Kaede 
photoconversion. We elaborated on established fate-maps of the mesoderm to 
label and track postchordal progenitor cells (Kimmel et al., 1990; Schilling and 
Kimmel, 1994). We injected embryos with Kaede mRNA, photoconverted 
endomesoderm cells adjacent to the shield at 6 hpf (Fig. 3.13A-B), and imaged 
their progression adjacent to the notochord at 10 hpf (Fig. 3.13C).  These labeled 
cells were then confirmed to contribute to the postchordal neurocranium at 4 dpf 
(Fig. 3.13D). Similar to control and Fgf single loss-of-function embryos, 
mesoderm cells in fgf3;fgf8a morpholino-injected embryos migrated to the 
notochord by 10hpf (Fig. 3.13H compared to 3.13E-G).  These results 
demonstrate that head paraxial mesoderm does migrate to its location lateral to 
the notochord in Fgf loss-of-function embryos and suggest that the postchordal 
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neurocranial defects may be due to a failure in specification of this population of 
head mesoderm cells.  
Because the head paraxial mesoderm expresses sox9a and col2a1a 
relatively early in development, we hypothesized that some genes important in 
chondrocyte maturation would be early markers of this population of head 
paraxial mesoderm. Hyaluronan synthetase 2 (has2) is required for hyaluronic 
acid synthesis (Bakkers et al., 2003; Moffatt et al., 2011; Necas et al., 2008; 
Weigel et al., 1997; Yoshida et al., 2000). Hyaluronic acid is an important 
extracellular glycosaminoglycan involved in numerous cellular processes 
including chondrocyte maturation (Moffatt et al., 2011; Necas et al., 2008). 
Mouse Has2 knockouts display cephalic mesoderm defects (Camenisch et al., 
2000) and in chick limb mesodermal cells, fetal bovine chondrocytes, mouse ear 
placodal cells, and breast cancer cells, Has2 is positively regulated by Fgf 
signaling (Bohrer et al., 2014; Hamerman et al., 1986; Munaim et al., 1991; 
Urness et al., 2010). These data suggest that has2 might not only be a marker of 
head paraxial mesoderm, but may also be important in the generation of the Fgf 
loss-of-function phenotype.  
Our earlier analysis revealed that localization of the head paraxial 
mesoderm was unperturbed in fgf3;fgf8 knockdown embryos at 10 hpf. However, 
by 10 hpf, has2-positive cells abutting the notochord in the most anterior region, 
where the postchordal neurocranium is developing, are lost in fgf3;fgf8 
knockdown embryos (Fig. 3.14D-D’, compared to 3.14A-C, 3.14A’-C’). No gross 
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alterations in earlier has2 expression, at 6 hpf, could be ascertained in fgf3;fgf8 
knockdown embryos (Fig. 3.15). This suggests that early cephalic mesoderm is 
not properly specified when Fgf signaling is attenuated.  
Chondrocyte maturation has been shown to rely on has2 function, 
however, it was unclear whether loss of has2 contributed directly to the 
postchordal neurocranial defects in fgf3;fgf8 knockdown embryos. Utilizing a 
previously published morpholino targeting has2 (Bakkers et al., 2004), we 
injected fgf8a mutants with a suboptimal dose of the has2 morpholino. Wildtype 
siblings are largely unaffected in the posterior neurocranium (Fig 3.14G 
compared to 3.14E), as are control morpholino-injected fgf8a mutants (Fig 3.14F 
compared to 3.14E). However, has2 morpholino-injected fgf8a mutants display 
partial loss of the postchordal neurocranium (Fig. 3.14H, arrowheads). These 
data suggest that the exacerbated postchordal neurocranial defects observed in 
fgf3;fgf8 knockdown embryos is, at least, partially due to loss of has2.  
The major function of Has2 is in the synthesis of hyaluronic acid (Bakkers 
et al., 2003; Moffatt et al., 2011; Necas et al., 2008; Weigel et al., 1997; Yoshida 
et al., 2000). To test the requirement of this function of has2, we treated fgf8a 
mutants with a suboptimal concentration of 4-methylumbelliferon (4-MU; Sigma-
Aldrich), which is known to inhibit hyaluronic acid production (Garcia-Vilas et al., 
2013). Treating fgf8a mutants with 4-MU between 6 and 10 hpf did not result in 
appreciable postchordal neurocranial defects (not shown). However, when 
treated between 10 and 30 hpf, 4 MU-treated fgf8a mutants display loss of 
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col2a1a expression at 30 hpf and, at 5 dpf, disruption of mesodermal-derived 
portions of the postchordal neurocranium, as compared to control-treated fgf8a 
mutants and 4 MU-treated wildtype siblings (Fig. 3.16). Collectively, these data 
suggest that the postchordal neurocranial defects found in Fgf-compromised 
embryos is dependent on hyaluronic acid production following gastrulation. 
Due to the loss of has2 expression at 10 hpf in fgf3;fgf8a knockdown 
embryos, we reasoned that Fgf signaling would be required early for postchordal 
neurocranial development. Using a suboptimal dose of SU5402 (Tocris 
Biosciences) from 6 to 10 hpf on fgf8a mutants and siblings, we found that, while 
SU5402-treated wildtypes showed normal neurocranial development (Fig. 3.17B 
compared to 3.17A and 3.17E), both heterozygote and mutant fgf8a zebrafish 
showed postchordal neurocranial defects, affecting the anterior basicapsular 
commissure in heterozygotes, and the entirety of the postchordal neurocranium 
in mutants (Fig. 3.17D compared to 3.17A-C, 3.17E). Furthermore, has2 
expression at 10 hpf in SU5402-treated fgf8a mutants is completely absent in the 
region of the developing postchordal neurocranium (compare Fig. 3.17I to 3.17F 
and 3.17G). These data strongly suggest that Fgf signaling is required during 





3.III.e. The notochord is dispensible in the formation of the postchordal 
neurocranium 
Our data shows that Fgf signaling, originating from the mesoderm and neural 
ectoderm, is required in the development of the postchordal neurocranium. 
Previous reports have shown the importance of Shh signaling from the notochord 
in this process (Balczerski et al., 2012). Considering our data, Fgf and Shh 
together may form a signaling hierarchy required for postchordal neurocranial 
development. Thus, we investigated the function of the notochord and Shh in the 
formation of the postchordal neurocranium.  
To directly ask whether the maintenance of a notochord is necessary for 
cephalic mesoderm induction and postchordal neurocranial formation, we 
analyzed brachyury mutants (previously known as no tail), which transfate the 
notochord early in development (Amacher et al., 2002). However, brachyury 
mutants express has2 at 10 hpf (Fig. 3.18B-B’, compared to 3.18A-A’), col2a1a 
at 24 hpf (Fig. 3.18D), and retain a postchordal neurocranium (Fig. 3.18F, 
compared to 3.18E). These data show that notochord maintenance is 
dispensable for the formation of the postchordal neurocranium.  
In brachyury mutants, midline sources of Hh remain. To directly test the 
involvement of Hh signaling in posterior neurocranial development, we analyzed 
smo mutants, which lack all Hh signaling and a postchordal neurocranium (Varga 
et al., 2001). In smo mutants, we find that has2 expression in the region of the 
postchordal neurocranium is present (Fig. 3.19B-B’ compared to 3.19A-A’), but 
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there are severe reductions in cells expressing the chondrocyte marker col2a1a 
(Fig. 3.19D compared to 3.19C, Eberhart et al., 2006; Wada et al., 2005). Our 
smo data suggests that Hh signaling is required for differentiation of 
chondrocytes in the mesoderm-derived postchordal neurocranium after 10 hpf.  
To directly test the temporal requirement of Hh in the formation of the 
posterior neurocranium, we utilized the pan-Hh inhibitor cyclopamine (Toronto 
Research Chemicals; Hirsinger et al., 2004). Treating wildtype embryos from 6 to 
10 hpf with cyclopamine did not alter has2 expression at 10 hpf in the anterior 
region of the embryo (Fig. 3.20B and 3.20B’ compared to 3.20A and 3.20A’). In 
these same embryos, col2a1a expression at 24 hpf remained as well (Fig. 3.20D 
compared to 3.20C), albeit to a potentially lesser degree. However, blocking Hh 
signaling between 10 and 24 hpf resulted in the complete of of col2a1a 
expression (Fig. 3.20E). Together, these data demonstrate that Hh signaling is 
required for cartilage differentiation, but not early specification of mesoderm-
derived postchordal neurocranial progenitors.  
 
3.IV. Discussion 
Here we describe a hierarchy of genetic signaling required for the specification 
and differentiation of the postchordal neurocranium in zebrafish. The postchordal 
neurocranium is a structure primarily derived from mesoderm, and is lost in 
embryos with attenuated Fgf or Shh signaling. Fgf signaling plays an early role in 
the specification of head mesoderm via has2, and the loss of has2 and 
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subsequent hyaluronic acid production is at least partly causative of the 
postchordal neurocranial defects. Shh signaling is then required for the later 
differentiation of sox9a and col2a1a-expressing chondrocytes in the postchordal 
neurocranium. Together, these results reveal a previously unknown genetic 
signaling hierarchy required in the development of the postchordal neurocranium.    
 
3.IV.a. The dual origin of the zebrafish neurocranium 
The zebrafish neurocranium originates from the neural crest and mesoderm. 
Frog, mouse, and chick fate-maps show similar neurocranial contributions 
(Couley et al., 1993; Gross and Hanken, 2008; Jiang et al., 2002; Koentges and 
Lumsden, 1996; McBratney-Owen et al., 2010). Our results strongly suggest that 
the ancestral pattern of neurocranial contribution is neural crest being largely 
restricted to prechordal regions, and mesoderm only providing contributions to 
postchordal regions. The prechordal neurocranium is exclusively of neural-crest 
origin. This region of the neurocranium has received a good deal of 
characterization in zebrafish (Eberhart et al., 2006; Kague et al., 2012; Mongera 
et al., 2013; Wada et al., 2005), therefore, here we will focus on the postchordal 
neurocranium.  
Using a pan-mesodermal Cre-transgenic line driven by draculin, we found 
that the majority of the postchordal neurocranium is mesoderm derived. In mouse 
and chick, the postchordal neurocranium is also primarily mesoderm-derived 
(Couley et al., 1992 and 1993; Koentges and Lumsden, 1996; McBratney-Owen 
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et al., 2008). This data is lacking in frog, however, in neural-crest labeling fate-
map studies, non-neural crest derived cartilages are all positioned in the 
postchordal neurocranium (Gross and Hanken, 2008).  
More effort has been spent in mapping the neural crest-derived portions of 
the skull (Couley et al., 1993; Gross and Hanken, 2008; Kague et al., 2012; 
Koentges and Lumsden, 1996; Jiang et al., 2002; McBratney-Owen et al., 2010). 
Our fate mapping has defined the precise postchordal structures that neural crest 
cells contribute to in zebrafish, including the most lateral regions of the 
basicapsular commissures, the lateral auditory capsule, and the parts of the 
lateral commissures. These areas are important for articulations with the jaw 
support element the hyosymplectic, as well as muscle attachment sites 
(Koentges and Lumsden, 1996). Furthermore, Hox-negative and Hox-positive 
neural crest contribute to distinct regions of the postchordal neurocranium. Along 
with results in chick (Koentges and Lumsden, 1996), this finding suggests an 
evolutionarily conserved function of neural crest in forming attachment sites in 
the postchordal neurocranium with the neural crest-derived jaw, jaw supports, 
and muscle attachment sites (Koentges and Lumsden, 1996).  
 
3.IV.b. Fibroblast growth factor signaling in the zebrafish neurocranium 
The vertebrate neurocranium is the product of the mesoderm and the cranial 
neural crest, yet requires interactions between multiple tissues. An important 
regulator of the development of the neural crest-derived portion of the 
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neurocranium is Fibroblast growth factor signaling (Creuzet et al., 2004; Crump 
et al., 2006; Monsoro-Burq et al., 2003). Our data reveals a second, and much 
earlier, role for Fgf signaling in the mesoderm-derived postchordal neurocranium.  
We show that loss of function of both fgf3 and fgf8a causes a severe 
defect in postchordal neurocranial development. The phenotypic differences 
between the fgf8a;fgf3 double mutant and the fgf3 morpholino-injected fgf8a 
mutants may be explained by the retention of maternally-supplied Fgfs early in 
development in the fgf8a;fgf3 double mutants (Reifers et al., 1998). Analysis of 
downstream constituents of Fgf signaling, including sprouty genes, may show the 
phenotypic differences are due to genotypic ones. However, these analyses 
show that loss of function of Fgf signaling causes defects to the postchordal 
neurocranium. 
 The root of this defect lies in the misspecification of cephalic mesoderm at 
the end of gastrulation via downregulated expression of the chondrocyte-
regulator hyaluronan-synthetase 2 (has2), which is essential for hyaluronic acid 
production. In fgf8a mutants, loss of has2 or hyaluronic acid, led to perturbed 
postchordal neurocranial defects similar to fgf3;fgf8 loss of function embryos. 
How Fgfs function to activate has2 expression remains to be elucidated. Fgf 
signaling could maintain has2 expression directly, via STAT3 activation 
(Saavalainen et al., 2005).  Indeed, Fgf receptors have been shown to activate 
HAS2 function in breast cancer cells via STAT3 (Bohrer et al., 2014). Our 
analysis suggests Fgfr3 could work in this capacity, as knockdown in an fgf8a-
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mutant recapitulates postchordal neurocranial defects. Elucidating the pathway 
that activates has2 in an fgfr3-dependent fashion will be of ongoing interest.  
 
3.IV.c. A signaling hierarchy orchestrates the specification and 
differentiation of the postchordal neurocranium 
Proper craniofacial development relies on complex hierarchies of signaling 
pathways. Our analysis implicates Fgf signaling from the mesoderm and 
neuroectoderm is a major regulator of postchordal neurocranial development. 
Otic placode development is dependent upon signals from the neuroectoderm 
(Leger and Brand, 2002; Sai and Ladher, 2015), which could confound our otic 
placode transplantation results. However, loss of the otic placode itself only 
results in variable anterior basicapsular commissure loss, not the severe 
postchordal neurocranial loss phenotype observed in fgf3;fgf8 knockdown 
embryos. Thus, the mesoderm and neuroectoderm appear to be the most 
important sources of Fgf for postchordal development. 
Other studies have purported that the notochord is also vital in postchordal 
neurocranial formation and that shh emanating from this structure mediates the 
formation of the postchordal neurocranium via chondrogenesis of the paraxial 
mesoderm (Balzcerski et al., 2012). Consistent with this report, we find a loss of 
differentiated chondrocytes in the postchordal neurocranium. In contrast, has2 
expression was retained in both smoothened mutants, which completely lack Hh 
signaling (Varga et al., 2001), and in embryos treated with cyclopamine from 6-
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10 hpf. This shows that, unlike Fgf signaling, Hh signaling is dispensible in early 
specification of postchordal neurocranium precursors, but is important in their 
terminal differentiation.  
The notochord has been thought to be a critical source of Shh for posterior 
neurocranial development (Balzcerski et al., 2012). Analysis of brachyury 
mutants, which transfate the notochord during gastrulation (Amacher et al., 2002; 
Halpern et al., 1993), showed that the postchordal neurocranium was fully 
developed and included a chondrocytic region expanded into the area where the 
notochord develops. Due to the retention of shh expression in brachyury 
mutants, this suggests that the notochord is not a structural requirement for 
postchordal neurocranial development, but instead serves purely a signaling 
function, either through maintenance of the shh signal or by some other 
unexplained mechanism.  
Our findings now place Fgf signaling prior to Hh in the formation of the 
postchordal neurocranium. Cephalic mesoderm is first specified in an Fgf-
dependent manner beginning at 10 hpf via activation of has2. Temporal-loss of 
Fgf signaling via SU5402 treatment also shows that Fgf signaling is required 
early, from 6 to 10 hpf, for has2 activation. Loss of has2 ultimately results in the 
loss of the chondrogenic program resulting in postchordal neurocranial defects in 
Fgf loss-of-function embryos. Shh, on the other hand, is not required for this early 
activation of has2, but supports proper chondrogenic differentiation of this group 
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of cells. Together, these results clarify the temporal and genetic control required 
for proper postchordal neurocranial development in zebrafish.  
 
3.V. Materials and Methods 
3.V.a. Fish husbandry and care 
All embryos were raised and cared for using established protocols (Westerfield, 
1993) with IACUC approval from the University of Texas at Austin. The fgf8ati282a 
 (Brand et al., 1996), fgf3t24149(Herzog et al., 2004), brachyury b195 
 (Schulte-Merker et al., 1994), smoothenedb577(Varga et al., 2001), sox10:Cre 
(Kague et al., 2012), sox10:KikGR (Balczerski et al, 2012), sox10:kaede 
(Dougherty et al., 2013), ubi:switch (Mosimann et al., 2011), and ubi:RSG 
(Kikuchi et al., 2010) alleles have all been described previously. The drl:CreERT2 
line was generated using a 3.8kb draculin promoter upstream of the ATG start 
site. Primers used to amplify this promoter were: 
for1: ATTGCGGCCGCTTCAATTGTGGTTGAGCAGTC 
rev1: ATTACTAGTCCAAGTGTGAATTGGGATCG. The 3.8KB fragment was 
amplified with iProof polymerase (BioRad), then cloned into TOPO-Blunt 
(Invitrogen). After verification, the promoter was sub cloned into the Tol2 vector 
(Kawakami et al., 2004) upstream of the CRE-ERT2 (Feil et al, PNAS 1996). The 
Tol2-drl-creert2 vector was co-injected with Tol2 mRNA into AB* in order to 
establish a founder line. Tamoxifen was added from 10-24 hours post fertilization 
on the drl:CreERT2 line, and the sox10:KikGR and sox10:kaede lines were UV-
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activated at 24 hours post fertilization using DAPI-filter attached to a Zeiss LSM 
710. Embryos were treated in embryo media with 5 µM SU5402 (Tocris 
Biosciences) from 6 to 10 hpf, and 100 µM cyclopamine (Toronto Research 
Chemicals) or 1 mM 4-methyllumbiferone (Sigma-Aldrich) from 6 to 10 and 10 to 
24 hpf. 
3.V.b. Morpholino and RNA injection 
Approximately 5 nl of morpholinos (Gene Tools), working concentrations of 5 
mg/ml of a combination of fgf3b and fgf3c morpholinos with sequences 
5’GGTCCCATCAAAGAAGTATCATTTG3’ and 
5’TCTGCTGGAATAGAAAGAGCTGGC3’, respectively (Maves et al., 2002), of a 
combination of fgf8aE212 and fgf8aE313 with sequences 
5’TAGGATGCTCTTACCATGAACGTCG3’ and 
5’CACATACCTTGCCAATCAGTTTCCC3’ (Draper et al., 2001), and control 
morpholinos with sequence 5’CCTCTTACCTCAGTTACAATTTATA3’ were 
injected into one- or two-cell stage embryos of fgf8a and fgf3 lines. 
Approximately 3 nl of a working concentration of 3 mg/ml of fgfr3 morpholino with 
sequence 5’AAATGAGGTGTAATGTCTGACCTGT3’ was injected into fgf8a 
mutants. This dose was suboptimal, as it did not cause any defects to wildtype-
injected embryos. This is a splice-blocking morpholino targeting the first exon-
intron boundary of fgfr3. To validate the targeting of this morpholino, whole 
embryo RNA extracts were isolated from uninjected and fgfr3 morpholino-
injected zebrafish at 24 hpf using Trizol extraction (Invitrogen). cDNA pools were 
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then synthesized using Superscript First-Strand Synthesis System (Invitrogen). 
To detect changes in mRNA transcripts in morphant embryos, PCR was 
performed on cDNA pools using the gene-specific primers spanning the 
morpholino-targeted exon-intron boundary ForTACAGTGCACACCTGCTGTC 
and revAGCCAATGGATACTGGGCG giving a final size of 491 bp in wildtype. 
Other morpholinos used that were previously described: fgfr1: 5’-
GCAGCAGCGTGGTCTTCATTATCAT-3’(Scholpp et al., 2004); fgfr2: 5’-
GTCGAACCTCGAACGGGAAAGCGTA-3’(Nakayama et al., 2008); fgfr4: 5’-
ATATCTGCTGGAGTAAAAAATGAGG-3’(Nakayama et al., 2008); dlx3b: 5’- 
ATATGTCGGTCCACTCATCCTTTAAT-3’ (Solomon et al., 2002); foxi1: 5’- 
TAATCCGCTCTCCCTCCAGAAACAT-3’ (Solomon et al., 2003) 
; and, has2, which required dual injection of two morpholinos: 5’- 
AGCAGCTCTTTGGAGATGTCCCGTT-3’ and 5’- 
CGTTAGTTGAACAGGGATGCTGTCC-3’ (Bakkers et al., 2004).  
Kaede mRNA was injected into one-cell stage embryos, with or without 
morpholinos, and UV activated at either 6 or 24 hpf using a Zeiss LSM 710 
Confocal microscope.  
3.V.c. Cartilage and bone staining  
Five and four day postfertilization (dpf) zebrafish embryos were stained with 
Alcian blue and Alizarin Red (Walker and Kimmel, 2007), and then were either 
flat mounted (Kimmel et al., 1998) or had the viscerocrania removed for imaging. 
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Images were taken with a Zeiss Axio Imager-AI microscope. Graphs were made 
in Microsoft Excel 2011. 
3.V.d. Confocal Microscopy and figure processing 
Confocal z-stacks were collected on a Zeiss LSM 710 using Zen software. 
Images were processed in Adobe Photoshop CS. Kaede and tissue fate maps 
were generated in Adobe Photoshop CS by overlaying images gathered on the 
Zeiss confocal. Graphs were generated using Microsoft Excel 2011. 
3.V.e. In Situ Hybridization 
RNA in situ hybridization was performed as reported in Miller et al. (2000). AB 
wildtype, fgf8a, fgf3;fgf8a morpholino, brachyury, and smoothened embryos were 
treated with 0.0015% PTU (1-phenyl 2- thiourea) to inhibit the production of 
melanin (Westerfield et al., 1993). Probes used were sox9a (Yan et al., 2002), 
col2a1a (Yan et al., 1995), and the has2 probe was generated using primers 
For:ACAAGTCACTGGCCCTATGC and Rev:GGTAGGTAATGGGCGTCTCG 
(NCBI ref# NM_153650.2). DIC images of in situ hybridizations were collected on 
a Zeiss Axioimager. 
3.V.f. Cell transplants 
Genetic mosaics were generated as described elsewhere (Crump et al., 2004; 
Maves et al., 2002; Stafford et al., 2006). For neural and otic placode tissue 
transplants, embryos were injected at the 1-2 cell stage with 2.5% Rhodamine 
Alexa 568 dextran. At shield stage (6 hpf), donor cells were removed and placed 
into corresponding areas in fgf3;fgf8 morpholino-injected hosts using previously 
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described fate maps (Kimmel et al., 1990 and Woo and Fraser, 1995). Mesoderm 
transplants were performed at shield stage (4 hpf) using donor tissue cells 
located at the margin and moved to the margins of fgf3;fgf8 morpholino-injected 
hosts (Kimmel et al., 1990). For endoderm transplants, donor 1 cell stage 
embryos were injected with a mixture of 2.5% Rhoadmine Alexa 568 dextran and 
sox32 mRNA and donor cells located at the margin at shield were transplanted 
into the margin of fgf3;fgf8 morpholino-injected hosts (Stafford et al., 2006). For 
double mesoderm and neural transplants, donor tissue from 2.5% Rhodamine 
Alexa 568 dextran injected hosts was transplanted at both sphere (taking cells 
from the margin) and shield (taking cells from the neural ectoderm-forming 
region) into fgf3;fgf8 morpholino-injected hosts. At 24 hpf, all hosts were 
screened using a LeicaM216F fluorescence stereomicroscope for substantial and 
tissue-specific contributions of donor tissue for subsequent analysis.  
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Figure 3.1: fgf8a mutants interact with ethanol to cause postchordal neurocranial 
defects. (A-D) Wholemounted zebrafish neurocrania at 5 days post fertilization. 
Anterior is to the left. Untreated (A) wildtype and (B) fgf8a mutants showing 
normal neurocranial development, compared to an (C) fgf8a mutant treated with 
ethanol showing variable postchordal neurocranial defects (arrowheads) and (D) 
fgf8a mutant treated with rapamycin showing variable postchordal neurocranial 







Figure 3.2: The postchordal neurocranium requires Fgf signaling. (A-E) 
Wholemounted zebrafish neurocrania with the viscerocrania removed at 5 days 
post fertilization. Anterior is to the left. (A) Wildtype, showing the prechordal 
versus postchordal regions of the neurocranium demarcated by a dashed line, 
(B) fgf8a mutant, (C) and fgf3 mutant embryos display normal neurocrania. (D) 
Variable neurocranial defects occur in 63% (n=5/8) of fgf8a-/-;fgf3+/- embryos 
(arrowheads). (E) The postchordal neurocranium in fgf8a-/-;fgf3-/- embryos is 
almost completely absent in 83% (n=5/6) of embryos, including the parachordals, 
anterior and posterior basicapsular commissure and the lateral commissures 
(arrowhead). abc- anterior basicapsular commissure, lc- lateral commissure, n- 
notochord, oc- occipital arch, pbc- posterior basicapsular commissure, pc- 
parachordals, prech.=prechordal neurocranium, postch.= postchordal 




Figure 3.3: Loss of Fgf signaling causes postchordal neurocranial defects. (A-J) 
Wholemount zebrafish neurocrania at 5 days post fertilization, with the 
viscerocrania removed. Anterior is to the left. Wildtype embryos injected with (B) 
control or (C) fgf3-morpholinos develop normal posterior neurocranial structures 
compared to (A) uninjected controls. (D and E) Un-injected and control 
morpholino-injected fgf8a mutants display normal posterior neurocranial 
development compared to (A) wildtype controls, but (F) develop severe posterior 
neurocranial loss when injected with fgf3 morpholino. (G) Wildtype injected with 
fgf8 morpholino, (H) fgf3 mutants, and (I) control morpholino-injected fgf3 
mutants display normal neurocranial development however, (J) fgf8 morpholino-




Figure 3.4: Fgfr3 and Fgf8 interact in postchordal neurocranial development. (A-
D) Wholemounted zebrafish neurocrania with viscerocrania removed at 5 days 
post fertilization. Anterior is to the left. (A and C) Control morpholino-injected 
wildtypes and fgf8a mutants display normal craniofacial development. (B) 
Injecting a suboptimal dose of fgfr3 morpholino does not affect craniofacial 
development in wildtype, however, (D) in fgf8a mutants causes variable 
postchordal neurocranial defects (arrowheads). (E) Gel showing RT-PCR 
analysis of the exon-intron boundary of fgfr3 targeted by the splice-blocking 
morpholino with cDNA isolated from either uninjected (C) or fgfr3-morpholino (M) 






Figure 3.5: The mesoderm and neural ectoderm are Fgf sources required for 
postchordal neurocranial formation. (A-E, A’-E’) 24 hours post fertilization 
confocal images of transplanted wildtype tissues into fgf3;fgf8 morpholino-
injected hosts with and without DIC, respectively; (A’’-E’’) corresponding 4 days 
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post fertilization (dpf) neurocranial wholemounts with viscerocrania removed. 
Transplanted side of neurocrania is marked with a T, and control side with a C. 
(F and G) 4 dpf postchordal neurocrania of uninjected and fgf3;fgf8 morpholino 
injected,embryos respectively. Anterior is to the left. (A,A’,A’’) Endoderm 
transplants, (B,B’,B’’) otic placode transplants, (C,C’,C’’) mesoderm only, 
(D,D’,D’’) neural ectoderm only, and (E,E’,E’’) mesoderm and neural ectoderm 
double-transplants. Endoderm and otic placode transplants fail to rescue the 
posterior neurocranium (compare A’’ and B’’ to F and G). Transplantation of 
mesoderm or neural ectoderm alone partially rescues the postchordal 
neurocranium (compare C’’ and D’’ to F and G). Transplantation of mesoderm 
and neural ectoderm together can fully rescue the postchordal neurocranium on 
the side of the embryo receiving the transplant (compare E’’ to F and G). 
Quantification of partial or full rescue is shown in graph H. scale bars=100 µm in 











Figure 3.6: The postchordal neurocranium is primarily intact in dlx3b;foxi1 
knockdown embryos. (A-B) DIC images of 24 hpf embryos and (A’B’) the same 
embryo at 5 dpf wholemounted neurocrania with viscerocrania removed. Anterior 
is to the left. (A-A’) Un-injected control embryos show an otic placode at 24 hpf 
(arrowhead) and normal posterior neurocrnaium at 5 dpf. (B-B’) dlx3b;foxi1 
double morpholino-injected embryos lack an otic placode at 24 hpf, but retain 
most of the posterior neurocranium at 5 dpf (arrowheads point to missing anterior 







Figure 3.7: The zebrafish postchordal neurocranium is derived from both 
mesoderm and neural crest tissues. (A-F) Confocal images of 5 days post 
fertilization flatmounted zebrafish neurocrania of (A,B) sox10:KikGR, (C, D) 
sox10:Cre;ubiRSG, and (E,F) dra:CreERT2;ubi:switch. Anterior is to the left. In 
C-D the red and green channels have been switched for clarity in comparisons to 
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A & B. (B, D, F) Lineage-traced cells only, neurocrania outlined in white. (A-D) 
Neural crest contributes to the prechordal elements the ethmoid plate and 
trabeculae, as well as the lateral and anterior regions of the anterior basicapsular 
commissures and the lateral auditory capsules. (E-F) Mesoderm contributes the 
parachordals, anterior and posterior basicapsular commissure, the occipital arch, 
and the lateral commissures. Schematic of results shown in G (n>10 for each 
transgenic line). abc- anterior basicapsular commissure, ac- auditory capsule, 
ep- ethmoid plate, lc- lateral commissure, n- notochord, oc- occipital arch, pbc- 






Figure 3.8: Mandibular- and hyoid-specific neural crest contributions to the 
postchordal neurocranium. (A-D’) Confocal images of sox10:kaede embryos at 
(A,C) 24 hours post fertilization and (B,B’, D, D’) 6 days post fertilization. Anterior 
is to the left in all images. (A) Photoconverted first arch neural crest cells, red 
fluorescence, contribute to the lateral anterior basicapsular commissure (B,B’, 
arrowhead, inset in B shows relative region shown in B and D). (C) 
Photoconverted second arch cells, red fluorescence, contribute to the lateral 
auditory capsule, with cells also labeled in the hyosymplectic, a second arch 
viscerocranial structure (D,D’). abc- anterior basicapsular commissure, ac- 
auditory capsule, hs- hyosymplectic, lc- lateral commissure.  
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Figure 3.9: cre expression in the drl:CreERT2 line confirms mesoderm-specific 
labeling at 6 hours post fertilization (hpf). All panels show Cre expression in 
drl:CreERT2 line at (A-A’) 6 hpf (lateral and dorsal views, respectively), (B) 8 hpf, 








Figure 3.10: Fate-mapping of head mesoderm shows the anterior/posterior 
organization of postchordal cells is set by 24 hours post fertilization (hpf). (A-C) 
Confocal images of a Kaede-injected embryo at (A) 24 hpf and (B,C) 4 days post 
fertilization (dpf). Anterior is to the left. (A) At 24 hpf Kaede was photoconverted, 
shown in red (the remaining green Kaede is not evident due to the intense green 
fluorescence from the fli1:EGFP transgene), and (B) at 4 dpf, this same embryo 
shows labeling in the postchordal neurocranium (inset shows relative position in 
the neurocranium of magnified view). (C) Red channel only, the neurocrania is 
outlined in white. (D) Schematic of panel C, with red cells depicting the 
photoconverted region. (E and E’) Graphical representation of Kaede-mediated 
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fate mapping at 24 hpf and 4 dpf. Inset in E’ shows relative position of magnified 
neurocrania. Question mark denotes a region that remained unlabeled in our 
analyses. ac- auditory capsule, o.c.-otic capsule. Scale bars=10 µm in A and 20 





















Figure 3.11: Individual kaede photoconversion fate mapping data points. (A and 
B) Graphical representation of data points of Kaede photoconversion. Anterior is 
to the left. (A) Circles denote photoconverted regions of Kaede-injected embryos 
at 24 hours post fertilization. (B) Corresponding colors demonstrate the location 





Figure 3.12: Cartilage and pre-cartilage markers col2a1a and sox9a are absent 
at 24 hours post fertilization (hpf) in fgf3;fgf8a knockdown embryos. (A-H) Images 
of 24 hpf embryos labeled with (A-D) col2a1a and (E-H) sox9a riboprobe. Dorsal 
view with anterior to the left, arrowhead denotes the anterior limit of the 
notochord. (A,E) Wildtype, (B,F) fgf8a mutant, and (C,G) fgf3 morpholino 
embryos display normal expression of both col2a1a and sox9a. However, (D,H) 
fgf3 morpholino-injected fgf8a mutants lose the expression of both col2a1a and 
sox9a (asterisk). scale bar=20 µm.  
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Figure 3.13: Kaede photoconverted endomesoderm postchordal-progenitor cells 
migrate appropriately in fgf3;fgf8a knockdown embryos. (A) Schematic of 6 hours 
post fertilization (hpf) zebrafish embryo showing the region of the embryo 
photoconverted in all subsequent experiments, dorsal to the right. (B-D) DIC 
confocal images showing the photoconverted area at 6 hpf (B, magnified region 
outlined in A), 10 hpf (C), and 4 days post fertilization (dpf) (D). Cells have 
migrated adjacent to the notochord by 10 hpf and contributed to the postchordal 
neurocranium at 4 dpf. At 10 hpf, cells in (E) control, (F) fgf8, (G) fgf3, and (H) 
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fgf3;fgf8 double morpholino-injected embryos are appropriately positioned 












Figure 3.14: Loss of has2 in Fgf knockdown embryos contributes to the 
postchordal neurocranial loss phenotype. (A-D, A’-D’) Images of 10 hours post 
fertilization embryos labeled with has2 riboprobe. Dorsal view and anterior to the 
left in all images. (E-H) Wholemounted zebrafish neurocrania with the 
viscerocrania removed at 5 days post fertilization. Anterior is to the left.  (A’-D’) 
Magnified areas of region outlined in (A-D). (A,A’) Uninjected wildtype, (B,B’) 
fgf8a mutants, and (C,C’) fgf3 morpholino-injected wildtype display normal 
expression of has2, however, (D,D’) fgf3 morpholino-injected fgf8a mutants 
exhibit loss of expression of has2 in the presumptive postchordal neurocrania (D 
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and D’). (E) Control morpholino-injected wildtype and (F) fgf8a mutants, as well 
as (G) has2 morpholino-injected wildtypes retain the postchordal neurocranium. 
However, (H) has2 morpholino-injected fgf8a mutants have a substantial loss of 
the postchordal neurocranium (arrowheads). n=notochord. scale bar=10 µm in A 




















Figure 3.15: Expression of has2 at 6 hours post fertilization does not require 
fgf3;fgf8 function. (A,B) has2 expression at 6 hpf in (A) control and (B) fgf3;fgf8a 
morpholino-injected embryos. Dorsal view. 
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Figure 3.16: Inhibition of hyaluronic acid in fgf8a mutants causes postchordal 
neurocranial defects. (A-D) Images of 30 hpf embryos stained with col2a1a 
riboprobe. Dorsal view, with anterior to the left. (E-H) Wholemount zebrafish 
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neurocrania at 5 days post fertilization, with the viscerocrania removed. Anterior 
is to the left. (A) Control-, (B) 4-MU-treated wildtype and (C) control-treated fgf8a 
siblings display normal col2a1a staining in the pre-postchordal neurocranium, 
however, (D) 4-MU-treated fgf8a mutants show a loss of col2a1a expression at 
the end of the treatment window (10-30 hpf). (E) Control- and (F) 4-MU-treated 
wildtype from 10 to 30 hours post fertilization, and (G) untreated fgf8a mutants 
have normal posterior neurocrania. However, (H) the mesoderm-derived regions 
of the neurocrania are lost in 4-MU treated fgf8a mutants (arrowheads). (I) 
Quantification of postchordal neurocranial defects including none (see E), ABC 
loss, or variable postchordal neurocranial loss (p. nc. loss) in control and 4-MU-
treated wildtype (fgf8a+/+), heterozygous (fgf8a+/-) and mutant (fgf8a-/-) 
embryos. abc- anterior basicapsular commissure, n- notochord, oc- occipital 
arch, pc- parachordals, pbc- posterior basicapsular commissure. Scale bar= 50 




Figure 3.17: Postchordal neurocranial development requires Fgf signaling during 
gastrulation. (A-D) Wholemount zebrafish neurocrania, anterior is to the left. (A 
and B) Wildtype neurocrania treated with DMSO or SU5402 develop normally. 
(C) DMSO-treated fgf8a mutants are also unaffected, however, (D) those treated 
with SU5402 from 6 to 10 hpf develop severe postchordal neurocranial loss. (E) 
Quantification of postchordal neurocranial defects including none (see A), ABC 
loss, or complete postchordal neurocranial loss (p. nc. loss) in DMSO and 
SU5402 treated wildtype (fgf8a+/+), heterozygous (fgf8a+/-) and mutant (fgf8a-/-) 
embryos. (F-H) DMSO-treated wildtype and fgf8a mutants and SU5402-treated 
wildtype express has2 appropriately; however, (I) SU5402-treated fgf8a mutants 
display a loss of expression of has2 in postchordal neurocranial precursors 
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(arrowhead denotes most anterior expression). abc- anterior basicapsular 
commissure, lc- lateral commissure, n- notochord, oc- occipital arch, pc- 
parachordals, pbc- posterior basicapsular commissure. scale bar=20 µm in A and 









Figure 3.18: Postchordal neurocranial development does not require brachury 
function or a notochord. Anterior is to the left in all panels. (A-B, A’-B’) 
hyaluronan synthetase 2 (has2) is expressed in cephalic regions at 10 hours post 
fertilization (hpf) in both wildtypes and brachury mutants. (C and D) The late 
chondrogenic marker col2a1a at 24 hpf appears in both brachury mutants and 
siblings in the forming postchordal area of the developing embryo (compare D to 
C, arrowhead in C denotes anterior notochord). (E and F) At 5 days post 
fertilization, postchordal neurocrania of brachury mutants are normal, sans 
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notochord, compared to siblings (compare F to E). scale bar=10 µm in A and 50 












Figure 3.19: Chondrocyte differentiation but not early cephalic mesoderm 
specification requires Hh signaling. All panels are anterior to the left. (A-B, A’-B’) 
At 10 hours post fertilization (hpf), the early mesoderm marker has2 is expressed 
similarly in the anterior region of smoothened mutants and wildtypes (Compare B 
to A, B’ to A’). (C and D) However, smoothened mutants display a marked 
reduction in col2a1a expression in the forming postchordal neurocranium at 28 
hpf compared to siblings (compare D to C, arrowhead denotes anterior 





Figure 3.20: Hh signaling is required after Fgf signaling for postchordal 
neurocranial development. The expression of has2 is retained following either (A-
A’) DMSO or (B-B’) cyclopamine treatment from 6-10 hours post fertilization 
(hpf). (C-D) DMSO- and cyclopamine-treated embryos from 6-10 hpf show 
expression of col2a1a at 24 hpf, however, (E) cyclopamine-treated embryos from 
10-24 hpf show a loss of col2a1a expression in the postchordal neurocranium at 




Chapter 4: pdgfra and pdgfrb synergistically interact in 
craniofacial development.1 
4.I. Abstract  
The cranial neural crest is the primary tissue source of the craniofacial skeleton 
and platelet-derived growth factors (Pdgf) are critically important in neural crest 
development. The Pdgf signaling family consists of two receptors, alpha and 
beta, of which pdgfra has a primary role in neural crest migration. It is unclear, 
however, the role pdgfrb plays in the neural crest, or whether pdgfra and pdgfrb 
have a synergistic role in craniofacial development. Using both pharmacological 
and genetic analyses, we find that loss of both pdgfra and pdgfrb in zebrafish 
results in exacerbated craniofacial phenotypes unobserved in either pdgfra or 
pdgfrb knockdown alone. Data in mouse suggests this synergistic relationship is 
conserved. In zebrafish, this phenotype is attributed to an increase in neural crest 
cell apoptosis, revealing an uncharacterized role of Pdgf signaling in the neural 
crest.  
1Authors: Neil McCarthy1, Jenna Rozacky1, Michelle D. Tallquist3, and Johann K. 
Eberhart1,2.  
1Department of Molecular Biosciences; Institute of cell and molecular biology, Waggoner 
Center for Alcohol and Alcohol Addiction Research, University of Texas, Austin, Texas. 
2Institute of Neurobiology, University of Texas, Austin, Texas.  
3Department of Medicine, University of Hawaii, Honolulu, Hawaii. 
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4.II. Introduction  
The craniofacial skeleton is derived primarily from the neural crest, and defects 
involving the neural crest lead to highly prevalent craniofacial abnormalities 
(Wilkie and Morriss-Kay, 2001; Stanier and Moore, 2004; Trainor, 2010). The 
neural crest is a pluripotent population of cells that are derived from the dorsal 
neural tube and migrate in distinct streams to the periphery of the embryo (Baker 
and Bronner-Fraser, 1997a; Basch et al., 2006). In cranial regions of the embryo, 
neural crest cells migrate into regions called pharyngeal arches (Baker and 
Bronner-Fraser, 1997a; Basch et al., 2006). These, in turn, will undergo 
morphogenetic events that result in the formation of the facial skeleton (Knight 
and Schilling, 2006). The proper induction, migration, proliferation, and survival of 
the neural crest require multiple signaling pathways, including the platelet-
derived growth factor (Pdgf) pathway (Soriano, 1997; Eberhart et al., 2008; 
Tallquist and Soriano, 2003).  
 The Pdgf signaling family consists of two receptors, alpha and beta, and 
four ligands in human and mouse, and six ligands in zebrafish (Bestholtz et al., 
2001; Tallquist and Kazlauskas, 2004; Eberhart et al., 2008). Ligands and 
receptors both homo- or heterodimerize, and upon ligand binding, 
autophosphorylation of intracellular receptor tyrosine residues occurs (Tallquist 
and Kazlauskas, 2004). This phosphorylation triggers the activation of numerous 
pathways, primarily PI3K and PLCγ, involved in processes including cell 
migration, proliferation, and survival (Tallquist and Kazlauskas, 2004). Pdgf 
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signaling is important throughout development in numerous tissues including the 
gonads, lung, intestine, skin, central nervous system, skeleton, vasculature, and 
both cardiac and cranial neural crest (Tallquist and Kazlauskas, 2004).  
Multiple studies have focused on the role Pdgfra plays in the cranial neural 
crest. Pdgfra is expressed in both premigratory and migratory neural crest cell 
populations in mouse and zebrafish (Eberhart et al., 2008; Liu et al., 2002; 
Schatteman et al., 1992). In mouse, conditional loss of Pdgfra in the neural crest 
leads to numerous cranial defects including cleft palate, a shortened skull, absent 
hyoid bone, and incomplete ossification of the basosphenoid, presphenoid, and 
alisphenoid bones (Tallquist et al., 2003).  A hypomorphic mutant of pdgfra in 
zebrafish has cleft palate as well (Eberhart et al., 2008), which is attributed to 
disrupted migration of  neural crest cells. This migratory defect has also been 
observed in mouse (Vasudevan and Soriano, 2014), highlighting the conserved 
function of this gene across species. While pdgfra is strongly implicated in 
craniofacial development, pdgfrb is currently not.    
Pdgfrb knockout mice exhibit kidney, heart, and hematological defects 
(Soriano, 1994; Mellgren et al., 2008), but no overt craniofacial abnormalities. 
Mutations specific to the PI3K-domains of both Pdgfra and Pdgfrb result in 
craniofacial defects more severe than a Pdgfra null (Klinghoffer et al., 2002). 
Furthermore, in the epicardium, Pdgfra and Pdgfrb play redundant roles in proper 
epithelial-to-mesenchymal transition (Smith et al., 2011). Collectively, these 
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results suggest that, in certain tissues, these receptors have synergistic 
functions.  
 Here, we sought to investigate the roles of the Pdgf receptors in neural 
crest development. While loss of pdgfrb does not cause any overt craniofacial 
defects, pdgfra hypomorphic mutant zebrafish show cleft palate. Double 
pdgfra;pdgfrb mutants show exacerbated defects, even when compared to a 
pdgfra hypomorphic mutant. Data in mouse reveals a conservation of this 
interaction. Using a broad Pdgf Inhibitor, Pdgf Inhibitor V, we show that 
craniofacial development requires Pdgf activity from the initiation of neural crest 
migration to early pharyngeal arch formation. Using in situ analysis, we observe 
that neural crest cells express both pdgfra and pdgfrb as they are populating the 
pharyngeal arches. The exacerbated phenotype observed in zebrafish double 
pdgfra;pdgfrb mutants may be due to increased neural crest cell death, revealing 
a previously unknown compensatory role of Pdgf receptors in neural crest cell 
survival.   
 
4.III. Results  
4.III.a. Dual knockdown of pdgfra and pdgfrb leads to exacerbated 
craniofacial defects. 
To investigate whether pdgfra and pdgfrb interact synergistically in craniofacial 
development, we generated pdgfra;pdgfrb double mutants. While pdgfrb-mutant 
embryos develop normal craniofacial skeletons (Fig. 4.1B, 4.1F, 4.1I, compared 
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to Fig. 4.1A, 4.1E), pdgfra mutant embryos exhibit cleft palate where the ethmoid 
plate fails to fuse, resulting in shorter neurocranial lengths (Fig. 4.1E,astericks, 
4.1I; Eberhart et al., 2008; McCarthy et al., 2013). Viscerocranial elements are 
quantifiably smaller as well, including the Meckel’s, palatoquadrate, pterygoid 
process, hyosymplectic, and symplectic cartilages (Fig. 4.1G, Table 4.1).  
While loss of a single allele of pdgfrb has no effect on the phenotype of 
pdgfra mutants, analysis of double pdgfra;pdgfrb mutants reveals a significantly 
reduced palate (Fig. 4.1D, arrowheads, 4.1I, Table 4.1) compared to all other 
genotypes. Neurocranial width and symplectic length are also reduced in double 
pdgfra;pdgfrb mutants compared to all other genotypes (Fig. 4.1G, Table 4.1). 
Other defects observed in double mutants include cartilage loss between the 
polar cartilages and the posterior basicapsular commissure, and loss of 
notochord ossification (Fig. 4.1G, arrows and arrowheads). Together, these data 
show that loss of both Pdgf receptors results in a synergistic interaction affecting 
the craniofacial skeleton. 
 Previous reports show conservation of pdgfra function across species 
(Eberhart et al., 2006; Tallquist et al., 2003; Vasudevan and Soriano, 2014). 
While loss of the PI3K domains of both Pdgfra and Pdgfrb genetically interact to 
recapitulate the defects observed in Pdgfra null mutants (Klinghoffer et al., 2002), 
it is unclear whether Pdgfra and Pdgfrb interact in the neural crest specifically, or 
the breadth of Pdgf signaling function in craniofacial development. To test this, 
we generated neural crest conditional Pdgfra;Pdgfrb null mice via Wnt1:Cre 
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mediated excision. Indeed, these mice have exacerbated craniofacial defects 
including reduced basisphenoid, alisphenoid, and hyoid bones (Fig. 4.2C 
compared to Fig. 4.2A and 4.2B, Fig. 4.2D) compared to either single mutant 
alone. These data reveal conservation of the Pdgfra;Pdgfrb interaction in 
craniofacial development. 
 
4.III.b. Pdgf activity is required between 6 and 30 hours post fertilization for 
proper craniofacial development.  
To determine when craniofacial development requires Pdgf function, we utilized 
PDGF Inhibitor V (Sigma), which broadly inhibits Pdgf activity. In an initial dose 
response analysis, three concentrations of inhibitor were tested on wild-type fish, 
1, 1.5, and 2 uM, at a broad time window from 6 hours post fertilization (hpf), or 
the beginning of gastrulation, to 30 hpf, when most neural crest cells have 
condensed within the pharyngeal arches. A concentration of 1 µM did not cause 
any gross craniofacial defects (data not shown) and 2 µM resulted in an increase 
in embryo death (data not shown). The most consistent and penetrant 
phenotypes occurred at a concentration of 1.5uM (Fig. 4.3). At high 
concentrations, this inhibitor has been shown to inhibit Kit function, required in 
melanocyte formation. However, we did not observe any gross alterations to 
melanocytes, suggesting that at this concentration the inhibition is most likely 
specific to Pdgf (Fig. 4.4).  
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 We next narrowed the window required for Pdgf function in craniofacial 
development. In these analyses the craniofacial phenotypes were marked as 
either unaffected, variable neurocranial defects, or complete loss of the palate 
(see Fig. 4.3A-C). A time window of inhibitor treatment from 12 to 30 hpf shows 
more severe defects compared to a time window of 18 to 30 hpf (Fig. 4.3). These 
data suggest that the function of Pdgf is required during a time window that 
encompasses both neural crest migration and pharyngeal arch formation. 
 
4.III.c. pdgfra and pdgfrb have overlapping expression in the head 
beginning at 20 hours post fertilization.  
Our previous analyses show that both receptors function synergistically in proper 
craniofacial development, and that this function is required between 6 and 30 hpf. 
We know that pdgfra is expressed and required cell-autonomously in the neural 
crest for proper craniofacial development (Eberhart et al., 2008). It was unclear, 
however, when or where pdgfrb was expressed during the crucial time window 
Pdgf is required. To test whether pdgfrb is expressed in the neural crest, we used 
fluorescence in situ of pdgfrb in a fli1:EGFP transgenic, which labels the neural 
crest and vasculature, to look for co-localization. Indeed, at both 24 and 36 hpf, 
pdgfrb expression occurs in the neural crest and the vasculature (Fig. 4.5A-A’, 
4.5B-B’; Wiens et al., 2010). These data show that pdgfrb is expressed in the 
neural crest during the time window that Pdgf signaling is required.    
 To pinpoint the timing of dual expression of pdgfra and pdgfrb in the 
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neural crest, we used double fluorescent in situ analysis. Prior to 20 hpf, we 
detect no overlap in the expression of pdgfra and pdgfrb (not shown). By 20 and 
24 hpf, both pdgfra and pdgfrb are expressed throughout the first and second 
arches (Fig. 4.6A-A’’, 4.6B-B’’). This is dual expression remains even at 36 hpf 
(Fig. 3.6C-C’’). The data suggest that neural crest cells express both pdgfra and 
pdgfrb during the window that Pdgf function is required for craniofacial 
development.  
 
4.III.d. Loss of both pdgfra and pdgfrb results in increased neural crest cell 
death. 
Loss of both pdgfra and pdgfrb led to markedly more severe craniofacial 
phenotypes compared to either loss of pdgfra or pdgfrb alone. Cell death is not 
observed by a singular loss of pdgfra (McCarthy et al., 2013). However, ethanol 
treatment causes increased neural crest cell death in pdgfra mutants (McCarthy 
et al., 2013), demonstrating that in certain contexts Pdgf signaling is critical for 
neural crest cell survival. Therefore, we analyzed cell death at 24 hpf in double 
pdgfra;pdgfrb mutants and compared them to the single mutants. Consistent with 
our previous results, pdgfra mutants do not exhibit any increase in cell death 
(McCarthy et al., 2013), but in the absence of both receptors, we see a 
synergistic and significant increase in cell death (Fig. 4.7B-B’, 4.7A-A’, 4.7C). 
Cell proliferation was not affected when comparing these two groups (data not 
shown). Loss of pdgfrb alone also does not cause any increase in cell death 
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compared to wildtype siblings (neural crest cell death: pdgfrb-/-  mean=1.29, 
pdgfrb+/+  mean=2.5, p=0.175). At 30 hpf, both cell death and proliferation are 
unaffected in double pdgfra;pdgfrb mutants compared to all other genotypes (not 
shown). Together, these data suggest that cell death may contribute to the 
exacerbated craniofacial phenotype observed in double pdgfra;pdgfrb mutants.  
 
4.IV. Discussion and future directions  
We show that pdgfra and pdgfrb synergistically interact during craniofacial 
development. Loss of both receptors leads to exacerbated neurocranial and 
viscerocranial defects in zebrafish, and neural crest conditional Pdgfra;Pdgfrb 
knockouts in mouse similarly reveal exacerbated craniofacial defects not 
observed in either single knockout alone. This suggests a high conservation of 
the Pdgfra;Pdgfrb interaction across species. In zebrafish, we go on to show that 
loss of Pdgf function during a time window when both receptors are expressed in 
the neural crest, is critical for proper craniofacial development. Finally, we find 
evidence that implicates neural crest cell death as a possible factor in the 
exacerbated phenotype observed in pdgfra;pdgfrb mutants.  
 Numerous publications have uncovered the functional role Pdgfra plays in 
craniofacial development (Eberhart et al., 2008; Hoch and Soriano, 2003; 
Tallquist and Kazlauskas, 2004; Vasudevan and Soriano, 2014). Pdgfrb, on the 
other hand, has never been observed to cause craniofacial defects (Soriano, 
1994; Wiens et al., 2010). Loss of the PI3K domains of both Pdgfra and Pdgfrb 
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genetically interacted to cause craniofacial defects as severe as a Pdgfra null 
(Klinghoffer et al., 2002). However, it remained unclear to what extent both Pdgf 
receptors functioned in craniofacial development and in the neural crest 
specifically. Here, we show that in neural crest-conditional Pdgfra;Pdgfrb mutant 
embryos, a more exacerbated craniofacial phenotype is observed compared to 
either Pdgfra or Pdgfrb neural crest-conditional knockouts alone. While Pdgfra 
can completely compensate for loss of Pdgfrb, our data suggests that in neural 
crest-conditional Pdgfra mutants, Pdgfrb has partial compensatory function. It will 
be of interest to see whether a specific tyrosine kinase residue of Pdgfrb allows 
this partial compensation. Data from Klinghoffer et al. would suggest that the 
PI3K activating-residue would be a strong contender for this role (Klinghoffer et 
al., 2002).  
 Our data implicates Pdgf to be important in craniofacial development in a 
window encompassing gastrulation to pharyngeal arch condensation. Future 
studies will aim to further assess the minimal window of Pdgf requirement for 
craniofacial development. Pdgfra is required for proper neural crest migration 
(Eberhart et al., 2008; Vasudevan and Soriano, 2014), and in zebrafish, this 
occurs beginning at 12 hpf. Inhibiting Pdgf signaling between 12 and 30 hpf 
resulted in less severe craniofacial defects compared to the 6 to 30 hpf time 
window. This could be due to the fact that inhibitor activity is often delayed 
compared to administration of the inhibitor. Thus, the timing that Pdgf function is 
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required could be condensed from just prior to migration, beginning at 10 hpf, to 
30 hpf.  
 While the inhibitor analysis suggests a broad time when Pdgf signaling is 
required in craniofacial development, our in situ expression analysis reveals a 
much more condensed window of time when pdgfra and pdgfrb are co-expressed 
in the neural crest. Indeed, our double fluorescent in situ analysis reveals pdgfra 
and pdgfrb co-expression occurring in the arches beginning at 20 hpf. We know 
that pdgfra is expressed and required in the neural crest beginning at the time of 
neural crest migration at 12 hpf (Eberhart et al., 2008), while our data shows 
pdgfrb expression in the neural crest beginning around 20 and 24 hpf. Thus, if 
the synergistic effects of pdgfra and pdgfrb are specific to the neural crest, it 
would suggest that pdgfrb is dispensable for early neural crest migration. It will 
be of interest to determine the extent of overlap of expression between pdgfra 
and pdgfrb in the neural crest, which may implicate the timing of the interaction 
between these two receptors.  
 The craniofacial defects associated with pdgfra loss-of-function embryos 
are due to neural crest migratory defects (Eberhart et al., 2008; Vasudevan and 
Soriano, 2014). At this point, it is unclear whether there is a further exacerbation 
of neural crest migration in pdgfra;pdgfrb double mutants. However, our in situ 
analysis suggests that pdgfrb may be dispensable for early migration of the 
neural crest. We did observe increased cell death in the neural crest beginning at 
24 hpf in our pdgfra;pdgfrb double mutants compared to single pdgfra mutants. 
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This is a time when we know both receptors are expressed in the neural crest. In 
the future, we will test the involvement of cell death in the craniofacial phenotype 
by blocking apoptosis in pdgfra;pdgfrb double mutants. Finally, it will be important 
to investigate whether a similar mechanism in mouse occurs, to lend further 
support of the conserved nature of Pdgf signaling in the craniofacial skeleton of 
vertebrates.  
  
4.V. Materials and methods  
4.V.a. Zebrafish care and use 
All embryos were raised and cared for using established protocols with IACUC 
approval. Lines used in this study include the pdgfrab1059(Eberhart et al., 2008), 
pdgfrbum148(Kok et al., 2014), and the transgenic Tg(fli1:EGFP)y1(Lawson and 
Weinstein, 2002) called fli1:EGFP in the text. Embryos were treated with 1, 1.5, 
and 2 µM Pdgf Inhibitor V (Calbiochem) from a 10mM stock in DMSO diluted in 
embryo medium.  
4.V.b. Mice 
Mouse lines used include pdgfrafl;fl(Tallquist et al., 2003), pdgfrbfl;fl(Richarte et al., 
2007), and Wnt1:Cre (Danielian et al., 1998). Skeletal preparations were 
performed as described (Klinghoffer et al., 2002).  
4.V.c. Immunohistochemistry and In situ hybridization 
Embryos were fixed and processed as described previously (Maves et al., 2002; 
McCarthy et al., 2013) using anti-active caspase 3 (Promega) and anti-phospho 
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histone H3 (Sigma) primary antibodies with AlexaFluor 568 secondary 
antibodies. Fluorescent in situ hybridization was performed as described 
previously (Jowett and Yan, 1996). Were performed, cell death was counted 
using anti-active caspase 3- positive neural crest cells, marked via fli:eGFP, and 
a students T-test was performed for statistical analysis.  
4.V.d. Zebrafish cartilage staining 
5 day old embryos were stained with Alcian Blue and Alizarin Red for cartilage 
and bone (Walker and Kimmel, 2007), then flat mounted (Kimmel et al., 1998). 
Images were taken with a Zeiss Axio Imager-AI scope and measurements of 
neurocranial and viscerocranial elements were performed as described 
(McCarthy et al., 2013). All graphs were made using Microsoft Excel 2011. We 
used ANOVA and Tukey-Kramer post-hoc test for all statistical analysis.  
4.V.e. Confocal microscopy and figure processing 
Confocal z-stacks were collected on a Zeiss LSM 710 using Zeb software. All 









4.VI. Figures  
 
 
Figure 4.1: pdgfra and pdgfrb synergistically interact in craniofacial development. 
(A-D) 5 dpf flatmounted zebrafish neurocrania and (E-H) viscerocrania. Anterior 
is to the left. (A,E) Wildtype and (B,F) pdgfrb mutants display normal craniofacial 
skeletons, while (C,G) pdgfra mutants display a shortened neurocrania, cleft 
palate (asterisk) and smaller viscerocranial elements. (D,H) pdgfra;pdgfrb double 
mutants display synergistic reductions of the neurocranium (arrowheads) and 
loss of the posterior neurocranium between the parachordals and the posterior 
basicapsular commissure (arrows) compared to pdgfra, pdgfrb, and wildtype 
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siblings.(I) Graph depicting neurocranial length measured from the tip of the 
anterior palate to the posterior base of the neurocranium. Similar bar shading 
represents not statistically significant (ANOVA, p=<0.5). ep=ethmoid plate, 
tr=trabeculae, pbc=posterior basicapsular commissure, pc= parachordals. scale 








Figure 4.2: Synergistic skeletal abnormalities observed in 
pdgfrafl/fl;pdgfrbfl/fl;wnt1:Cre mice. (A-C) A ventral view of the skull derived from 
E16.5 embryos with corresponding genotypes listed below each panel. Anterior 
is up. (D) Individual craniofacial skeletal elements dissected and flatmounted in 
one wildtype and three pdgfrafl/fl;pdgfrb+/+;wnt1:Cre+ and 
pdgfrafl/fl;pdgfrbfl/fl;wnt1:Cre+ mice. In pdgfrafl/fl;pdgfrbfl/fl;wnt1:Cre+ the alisphenoid 
and basisphenoid is reduced, while the hyoid fails to form compared to 
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pdgfrafl/fl;pdgfrb+/+;wnt1:Cre+ mice. as=alisphenoid, bs=basisphenoid, hy= hyoid, 












Figure 4.3: Pdgf signaling is required between 6 and 30 hours post fertilization for 
proper craniofacial development. (A-C) 5 dpf wholemounted zebrafish treated 
with 1.5 µM PDGF inhibitor V and stained for cartilage and bone, anterior is to 
the left. (A) Wildtype, (B) mild, showing reduced palate (asterisk) and broken 
trabeculae (arrowhead) and (C) severe reductions in the neurocrania 
(arrowhead) of PDGF inhibitor V treated embryos. Graph depicts percentage of 
embryos treated with PDGF inhibitor V at varying time windows and resulting 
phenotypes observed shown in shaded bars that correspond to the phenotypes 





Figure 4.4: PDGF Inhibitor V treatment does not affect melanocyte formation. (A-
B) Full-mount DIC images of 40 hpf zebrafish embryos treated with either DMSO 








Figure 4.5: The neural crest expresses pdgfrb in zebrafish at 24 and 36 hours 
post fertilization. (A-A’) A 24 hpf fli1:EGFP transgenic embryo and labeled for 
pdgfrb mRNA via fluorescence in situ hybridization, anterior is to the left.  (B-B’) 
A 36 hpf fli1:EGFP transgenic embryo and labeled for pdgfrb mRNA via 





Figure 4.6: Neural crest cells express both pdgfra and pdgfrb beginning at 20 
hours post fertilization. (A-A’’) A 20, (B-B;;) 24, and (C-C’’) 36 hpf embryo stained 
for both pdgfra and pdgfrb mRNA via fluorescence in situ hybridization. scale 









Figure 4.7: pdgfra;pdgfrb mutants show increased neural crest cell death at 24 
hours post fertilization. (A-A’, B-B’) 24 hpf fli1:EGFP (pseudo-colored blue) 
zebrafish embryo with corresponding genotypes listed left of panels, stained for 
active caspase 3 (shown in grey). Anterior is to the left. (C) Graph representing 
number of active caspase 3 positive neural crest cells in corresponding 






Table 4.1: pdgfra;pdfgfrb double mutants show statistically significant differences 
in craniofacial measurements. Compared to all other genotypes, excluding 
pdgfra-/-;pdgfrb+/+, pdgfra-/-;pdgfrb+/-, and pdgfra-/-;pdgfrb-/- genotypes, pdgfra-
/-;pdgfrb+/+, pdgfra-/-;pdgfrb+/-, and pdgfra-/-;pdgfrb-/- genotypes have 
statistically significant differences in neurocranium (nc) length, nc width, Meckels 
cartilage area (Mc), palatoquadrate area (pq), length of pterygoid process, 
hyosymplectic area, and symplectic length, but not in ceratohyal (ch) area. 
Pdgfra-/-;pdgfrb-/- genotypes have significantly different nc length, nc width, and 
sympectic length when compared to pdgfra-/-;pdgfrb+/+ and pdgfra-/-;pdgfrb+/- 
genotypes.  Y= statistically significant, N= not statistically significant (ANOVA, 







Chapter 5: Summary and future directions 
 
The variability and severity of birth defects are modulated by both genetics and 
the environment (Carinci et al., 2007; Das et al., 2004; Green et al., 2004; 
Jacobson et al., 2006; Wu et al., 2014). A highly prevalent and variable birth 
defect is FASD. Although it is environmentally induced, genetics contributes to 
the risk for FASD (Das et al., 2004; Green et al., 2004; Jacobson et al., 2006). 
My work has provided important insight into the role genetics plays in the 
variability and susceptibility to ethanol-induced craniofacial defects.  
 I helped develop a zebrafish model to uncover gene-ethanol interactions 
and apply these findings to humans. In chapter 2, I showed that pdgfra interacts 
with ethanol in zebrafish and found support for this interaction in a human 
dataset. In zebrafish, not only does ethanol increase the severity of the mutant 
phenotype, it causes haploinsufficiency in heterozygous siblings. My findings 
demonstrated that pdgfra and ethanol synergistically interact, due to a role for 
Pdgfra in protecting against ethanol-induced neural crest apoptosis. I showed 
that the mechanism of the interaction was due to combinatorial inhibition of the 
PI3K/mTOR pathway. Collectively, how pdgfra functioned in an optimal (control) 
environment did not translate to how it functioned in a less desirable environment 
(ethanol). Thus, phenotypes generated by synergistic gene-ethanol interactions 
are not readily predicted by mutant phenotypes in other contexts. In fact, it 
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suggests that the function of a gene can only ever be completely cataloged when 
tested in multiple environmental contexts, including ethanol.     
 My work with pdgfra suggested that ethanol may interact synergistically 
with other growth factor pathways and so I tested if fgf8a mutants were ethanol 
sensitive. While the pdgfra and ethanol interaction caused defects specific to 
neural-crest derivatives of the craniofacial skeleton, ethanol disrupted 
postchordal, mesoderm-derived, structures in fgf8a mutants. Because the 
development of this portion of the skull is very poorly characterized, I focused my 
efforts to understand Fgf function in the normal development of this structure in 
chapter 3. I recapitulated the fgf8a-ethanol phenotype by blocking both fgf8a and 
fgf3. I found that Fgf signaling from the brain and mesoderm was essential to 
specify the precursors of the postchordal neurocranium. Following this 
specification, Shh signaling was essential for proper differentiation of the 
postchordal mesoderm precursors. The neural ectoderm is the most likely source 
of Shh signaling, as the notochord appears dispensible for proper postchordal 
neurocranial formation.  These results provided clarity into the mechanism of how 
Fgfs function in proper postchordal neurocranial development, and provided new 
developmental insights into this relatively neglected organ in research. As the 
fgf8a;fgf3 and fgf8a-ethanol interactions showed mirroring phenotypes, it 
suggested that ethanol may broadly attenuate growth factor signaling pathways. 
Thus, the pdgfra-ethanol interaction may, in part, be due to combinatorial loss of 
signaling across Pdgf receptors. I tested this in chapter 4.  
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There are two Pdgf receptors and, unlike pdgfra, pdgfrb has not been 
implicated in craniofacial development. However, through genetic analysis, I 
found that double pdgfra;pdgfrb mutants have a more severe craniofacial 
phenotype compared to either a pdgfra or pdgfrb mutant alone. Conservation of 
this interaction was shown in mouse. Lastly, data in zebrafish shows that cell 
death might contribute to the severe craniofacial phenotype found in 
pdgfra;pdgfrb double mutants. The full mechanism of this interaction and whether 
it fully phenocopies the ethanol-pdgfra interaction is still of ongoing interest.  
Collectively, my dissertation focuses on how growth factor signaling and 
the environmental ethanol exposure can synergistically interact during 
craniofacial development. Specifically, I focused on pdgfra and fgf8a as ethanol-
sensitive genes. While I did uncover a specific mechanism involving 
PI3K/AKT/mTOR signaling as the target of the pdgfra-ethanol interaction, this still 
needs to be tested in my fgf8a-ethanol interaction. Also, I focused on the 
craniofacial defects associated with these gene-ethanol interactions. Significant 
neurological defects are present in FASD (Calhoun and Warren, 2997; Hoyme et 
al., 2005; Jones, 2011; Moore et al., 2014), and we know that both pdgfra and 
fgf8a have functions in brain development (Echevarria et al., 2005; Zhu et al., 
2014). Future studies will be aimed at elucidating whether these gene-ethanol 
interactions cause neurological defects. Furthermore, there are numerous genes 
involved in growth factor signaling that may interact with ethanol. These will need 
to be tested to further support my hypothesis that genes involved in growth factor 
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signaling broadly interact with ethanol. Lastly, with the data that I have 
generated, it would be of high interest to propose therapeutic treatments for 
FASD specifically targeting growth factor signaling genes in especially prone 
individuals.   
 
5.I. FUTURE DIRECTIONS 
5.I.a. Mechanistic understanding of the fgf8a-ethanol interaction 
Two main questions remain concerning the fgf8a-ethanol interaction: 1) Is the 
fgf8a-ethanol interaction caused by a mechanism similar to the pdgfra-ethanol 
interaction? and, 2) Is the cause of the postchordal neurocranial loss the same 
between the fgf8a-ethanol interaction and the fgf8a;fgf3 interaction? Based on 
my pdgfra-ethanol work, I hypothesized that ethanol interacts with genes 
involved in activation of growth factor signaling at the level of mTOR. Similarly, 
Fgf receptors activate growth factor signaling and so the fgf8a-ethanol interaction 
may impede proper Fgf function at the level of mTOR. 
 I have already shown that blocking mTOR in fgf8a mutants recapitulates 
the ethanol-induced fgf8a defects. This supports my theory that ethanol impedes 
proper growth factor signaling at the level of mTOR, however, further analysis is 
required. Direct evidence that mTOR function is disrupted in the fgf8a-ethanol 
would require protein analysis showing decreased phosphorylated forms of 
downstream constituents. My model predicts that increasing mTOR signaling, via 
L-Leucine supplementation, would rescue fgf8a mutants treated with ethanol.  I 
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would test whether cell death contributes to the ethanol-induced fgf8a effects by 
staining for active caspase-3 in the Dra:Cre transgenic background, which labels 
cephalic mesoderm. If ethanol inhibits growth factor signaling downstream of 
receptor activation at the level of mTOR, I would expect to observe cell death in 
cephalic mesoderm. Collectively, these results would support my hypothesis that 
ethanol broadly interacts with growth factor signaling pathways through 
synergistic inhibition of mTOR signaling leading to apoptosis.  
In the case that mTOR is inhibited, but cell survival appears unaffected, it 
would suggest that the fgf8a-ethanol interaction is due to a similar 
misspecification defect found in fgf8a;fgf3 double mutants. My work in chapter 3 
showed that the cephalic paraxial mesoderm was misspecified in fgf3;fgf8a 
double mutants, as evidenced by a loss of has2 expression. I would perform 
protein analysis on Fgf3 and Fgf8 ligands to determine if they are directly 
decreased in ethanol, because studies using NIH 3T3 cells suggests that mTOR 
targets translation of fgf10 ligand directly (Hertzler-Schaefer et al. 2014). If the 
mechanism occurs through mTOR, I would expect to see a rescue of 
specification with increased mTOR activity in ethanol-treated fgf8a mutants. 
Collectively, these results would demonstrate that ethanol can disrupt distinct 
cellular processes, apoptosis versus specification, via the same mechanism of 
mTOR inhibition.  
The other alternative is that the fgf8a-ethanol interaction is independent of 
mTOR inhibition. Ethanol has been shown to reduce Erk activity (Sanna et al., 
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2002), a major effector of Fgf signaling. This could be easily tested via Erk 
inhibitor analyses recapitulating the fgf8a-ethanol interaction. Although my overall 
hypothesis predicts growth factor signaling genes to interact with ethanol at the 
level of mTOR, due to the many signaling pathways growth factors feed into, 
ethanol may in fact interact with them through multiple mechanisms.  
   
5.I.b. Other defects associated with gene-ethanol interactions 
My work has focused primarily on craniofacial defects associated with gene-
ethanol interactions. However, FASD also causes debilitating neurological 
defects (Calhoun and Warren, 2997; Hoyme et al., 2005; Jones, 2011; Moore et 
al., 2014). Furthermore, both pdgfra and fgf8a have functions in neural tissues. 
For instance Pdgfra is critical in developing oligodendrocytes (Zhu et al., 2014) 
and Fgf8 is necessary to pattern brain regions, including the midbrain-hindbrain 
boundary and rhombomere 4 (Echevarria et al., 2005). Experiments that could be 
utilized to elucidate whether ethanol disrupts the neurological functions of these 
genes include histological analysis of brain regions and immunohistochemistry of 
markers of neural cell types including the oligodendrocyte marker O4+ 
(Ackerman et al., 2015), and the hindbrain-marker Kitb (Staudt et al., 2015). 
There are also numerous transgenic zebrafish lines labeling neural-specific cell 
types and regions that could be utilized to investigate neurological defects in 4D 
in these gene-ethanol interactions, including the oligodendroycte and purkinje 
neuron labeling transgenic olig2:RFP (Shin et al., 2003) and the neuroepithelial 
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transgenic nestin:EGFP (Kaslin et al., 2009). There is a possibility, however, that 
more subtle behavioral defects could be caused by these gene ethanol 
interactions, rather than physical defects.  
 To test whether gene-ethanol interactions can disrupt behavior, new 
behavioral analyses that have just recently been characterized in zebrafish FASD 
models can be utiilzed (Fernandes et al., 2015a, Fernandes et al., 2015b). In 
these tests, wild-type zebrafish exposed to a subteratogenic level of ethanol at 
an early developmental timepoint showed behavioral deficits months later 
(Fernandes et al., 2015a). Since both pdgfra and fgf8a mutants are embryonic 
lethal, only heterozygous siblings exposed to ethanol could be tested for gene-
ethanol behavior deficits. Whether genetic background influences enhancement 
of ethanol-induced behavioral deficits remains to be seen. These experiments 
are currently underway.  
 
5.I.c. Screening for ethanol sensitivity in other growth factor signaling 
genes 
My dissertation shows genes involved in growth factor signaling interact with 
ethanol. At least for pdgfra, this interaction occurs at the level of mTOR, and so 
mutations in any gene involved in activating this pathway could potentially show 
an interaction with ethanol. Furthermore, any gene, which naturally functions to 
inhibit this pathway, could protect against ethanol teratogenesis. The easiest and 
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quickest way to uncover these genes would be to perform zebrafish genetic 
screens.   
Many thousand zebrafish mutants are available and genome-editing 
technologies have advanced to where generating new zebrafish mutants is 
straightforward. Genes that I would hypothesize to interact with ethanol would be 
those involved in the transduction of the mTOR pathway, including mTOR, 
eIF4B, upstream activator AKT as well as the PI3K inhibitor pten. There are 
numerous growth factor signaling genes that should be tested as well, including 
those implicated in my work, including pdgfrb as well as the Pdgf ligands, and 
fgfr3 and fgf3. Studies, in mostly in vitro assays, have implicated ethanol 
interacting with other growth factor genes, including insulin-like receptor 
(McClure et al., 2011; de la Monte et al., 1999; Sasaki et al., 1994), BDNF (de la 
Monte, 2000), TGFB (Jegou et al., 2013), and VEGF (Feng et al., 2005). Lastly, 
our efforts focusing on growth factor genes interacting with ethanol could be 
focused through our collaboration with the Foroud lab, whom have generated 
human data on gene by ethanol interactions.  
 
5.I.d. Developing treatments and therapies to mitigate ethanol 
teratogenesis 
A driving motivation in the health sciences is improving health care. FASD affects 
nearly 1% of the population (Sampson et al., 1997). With unplanned pregnancies 
accounting for nearly 50% of all pregnancies (Finer and Henshaw, 2006), fetal 
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exposure to ethanol is a problem that will not likely end soon. How do we mitigate 
the effects of ethanol on fetus health?  
 Numerous studies have focused on the importance of nutrition in reducing 
ethanol effects on the fetus (see review Young et al., 2014). Research has also 
shown that supplementation with either retinoic acid (Marrs et al., 2010), choline 
(Hunt, 2012), or shh (Aoto et al., 2008; Li et al., 2007) can reduce ethanol-
induced defects in various animal models. However, application of shh would be 
difficult to implement, and data on retinoic acid suggests these supplements may 
not be advisable to use during pregnancy (Arnhold et al., 2002). My work adds L-
Leucine to this list of potential therapeutic supplements and is not likely to cause 
birth defects on its own. Whereas my study focused on L-leucine 
supplementation rescuing ethanol-induced defects in a genetic-dependent 
context, these other studies were more general in the supplementation of these 
nutrients/genes in wildtype genetic backgrounds with high doses of ethanol. 
Thus, it may be important in the future to consider genetic background in 
implementing appropriate treatments.  
Although my hypothesis that growth factor signaling genes are especially 
sensitive to ethanol needs to be further tested, it is possible to imagine 
treatments being implemented in the future to help reduce the effects of ethanol 
during pregnancy by targeting growth factor genes. The majority of work focusing 
on growth factors in the clinical setting is in their inhibition, primarily because of 
their upregulation in cancer (Brooks et al., 2012; Demoulin and Essaghir, 2014). 
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There are a few cases where growth factors are used therapeutically, namely in 
wound healing aspects (Finnson et al., 2013; Greenhalgh et al., 1990; Penn et 
al., 2012). With the coming age of personalized medicine, numerous aspects of 
health including genetics will be considered to determine appropriate treatments 
and therapeutics to a given disease or life-state. Given the paucity of information 
available on gene-environment interactions, continued work in animal models, 
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